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Abstract 
 
This thesis is embedded in the pharmaceutical analytical research field and has 
envisaged the development of different analytical methods by a chemometric approach. 
In this context, pseudostationary phases have been studied and applied on electrokinetic 
chromatography and analytical methods have been developed in order to be used in the 
field of quality assurance.  
This thesis project has focused on multivariate strategy development of capillary 
electrophoresis methods facing up different pharmaceutical issues including those 
related to classification problems. The multivariate approach has made it possible to get 
the most amount of information with time and cost savings, obtaining additional 
information on the interactions between the factors studied.  
Six projects focused on the optimization of methods for simultaneous 
determination of active ingredients and their impurities in pharmaceutical formulations. 
 The drugs under consideration were Glibenclamide, Zolmitriptan, Captopril, 
Hydrochlotothiazide, Ambrisentan, Diclofenac.  
After the optimization phase, the methods studied were validated according to the 
ICH guidelines to ensure the appropriate performance of the method and reliable data 
for the specific application to which they were intended. Molecular Modeling and NMR 
techniques were investigated as the basis for the separation of analytes in the presence 
of complex pseudostationary phases such as microemulsions and cyclodextrins. 
 The pseudostation phases study was further investigated by conducting a 
multivariate study of a micellar electrokinetic chromatographic and microemulsion 
electrokinetic chromatography solvent modified studying the complexation and 
separation mechanisms amoung drugs and pseudostationary phases.  
The method was applied for the determination of Sulpiride, Ambrisentan and 
Diclofenac. Multivariate classification methods were used to analyze some types of 
green tea of different botanical and geographical origin. 
To conclude the Quality by Design approach was applied to investigate and study 
in depth the critical process parametes of dried blood spot sample preparation with 
liquid- chromatography mass spectrometry analysis. 
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1. Introduction   
 
Quality is a benchmark of excellence for the health safety, is the process of 
vouching for integrity of products to meet the standard for the proposed goal. 
Quality assurance is a wide concept that covers all aspects that collectively or 
individually impact the quality of the product. That is, the sum of organized 
arrangements that are made with the aim of ensuring pharmaceutical product satisfying 
the required quality for the intended use. Quality assurance play the role of sentinel, 
ensuring adherence to regulations as well as identifying possible shortfalls and making 
recommendations for improvements that may be made over time.  
The quality control of active pharmaceutical ingredients is a prerequisite for the 
safe use of drug products. In the drug life cycle, drug impurity profiling plays a key role 
for assuring the safety and efficacy of a dosage form.  
Since the world has gathered together to harmonize its practices and guides and 
the launching of the FDA current good manufacturing practices – the cGMP, for the 
21st century, there has been a growing awareness for the significance of the quality of 
the pharmaceutical products. 
Impurities within pharmaceutical products provide no benefits to the patient, and 
for many years regulators have wrestled with different strategies to address this problem 
[1]. Impurities will always be regarded as a ‘necessary evil’, but with the advent of 
more safety based limits to control related substances (ICH Q3A-D and M7) there is an 
increasing acceptance that control strategies based on process understanding will allow 
an appropriate tolerability of risk (patient needs versus commercial necessities) [1]. 
The control of impurities is a fundamental part and a critical analytical issue of the 
quality control of drug products. The development of suitable separation analytical 
methods for impurity assay is characterized by the need of adequate sensitivity and 
selectivity [2], which can only be reached by a comprehensive investigation of the 
analytical system. 
In present days, analytical method failure is becoming more common especially 
during method transfer as well as in quality control departments. 
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Chromatographic methods are more commonly employed as right analytics at all 
the stages during the product life cycle. Common analytical methods for content 
uniformity, assay, impurity profile, and stability indicating assay are based on high 
performance liquid chromatographic (HPLC) or ultraperformance liquid 
chromatographic (UPLC) or rapid resolution liquid chromatography methods (RRLC). 
Regarding chromatography, due to complex parameters involved in the method 
development phase, low sensitivity, selectivity, and inadequate understanding between 
method performance and method parameters, always the revalidation protocol has been 
recommended in procedures [3]. 
Capillary Electrophoresis (CE) offers many advantages in analytical laboratories 
in spite of chromatographic techniques due to its low cost, small sample volume, high 
efficiency, high separation power, eco-friendly characteristics and possibility of 
performing chiral separations directly dissolving the chiral selector in the background 
electrolyte [4]. 
Currently the implemented analytical methods were based on one factor at a time 
(OFAT), in which one parameter alone is optimized for the expected response whilst 
others remained constant. This practice always yielded a narrow robust behavior of the 
method for instrumental variables used in method development phase. Hence the 
present strategy of analytical method (i.e., OFAT) development has high risk in method 
failure and always requires revalidation protocol after method transfer or alternative 
method development; there by it has been increasing the cost of the method [3]. 
Design Space (DS) concept finally marks the difference between the univariate 
optimization process approach, that allows only a single optimum point to be found, and 
experimental design approach that instead allows an optimum multidimensional zone to 
be obtained. In particular, regulatory documents are strongly recommending the 
implementation of Quality by Design (QbD) approach that implies the definition of a 
multidimensional zone, named Design Space, within which all combinations of the 
variables under study assure the quality of the process with defined probability.  
QbD is a science risk-based approach that focuses on safety, efficacy, and quality 
throughout the product’s life cycle. 
Implementation of QbD concept is expected to strengthen the concept of “right 
analytics at right time” which plays significant role in drug product development cycle. 
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The process of developing and validating analytical methods parallel to product QbD 
benefits the quality of the product furthermore, with high degree of assurance, and it 
may be similarly benefitted. The dependence of pharmaceutical development and 
manufacture on robust analytical data intensifies the need for rigor in analytical method 
development and increasingly an analytical QbD. 
CE is widely used as enantioseparation technique mainly due to its high efficiency 
and to the possibility of adding the chiral selector directly to the background electrolyte 
(BGE). In contrast to chromatography, either the binding constant difference between 
the enantiomers and the chiral selector or the mobility difference of the corresponding 
diastereomeric complexes may both result in enantioseparations [5]. 
Stereospecific recognition of chiral molecules is an important issue in various 
aspects of chemistry and life sciences [6].  
Most often, the so called direct approach has been realized, in which 
stereoisomers, in most cases enantiomers, are separated in a chiral environment 
containing a chiral selector either fixed to an immobile support or added to the mobile 
phase or background electrolyte in chromatographic or electromigration techniques, 
respectively. This approach is based on the formation of transient diastereomeric 
complexes between the selector and the analyte enantiomers in thermodynamic 
equilibria [6]. 
As a matter of fact, CE does not provide any direct information regarding 
chemical and structural mechanism of analyte-pseudostationary phases interactions, 
therefore further techniques such as Nuclear Magnetic Resonance (NMR) spectroscopy 
and Molecular Dynamics Simulations (MD) have been used in combination in order to 
elucidate these intermolecular interactions. NMR is valuable for enabling conclusions 
about the spatial proximity of functional groups of host and guest, thus providing 
information on the involvement of different moieties of the molecules in the 
intermolecular complex formation [5]. MD constitutes an essential tool for exploring 
the mechanism of separation and spectroscopic methods in general. 
This technique has been used to illustrate selector-selectand complexes. 
Systematic variations of the analyte structure were applied to deduce structure 
separation relationships [6]. NMR in particular, should be used to confirm the results of 
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MD simulations obtaining complementary information about intermolecular 
interactions. 
 
 
In this thesis project different CE analytical methods were applied and validated 
facing up to various pharmaceutical challenges exploiting the implementation of QbD 
concept in particular, and Design of Experiment in general. MD and NMR were used 
for the investigation of intermolecular affinities, complexation and separation 
mechanisms involved in the interactions amoung drug and pseudostationary phases. Six 
studies regarded the method optimization for the simultaneous quantification of active 
principles and the main related substances in pharmaceutical formulations, respectively 
Zolmitriptan, Glibenclamide, Diclofenac, Captopril, Sulpiride, Ambrisentan. The 
methods were validated following the ICH guidelines in order to fulfill the needed 
requirements. Furthemore linear discriminant analysis and quadratic discriminant 
analysis were utilized as discrimination techniques for green tea samples origin 
discrimination. Thoroughly in some of these studies a comprehensive investigation was 
performed to deeply explore the intermolecular interactions between analytes and 
pseudostationary phases and their respective role in the electrophoretic migration by 
using MD and NMR. 
Furthermore, during my abroad collaboration with the Inorganic and Chemistry 
Department of the University of Geneva the Quality by Desig workflow was applied to 
underline and study in depth the critical process parameters of Dried Blood Spots 
sample preparation with liquid chromatography-mass spectrometry. 
 
 
2. Materials and Methods 
 
The discussed techniques and developed methods presented in this thesis project 
are currently in press or already been published. Therefore, Materials and methods 
according each study are reported in chapter 10 “Appendix”. 
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3. Chemometric techniques 
3.1. Design of Experiments (DoE) 
 
Chemometrics, the science of relating measurements made on chemical systems 
or processes to their state via application of mathematical and statistical modeling has 
become a well-recognized sub-discipline in contemporary analytical chemistry [7]. 
Chemometric tools with suitable statistical analysis have become popular by the 
way, considering multiple advantages viz. reduction in the number of experiments and 
lower reagent consumption and less laboratory work.  
The significance of chemometry has been well reflected by the fact that in the 
recent years numerous books, book chapters, review papers and innumerable research 
papers have been published describing its various applications in analytical chemistry. 
All these works emphasize chemometric approach as an emerging tool in the field of 
pharmaceutical analysis [7]. 
Experimental design is a classical statistical method that has found utility in 
pharmaceutical development, as well as in many other fields requiring determination of 
optimal conditions and modelling of response surfaces [8]. Statistically designed 
experiments are highly efficient since they give a fixed amount of information with 
much less effort than the classical one-variable-at-a-time approach, and many of them 
give additional information about interactions [9]. Information on interactions is an 
important clue in the search for optimum conditions, since their existence implies that 
the value assumed by one factor influences the effect on the response of another factor. 
With this technique the experimentation evolves in pre-planned stages. When a 
preliminary screening investigation has been completed, the increased knowledge about 
the system allows a more detailed study to be performed and a response surface 
describing the problem to be obtained [10]. 
Even though the number of variables is high, an empirical relationship between 
the responses and the individual factors can be obtained with a limited number of 
experiments. In particular, it was important to detect active factors: the variables whose 
level change determined a statistically significant variation of the response. Thus, a 
linear relationship was postulated, and the influence of factors was evaluated by means 
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of the model coefficients [8]. 
Linear methods reveal main effects and interactions, but cannot find quadratic (or 
cubic) effects.  Therefore, they have limitations in optimization; the optimum is found 
in some edge point corresponding linear programming. They cannot model non linear 
systems; e.g. quadratic phenomena. In an industrial process even third-order models are 
highly unusual. Therefore, the focus will be on designs that are good for fitting 
quadratic models. Choice of appropriate types of experimental designs so as to either 
screen the most influential factors or optimize the selected factors’ combination and the 
mathematical models in chemometry have been briefly recalled and the advantages of 
chemometric approaches have been emphasized [7]. 
Experimental designs are often written in terms of coded variables. For example, a 
design that requires only two values of a variable (so-called ‘two-level’ design) factor 
values are usually given as a series of +1 and −1 indicating whether one value (+1) or 
the other value (−1) is to be chosen. There are mathematical reasons for this practice, 
but also a practical use is that designs can be written independently of the particular 
factors under study [11]. 
Coded variables are calculated by the following equation after settling the center 
and the step of variation:  
j
jij
ij
U
UU
X



 
where: 
ijX  is the value of the coded variable j in i-th test 
ijU  is the value of natural variable  j in  i- th test 
jU  is the value of natural variable j in the center of the experimental domain 
jU  is the variation step of natural variable j. 
The set of different experimental conditions is given by the experimental matrix 
which is a mathematical object that represents in coded form the experiments to be 
performed [12]. It consists of a data table consisting of N rows, corresponding to n 
experiments, and K columns, corresponding to the k variables studied. The xij element 
of the matrix thus formed corresponds to the value that assumes the j-th variable in the 
i-th experiment. 
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The experimental plan is the translation of an experimental matrix into natural 
variables: it is a table containing the data expressed in their units of measurement, 
directly usable by the researcher. 
The effect of a factor is the change in response observed following level change. 
The response, indicated by y, is the experimental result of an experience (time of 
analysis, reaction and so on), that is, a measurable manifestation of what is observed by 
varying the factors studied. The response variation is here mathematically schematized:  
 
),...,,( 21 kxxxfy   
 
function f is called response function and is a polynomial mathematical function 
that describes the response as factor function. In general, it is possible to represent a 
problem of this kind in a matrix form: 
 
 y = Xβ+ε 
 
where y is the column vector of the n responses, β is the vector of the coefficient 
estimates, X is the matrix n x k that defines the experimental points and ε is the error 
column vector. 
The experimenter's goal is to find the relation between one or more experimental 
responses and the factors selected, that is, a mathematical model that relates the 
response to variables [12]. 
Because the expected outcome is no significant change of the response, allowing 
the claim of a rugged/robust method, many factors can be screened without concerns 
about interacting and non-linear effects. A main effects model will suffice. 
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And with interactions: 
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For chromatographic separations it is important to have an acceptable response 
that meets minimum criteria and so the aim is often to locate that region (e.g. high pH, 
lower temperature) rather than find the absolute optimum. This makes DoE very 
powerful when the polynomial function does not fit the data perfectly, but does describe 
the response sufficiently to locate an acceptable region [11]. 
In order to have the possibility of a maximum (or minimum) quadratic terms are 
needed: 
   









ki
i
kj
ij
ki
i
iiijiij
ki
i
ii xxxxR
1
1
1
2
1
0
 
 
 
The choice of the model is closely linked to the experimental domain: for a 
restrain domain a simple model is needed. The type of information obtained will depend 
on the model choice, the number and type of experiments to be conducted, and then the 
type of experimental planning. The experimental matrix must contain at least a number 
of experiments equal to the number of coefficients to be determined. 
The model matrix is obtained from the experimental matrix using the equation of 
the model: this is made up of of lines coincinding with the number of experiments and a 
number columns coincinding with the terms present in the model equation. In the case 
of a linear model without interaction, the matrix of the model differs from the 
experimental matrix for the only column related to the known term b0, which is 
constituted by all +1. In the case of a model with interactions, there is also the addition 
of columns related to each interaction obtained by multiplying the columns related to 
the variables for which the interaction is to be known. 
The transposed X ' is calculated from the model matrix (exchanging its rows with 
the columns) and then the information matrix given by X'X, whose inverse is the 
dispersion matrix (X'X) -1, which is useful for calculating the matrix characteristics. 
The dispersion matrix also appears in the calculation of model coefficients (the β 
coefficients are not affected by error, while the b coefficients estimate the β are 
inclusive of experimental error), which are obtained by means of linear regression 
analysis multivariate by applying the following formula: 
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B = (X'X) -1X'Y 
 
where B is the vector of estimates bj, Y is the vector response containing the 
responses obtained from experiments carried out according to a suitable experimental 
matrix, X' is the transposition of the model matrix and (X'X) -1 is the dispersion matrix. 
Once the experiments have been carried out and the coefficients calculated, the 
results can be analyzed and interpreted primarily through statistical tests. In particular, 
the application of statistical methods to collected data is made possible by the fact that 
experiments are performed according to a suitable initial design and therefore according 
to suitable matrices. 
The importance of an accurate estimation of the coefficients consists in the fact 
that this allows to evaluate the effect each variable has on the response individually or, 
in the case of an interaction between variables, the effect of such interaction or even in 
the case of a quadratic term, of the quadratic effect of the variable. In particular are 
descibed as main effects, grouped in linear and quadratic, and of interaction effects 
between variables. The first give information about the weight applied by the variable to 
which the effect is related to the response (or curvature of the model if it is a quadratic 
term); the second are the index of the interaction between variables and hence the effect 
that a variable has on the effect exerted on the response from another variable. From the 
coefficient sign, however, you have information on which area of the experimental 
domain offers the best results [12]. Linear models with quadratic interactions or models 
can be represented graphically and this graphical representation of the model equation is 
named the response surface. The response surface represents the variation of the 
response in space by varying the different values assumed by the factors. The two-
dimensional representation of the response surface constitutes the isoresponse surface 
and is represented by concentric lines along which the response is kept constant. 
The selection of the best experimental strategy must be carried out as a result of 
the accurate and complete definition of the problem [13], is assessing the possible 
presence of experimental limitations, the risk of systematic error, the way in which 
experimental error is estimated, whether or not need to study all the factors from the 
beginning. Based on the objectives of an experiment, all the designs can be classified 
into two broad categories: Screening Designs, Response Surface Designs (optimization 
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design) here schematized in the Fig. 3.1: 
 
Fig. 3.1.  Represantative models of Screening and Optimization design in the multivariated approach of the Design of 
Experiments. 
 
3.1.1. Screening Designs 
 
Since a huge number of factors influence the chromatographic process, some of 
them that do not have significant effect on it must be discarded. Screening of the most 
influential factors becomes the primary objective of employing experimental design in 
chromatography. These designs are used with a purport to identify the most important 
factors and their interactions from all potential factors. They are very useful to examine 
qualitative, quantitative and mixer-related factors simultaneously [7]. Two-level designs 
are chosen for screening factors and can give main and interaction effects, but not 
higher orders. Fractionation leads to designs that give main effects only with fewer runs. 
Calculation of effects in two level designs is easy and can be performed in a spread 
sheet. If the two levels are coded +1 and -1, then the column of +1 and -1 under each 
factor is multiplied by the response for each experiment. The product is summed and 
divided by half the number of experiments. This is the main effect for the factor. For an 
interaction effect a column is created that is the product of the level codes and the 
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procedure outlined above is applied to this column [11]. 
 
 
 
 
 
 
 
 
Fig. 3.1.1 Two-level designs for screening factors. 
 
From the literature it is evidenced that Full Factorial designs (FFD), Fractional 
Factorial designs (FrFD) and Plackett-Burman designs (PBD) are frequently used as 
screening designs. Such two-level designs allow screening of high number of factors 
with fewer experiments. Analysis of variance (ANOVA) or regression analysis can be 
the basis for computing effect of the studied factors on a particular response. They are 
frequently applied for improvement of separation techniques, formulations, products or 
processes of quality control and robustness and ruggedness testing. The steps to be 
performed in such designs are identical to that of robustness or ruggedness test with the 
discrepancy in the intervals within the two levels of the factors. Several applications of 
three or more or mixed-level screening designs also has been evidenced from the 
literature.  
 
 
3.1.2. Response Surface Designs 
 
Optimization is an additional practice of chemometric approach that endorses the 
optimal condition or settings of a process. 
 Such approach usually preceedes with a screening design to select the potential 
factors. Response surface designs are of two types: symmetrical designs and 
asymmetrical designs.  
  
20 
 
Three-level FFD, Central Composite design (CCD) and Box-Behnken design 
(BBD), Taguchi design (TD), and Doehlert designs cover a symmetrical domain with a 
center point to estimate experimental error.  
 
Fig. 3.1.2 Three-level FFD, Central Composite design (CCD) and Box-Behnken design (BBD), Taguchi design (TD), 
and Doehlert designs cover a symmetrical domain with a center point to estimate experimental error.  
  
Asymmetrical designs such as D-optimal design form an asymmetrical shape 
when an asymmetrical experimental domain is examined. Such designs can also form a 
symmetrical shape in a symmetrical domain. Mixture designs are applied to study 
mixture variables only, i.e. to optimize the composition of mixture. ANOVA, signal-to-
noise ratio and range analysis are the basis of the statistical analysis methods for 
response surface designs. Range analysis is used to find the effect of each factor and 
determine the optimal level of different factors. For a factor, the range of means is the 
difference of the maximum and minimum means of all levels. For a system, the factor 
with the largest range of means has the strongest influence on the performance. Range 
analysis can find the optimal value of different factors, but this method cannot clearly 
and quantitatively determine the significance of different factors.  
In the ANOVA, the data are analyzed by a F-test. The F value of each factor 
implies the ratio of the variance for each factor to that of the experimental error. The 
percentage contribution of each factor is the percentage of the sum of square deviation 
due to that factor in the total sum of square deviation. It reflects the factor’s influence. 
Regression analysis enables to estimate the relationships among variables via a 
regression function. Linear first order and second order models are quite common. A 
fruitful implementation of experimental design in chromatography can be executed 
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through four common stages; i.e.: (i) choosing the convenient design, (ii) suitable 
software, (iii) experimental trials, data analysis, and (iv) interpretation.  
 
3.1.3. Analysis of Variance (ANOVA) 
 
In an analysis of variance, ANOVA, the total variation of the response is defined 
as a sum of two components; a regression component (SSregr) and a component due to 
the residuals (SSresid). The sum of squares of the total variation, corrected for the mean 
(SS), can thus be written as 
residregr SSSSSS   
Where  2yySS i  ,  
2
ˆ yySS iregr  ,  
2
ˆ
iiresid yySS  , iy  are the 
responses,  y  is the average of the responses,  iyˆ  
are the predicted responses of the 
selected model. If there are replicates among the experiments, the residuals component 
are further divided into parts that are the sum of squares of lack of fit (SSlof) and the sum 
of squares of pure experimental error (SSpe):  
 
where  2iipe yySS   and iy  is the average of the obtained responses in the 
same operative conditions of the replicates [14]. 
In the ANOVA plot, the regression component of the total variation is compared 
to the residual component. If the standard deviation of the response explained in the 
model (SD regression) is larger than the standard deviation of the residuals multiplied 
by the square root of the critical F (RSD*), then the model is significant at the chosen 
probability level (usually P=0.05%) [14]. 
The lack of fit component of the residuals is compared to the pure experimental 
error component. If the standard deviation of lack of fit (SD LoF) is larger than the 
standard deviation of the pure experimental error, multiplied by the square root of the 
critical F (SD pe*), then the model suffers from a significant lack of fit [14]. 
pelofresid SSSSSS 
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The comparison of the bars in the ANOVA plots is similar to the ordinary 
variance ratio test, or F-test.  In an F-test, the variance ratio between lack of fit (lof) and 
pure experimental error (pe), is being compared to tabled values of F-distribution. If 
Flof/pe exceeds the critical F, then there is a significant lack of fit at the probability level 
that is chosen (usually P=0.05) and the model is incorrect. In the ANOVA plots in 
Modde, the variances are simply exchanged for the standard deviations (SD=√variance), 
and the comparison SDlof/SDpe vs. the equally converted √Fcrit has been rearranged to 
SDlof vs. SDpe*√Fcrit [14]. 
 
 
3.1.4. Quality Criteria 
 
The matrix quality criteria allow to know beforehand, ie before conducting the 
experiments, with what accuracy the coefficients will be estimated and then evaluating 
the quality of matrices to determine what is best suited to the purpose. 
 
Criteria related to estimating model coefficients 
The estimate of coefficients must be accurate and not correlated. The βi coefficient 
is estimated by bi and defined as accurate if the bi -centered interval, with a certain 
probability of the true coefficient value, is as small as possible; variance of  the estimate 
var (bi) measures that interval.  
Therefore, it is possible to assign confidence limits to each coefficient and 
consider all factors simultaneously, so that the confidence limits of all the coefficients 
(joint confidence region) are defined by a hyperelliside in the coefficient space. This 
hyper-bissoid of confidence is centered on vector B, that is, on vector estimate of 
coefficients b. Hyperellissoid is reduced to an ellipse if the coefficients are only two. 
The characteristics of this hyperelliside, such as its orientation and extension, can be 
used as criteria for assessing the quality of the coefficient estimation. Such aspects 
depend in turn on the properties of the dispersion matrix (X'X) -1. 
The volume of hyperelliside translates the overall accuracy of the coefficient 
estimation; for a given probability, smaller is the volume more accurated is the 
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estimatio. The form of hyperelliside is linked to the accuracy with which each estimate 
is determined. Because the accuracy in the estimate of the coefficients is the same for all 
coefficients, the shape of the hyperelliside must be that of a hypersphere. The 
hyperelliside orientation indicates the degree of correlation between coefficient 
estimates. Estimates of the coefficients are independent if the main axes of the 
hyperelliside are parallel to the axes of the coefficients [14].  
In particular, as regards the volume of the hyperelliside and hence the accuracy in 
the estimation of the coefficients, this is proportional to the root of the dispersion matrix 
determinant 1)'()(  XXD  . 
21
1)'(  XXaV  
For a given model / experimental matrix, this criterion is defined as the 
determinant criterion: smaller is the dispersion matrix determinant smaller is the volume 
of the hyperelliside, and therefore the coefficients estimate is more accurate. 
D-optimal design is based on the hyperelliside volume criterion.  
The experimental matrix is called D-optimal if between all domain matrices is one 
that leads to the smallest value of the dispersion matrix determinant.  
It is therefore the experimental matrix for which the confidence ellipsoid of the 
coefficients is as small as possible. 
 
Criteria related to the quality of the predicted model 
In order to obtain a good predicted model, a model that allows predicting the 
value of the answer at any point in the experimental domain, the objective is to obtain 
the best possible quality in predicting the response [14]. 
Among the quality criteria that indicate the predictive quality of the model, I-
optimal criterion is based on the calculation of the average variance of model 
predictions in the experimental region. 
 The I-optimal design therefore, minimizing this average variance, produces a 
more accurate estimate of the above response. This in turn leads to a better placement of 
the optimal response [15] 
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3.2. Mixture-process Variable approach (MPV) 
 
The Design Space is the region of the experimental space where multidimensional 
combinations of mixture components (MCs) and process variables (PVs) have been 
demonstrated to provide assurance of quality. MCs are the ingredients in a mixture, 
typically expressed as proportions. PVs are factors in an experiment that do not form 
any portion of the mixture, but whose settings (when changed) can affect the responses 
[16]. 
Using the data resulting from a mixture-process variable (MPV) experimental 
design, MPV models are developed to represent the relationship of system performance 
with MCs and PVs. Such data-based models provide an in-depth understanding of the 
problem and the basis for developing the design space and optimizing the quality of the 
analytical method [16]. 
Sometimes a two-stage approach is used to address MPV optimization problems. 
In the first stage, a mixture experiment is performed, mixture models for the responses 
are fit to the experimental data, and then the mixture models are used to develop an 
optimum mixture at fixed settings of the PVs (e.g., at standard or central values of PVs). 
In the second stage, the PVs are investigated using a response surface experiment, 
response surface models are fit to the resulting data, and the models are used to develop 
optimal settings of the PVs for the optimal mixture developed in the first stage. 
Unfortunately, this two-stage approach to MPV experiments does not provide for 
investigating interactions between MCs and PVs. This problem is avoided by (1) using 
a MPV approach that varies both MCs and PVs simultaneously in one experiment, (2) 
developing MPV models from the resulting data, and (3) using the MPV models to 
identify the design space, optimal subregion, and desirable MC proportions and PV 
settings within the optimal subregion [17]. 
MPV experimental designs and models (that approximate the true, unknown 
relationships between response variables and the MCs and PVs) can be very large as the 
number of MCs and/or PVs increases. For example, MPV designs and models are often 
formed by “crossing” separate mixture designs and models with separate PV designs 
and models: 
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  321123322331132112332211 xxxxxxxxxxxxyMC  (1) 
 
Where βi, βij, e β123 represent, respectively, the linear, quadratic, and special-cubic 
blending properties of the three MCs, and the xi represent proportions of the MCs.  
The MC proportions xi satisfy the constraint   x1+x2+x3=1. 
For PVs, the quadratic models is here reported: 
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Where αi, αij, e αii represent, respectively, the linear, quadratic, and special-cubic 
blending properties of the three PVs. 
Crossing the models in (1) and (2) involves multiplying all terms in one model by 
all terms in the other model, yielding a (special-cubic mixture) x (quadratic PV) MPV 
model of the form:  
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In models (1), (2) and (3), the ε term at the end of the model represents 
experimental and measurement error (uncertainty) in the response variable. When 
models are fit to data using ordinary least squares (OLS) regression, the ε errors are 
typically assumed to be statistically independent and identically distributed (i.e., with 
the same mean and variance). When the errors have a normal (Gaussian) distribution, 
many standard statistical data analysis methods can be applied [16]. 
The MPV model (3) contains 7×10=70 terms, a large number. An experimental 
design to support fitting this model would require at least 70 data points to fit the model, 
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plus extra data points to quantify “pure error” (experimental and measurement 
uncertainty) and to assess model lack-of-fit (LOF) [16]. A separate mixture design that 
supports fitting (1) consists of the four vertices, four edge centroids, and overall 
centroid of the irregular polyhedral region defined by the lower and upper bounds on the 
MCs. A separate central composite design in the three PVs that supports fitting (2) 
contains 8 vertices, 6 axial points, and the overall center point of the cube defined by the 
PV lower and upper bounds. Crossing these designs would yield a MPV design with 
9×15=135 points.  
 
 
Fig. 3.2.  MPV for 3 factors (23) with simplex design for a 3 components-mixture.  
 
An alternative for generating MPV designs containing fewer points is to use an 
optimal experimental design approach [16]. With this approach, the researcher specifies 
a MPV model form that he/she believes will adequately approximate the relationships 
between the response variables and the MCs and PVs.  
Then, software (e.g., Design-Expert [18], JMP [19], Minitab [20]) is used to 
generate a MPV design (containing a specified number of points) that optimizes a 
mathematical design criterion.  
Atkinson et al. [15] discuss several optimal design criteria, including D-
optimality, I-optimality, and others. D-optimality focuses on minimizing the 
uncertainties of the model coefficients, while I-optimality focuses on minimizing the 
average uncertainty of model predictions over the experimental region. 
The number of points in an optimal MPV design must be at least as large as the 
number of terms in the MPV model selected for use with the optimality criterion 
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chosen. Further, the design should have at least 5 replicates to estimate experimental 
and measurement uncertainty for each response and 10 additional (non-replicate) points 
to assess the adequacy of the models fitted to the response data.  
In summary, care must be taken in (1) selecting a MPV model that will adequately 
approximate the relationships between responses and the MCs and PVs and (2) 
generating a MPV experimental design that will support fitting the selected MPV model 
to experimental data and assessing model adequacy. After MPV models for the response 
variables have been developed and assessed using the experimental data, the fitted 
models can then be used to develop equations that specify the design space and 
determine the settings of the MCs and PVs to optimize the responses [16]. 
 
3.3. Principal Component Analysis (PCA) 
 
 
Principal component analysis (PCA) is a multivariate technique that analyzes a 
data table in which observations are described by several inter-correlated quantitative 
dependent variables. Its goal is to extract the important information from the table, to 
represent it as a set of new orthogonal variables called principal components, and to 
display the pattern of similarity of the observations and of the variables as points in 
maps.  
The quality of the PCA model can be evaluated using cross-validation techniques 
such as the bootstrap and the jackknife. PCA can be generalized as correspondence 
analysis (CA) in order to handle qualitative variables and as multiple factor analysis 
(MFA) in order to handle heterogeneous sets of variables.  
Mathematically, PCA depends upon the eigen-decomposition of positive semi-
definite matrices and upon the singular value decomposition (SVD) of rectangular 
matrices.  
In PCA linear combinations of the measured chemical descriptors are derived, 
producing new variables called principal components (PCs), which are uncorrelated. 
The first PC (PC1) accounts for the largest portion of explainable data variability in the 
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measured data, and each successive PC accounts for as much of the remaining 
variability as possible. PCA cannot be used as a classification tool, but it can be applied 
with the aim of a better understanding of the discriminating efficiency of the descriptors 
and of visualizing the data trends, by generating score plots for groupings of the 
observations [4]. 
 
Fig. 3.3.  Example of the case of a sample described by two variables by PCA. 
 
In multivariate analysis, each variable m defines an axis and hence the variable m 
defines a M-dimensional space. Each object is located in this space by a point, whose 
coordinates are given by the value of the corresponding variables.  
 
Fig. 3.3.1.  Example of the case of a sample described by three variables by PCA.  
 
 
The n objects in the variable m space define a set of points in a multidimensional 
space. If the objects are similar to each other, this set appears compact, whereas if there 
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is diversity, a dispersion of objects is observed. The following figure shows an example 
of a data set described by three variables. 
 
Fig. 3.3.2 Example of the case of a sample described by three variables by PCA..  
 
PCA aims to decrease the number of original variables by operating a orthogonal 
rotation of Cartesian axes along the line of variation of the points plotted in the plane 
according to their natural variables. This rotation allows, starting from a large number 
of more or less correlated variables, to obtain a small number of unrelated variables. 
The first PC1 component is then defined in such a way that it explains in its 
direction the maximum dispersion and hence the maximum variance existing between 
the data and around which the minimum dispersion is. Once this new axis is identified, 
PC2 is defined, ie the axis perpendicular to PC1. The two lines thus defined identify a 
planar pattern and the search for the subsequent components can proceed further until 
exhaustion of all variance contained in the data. However, the relevant information is 
usually contained in the first 2 or 3 main components and is therefore identifiable and 
visualizable.  
Each autovector is obtained as a linear combination of the original variables, 
meaning that each variable gives its contribution more or less to the construction of 
each new axis. This contribution is expressed through a coefficient called loading. The 
scores instead represent the new coordinates of objects in the space of the main 
components. The PCA allows very good graphic representations of both plot scores and 
variable loads as well as objects and variables simultaneously (biplot). The loadings 
chart allows you to analyze the role of each variable in the different components and 
their importance. The score graph allows instead to analyze the behavior of objects in 
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different components and their similarity. Finally, the biplot graph enables objects and 
variables simultaneously to be represented in order to evaluate the relationships between 
them [22]. 
 
 
3.4. Multivariate optimization methods 
 
      Linear and quadratic discriminant analysis 
 
Supervised pattern recognition refers to the techniques in which a priori 
knowledge about the category membership of samples is used for classification. The 
discrimination model is developed on a training set of samples with categories. The 
model performance is evaluated by means of some samples from a prediction set by 
comparing their predicted categories with their own true categories. Therefore, all 
samples were divided into a training set, used to built model, and an external set (test 
set), used to test the model. Two supervised pattern recognition techniques were 
applied: LDA (Linear Discriminant Analysis) and QDA (Quadratic Discriminant  
Analysis) 
 
Fig. 3.4.  LDA (Linear Discriminant analysis) and QDA (Quadratic Discriminant Analysis). 
 
 
By using LDA, linear combinations of the selected descriptors can be performed, 
allowing the so-called discriminant functions to be obtained; the application of this 
approach best separates the classes according to the minimization of the ratio of within-
class and between-class variances. The obtained latent variables are called canonical 
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variates and for k classes, k−1 canonical variates can be calculated [23]. QDA is 
identical to LDA, but class borders are quadratic curves instead of straight lines. 
Prior to LDA and QDA the data were autoscaled and the normal distribution was 
assumed for the classes in both cases. LDA and QDA discrimination rates by cross-
validation were used to optimize the number of variables, plotting the percentage of 
correct classification rate of the training set samples using cross-validation for the 
models with different number of variables as a function of the number of variables. 
Both LDA and QDA can be derived from simple probabilistic models which 
model the class conditional distribution of the data  
 
 
 
for each class . Predictions can then be obtained by using Bayes’ rule: 
 
 
 
        and we select the class  which maximizes this conditional probability. More 
specifically, for linear and quadratic discriminant analysis 
 
 is modelled as a multivariate Gaussian distribution with density: 
 
 
To use this model as a classifier, we just need to estimate from the training data 
the class priors  (by the proportion of instances of class ), the class means 
  (by the empirical sample class means) and the covariance matrices (either by the 
empirical sample class covariance matrices, or by a regularized estimator: see the 
section on shrinkage below). 
In the case of LDA, the Gaussians for each class are assumed to share the same 
covariance matrix:    for all . This leads to linear decision surfaces between, as 
can be seen by comparing the log-probability ratios: 
  
32 
 
 
 
 
 
 
In the case of QDA, there are no assumptions on the covariance matrices    of 
the Gaussians, leading to quadratic decision surfaces.  
 
 
4. Nuclear Magnetic Resonance (NMR) and Molecular 
Dynamics Simulation (MD) 
4.1. Background 
 
Over the past fifty years nuclear magnetic resonance spectroscopy, commonly 
referred to as NMR, has become the preeminent technique for determining the structure 
of organic compounds. Of all the spectroscopic methods, it is the only one for which a 
complete analysis and interpretation of the entire spectrum is normally expected. 
Although larger amounts of sample are needed than for mass spectroscopy, NMR is 
non-destructive, and with modern instruments good data may be obtained from samples 
weighing less than a milligram. Nuclear magnetic resonance (NMR) spectroscopy was 
discovered shortly after the Second World War, and since then its applications to 
chemistry have been continuously expanding. It was natural then that NMR took an 
important part in undergraduate chemistry education, being taught within various 
courses: physical chemistry, organic, inorganic and analytical chemistry. In recent 
years, the applications of NMR have been extended to biology and medicine, so they 
have also become an integral part of courses in these subjects [25].  NMR spectroscopy 
in depth is an analytical chemistry technique used in quality control and research for 
determining the content and purity of a sample as well as its molecular structure. For 
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example, NMR can quantitatively analyze mixtures containing known compounds. For 
unknown compounds, NMR can either be used to match against spectral libraries or to 
infer the basic structure directly.  
NMR technique is based 
on the fact that when a 
population of magnetic nuclei is 
placed in an external magnetic 
field, the nuclei become aligned 
in a predictable and finite 
number of orientations [25]. 
For 1H there are two different 
orientations. The first one is the orientation represented by the concident alignment of 
protons with the external magnetic field (north pole of the nucleus aligned with the 
south pole of the magnet and south pole of the nucleus with the north pole of the 
magnet) and the second one is represented by the alignment of the nuclei against the 
field (north with north, south with south). The alignment with the field is also called the 
"alpha" orientation and the alignment against the field is called the "beta" orientation.  
 
 
Fig. 4.1.  Example of a NMR technique. 
 
This angular moment (also called spin) has an associated magnetic moment. A 
few examples of magnetic isotopes are 13C, 1H, 19F,14N, 17O, 31P, and 33S. If a nucleus is 
not magnetic, it can't be studied by nuclear magnetic resonance spectroscopy.  
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The nuclear magnetic resonance (NMR) spectroscopy experiment involves using 
energy in the form of electromagnetic radiation to pump the excess alpha oriented 
nuclei into the beta state. When the energy is removed, the energized nuclei relax back 
to the alpha state. The fluctuation of the magnetic field associated with this relaxation 
process is called resonance and this resonance can be detected and converted into the 
peaks recovered in an NMR spectrum. Once the basic structure is known, NMR can be 
used to determine molecular conformation in solution as well as studying physical 
properties at the molecular level such as conformational exchange, phase changes, 
solubility, and diffusion. In order to achieve the desired results, a variety of NMR 
techniques are available. NMR spectra are usually measured using solutions of the 
substance being investigated. It is important that the solvent itself doesn't contain any 
simple hydrogen atoms, because they would produce confusing peaks in the spectrum. 
In order to avoid this interference a solvent such as tetrachloromethane, CCl4, which 
doesn't contain any hydrogen, can be used, or a solvent in which any ordinary hydrogen 
atoms are replaced by its isotope, deuterium - for example, CDCl3 instead of CHCl3. All 
the NMR spectra used on this site involve CDCl3 as the solvent. 
Deuterium atoms have sufficiently different magnetic properties from ordinary 
hydrogen that they don't produce peaks in the area of the desired spectrum.  
 
 
 
4.2. Chemical Effects in NMR 
 
4.2.1. Chemical Shift 
 
Unlike infrared and uv-visible spectroscopy, where absorption peaks are uniquely 
located by a frequency or wavelength, the location of different nmr resonance signals is 
dependent on both the external magnetic field strength and the rf frequency. Since no 
two magnets will have exactly the same field, resonance frequencies will vary 
accordingly and an alternative method for characterizing and specifying the location of 
nmr signals is needed. The precise resonant frequency of the energy transition is 
dependent on the effective magnetic field at the nucleus. This field is affected by 
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electron shielding which is in turn dependent on the chemical environment. As a result, 
information about the nucleus' chemical environment can be derived from its resonant 
frequency. In general, the more electronegative the nucleus is, the higher the resonant 
frequency. Other factors such as ring currents (anisotropy) and bond strain affect the 
frequency shift. It is customary to adopt tetramethylsilane (TMS) as the proton 
reference frequency. This is because the precise resonant frequency shift of each 
nucleus depends on the magnetic field used. The frequency is not easy to remember (for 
example, the frequency of benzene might be 400.132869 MHz) so it was decided to 
define chemical shift as follows to yield a more convenient number such as 7.17 ppm. 
 
δ = (ν-ν0)/ν0 
 
The 1H chemical shift, using this equation, is not dependent on the magnetic field 
and it is convenient to express it in ppm where (for proton) TMS is set to ν0 thereby 
giving it a chemical shift of zero. For other nuclei, ν0 is defined as Ξ 
νTMS where Ξ (Greek letter Xsi) is the frequency ratio of the nucleus (e. g., 25.145020 % 
for  13C). In the δ-scale more highly shielded protons appear at lower δ values, whereas  
 
 
 
Fig. 4.2.1 The 1H chemical shift for samples in CDCl3. 
 
relatively deshielded protons appear at higher δ values. Therefore, protons 
attached to carbon, which is less electronegative than oxygen, will be more shielded and 
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will typically appear around 1 ppm. Protons attached to oxygen, or those which are 
relatively close to more electronegative atoms, will be deshielded and will appear at 
higher δ values, as shown previously. 
In the case of the 1H NMR spectrum of ethyl benzene, the methyl (CH3) group is 
the most electron withdrawing (electronegative) and therefore resonates at the lowest 
chemical shift. The aromatic phenyl group is the most electron donating 
(electropositive) so has the highest chemical shift. The methylene (CH2) falls 
somewhere in the middle. However, if the chemical shift of the aromatics were due to 
electropositivity alone, then they would resonate between four and five ppm. The 
increased chemical shift is due to the delocalized ring current of the phenyl group. 
 
 
4.2.2. Absorption Intensities 
 
The magnitude or intensity of NMR resonance signals is displayed along the 
vertical axis of a spectrum, and is proportional to the molar concentration of the sample. 
Thus, a small or dilute sample will give a weak signal, and doubling or tripling the 
sample concentration increases the signal strength proportionally. If we take the NMR 
spectrum of equal molar amounts of benzene and cyclohexane in carbon tetrachloride 
solution, the resonance signal from cyclohexane will be twice as intense as that from 
benzene because cyclohexane has twice as many hydrogens per molecule [25]. This is 
an important relationship when samples incorporating two or more different sets of 
hydrogen atoms are examined, since it allows the ratio of hydrogen atoms in each 
distinct set to be determined. To this end it is necessary to measure the relative strength 
as well as the chemical shift of the resonance signals that comprise an NMR spectrum.  
 
 
4.2.3. Spin-Spin Coupling 
 
The source of signal splitting is a phenomenon called spin-spin coupling, a term 
that describes the magnetic interactions between neighboring, non-equivalent NMR-
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active nuclei. The splitting patterns found in various spectra are easily recognized, 
provided the chemical shifts of the different sets of hydrogen that generate the signals 
differ by two or more ppm. The patterns are symmetrically distributed on both sides of 
the proton chemical shift, and the central lines are always stronger than the outer lines. 
The most commonly observed patterns have been given descriptive names, such as 
doublet (two equal intensity signals), triplet (three signals with an intensity ratio of 
1:2:1) and quartet (a set of four signals with intensities of 1:3:3:1). The line separation 
is always constant within a given multiplet, and is called the coupling constant (J).  
The splitting patterns display the ideal or "First-Order" arrangement of lines. This 
is usually observed if the spin-coupled nuclei have very different chemical shifts (i.e. Δν 
is large compared to J). If the coupled nuclei have similar chemical shifts, the splitting 
patterns are distorted (second order behavior). In fact, signal splitting disappears if the 
chemical shifts are the same.  
The scalar coupling constant of two nuclei separated by n bonds is denoted as nJ. 
As the number of the bonds that separate the two coupled nuclei increases, the 
interacting energy becomes lower and consequently the coupling constant becomes 
smaller. 
On the other hand, 2J and 4J give smaller but still detectable effects in a spectrum. 
Couplings over larger number of bonds (n ≥ 5) can generally be ignored [15]. An 
additional point is that J varies with the dihedral angle between the bonds. Thus, a 3JHH 
coupling constant is often found to depend on the angle φ according to the Karplus 
equation:  
J = A + Bcosφ + Ccos2φ 
 
with A, B, C empirical constants taking values close to + 7 Hz, - 1 Hz, + 5 Hz 
respectively. Consequently, the measurement of 3JHH in a series of related compounds 
can be used to determine their conformations 
 
 
4.3. Carbon NMR Spectroscopy 
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The most important operational technique that has led to successful and 
routine 13C NMR spectroscopy is the use of high-field pulse technology coupled with 
broad-band heteronuclear decoupling of all protons.  
The results of repeated pulse sequences are accumulated to provide improved 
signal strength.  
Also, for reasons that go beyond the present treatment, the decoupling irradiation 
enhances the sensitivity of carbon nuclei bonded to hydrogen.  
When acquired in this manner, the carbon NMR spectrum of a compound displays a 
single sharp signal for each structurally distinct carbon atom in a molecule (remember, 
the proton couplings have been removed). The dispersion of 13C chemical shifts is 
nearly twenty times greater than that for protons, and this together with the lack of 
signal splitting makes it more likely that every structurally distinct carbon atom will 
produce a separate signal. The only clearly identifiable signals in the proton spectrum 
are those from the methyl groups.  
The remaining protons have resonance signals between 1.0 and 2.8 ppm from 
TMS, and they overlap badly thanks to spin-spin splitting. 
 
 
Fig. 4.3. The 13C NMR spectroscopy for samples in CDCl3. 
 
Unlike proton NMR spectroscopy, the relative strength of carbon NMR signals 
are not normally proportional to the number of atoms generating each one. Because of 
this, the number of discrete signals and their chemical shifts are the most important 
pieces of evidence delivered by a carbon spectrum.  
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The general distribution of carbon chemical shifts associated with different 
functional groups is summarized in the Fig. 4.3. 
Bear in mind that these ranges are approximate, and may not encompass all 
compounds of a given class.  
Note also that the over 200 ppm range of chemical shifts shown here is much 
greater than that observed for proton chemical shifts. 
 
 
4.4. Two-dimensional nuclear magnetic resonance 
 
Two-dimensional (2D) NMR spectroscopy is of unprecedented value for structure 
determination by NMR.  
In this paragraph, the general concepts of 2D NMR spectroscopy and the 2D 
experiments used in this thesis will be shortly introduced.  
To other texts is referred for more in-depth information (100, 102, 104).. There 
are two frequency axes in a 2D NMR spectrum and it is possible to generate cross-peaks 
between connected resonances.  
The nature of these cross-peaks and the structural information which can be 
extracted from such a spectrum depends on the type of 2D experiment used.  
Traditional 2D NMR is a 2D map consisting of two axes of independent variables, 
both in frequency, denoting the chemical shifts or coupling constants.  
The contour map of the signal intensity in the 2D domain represents the 2D 
spectroscopic correlation, which delineates the correlation of different atomic sites due 
to chemical exchange, diffusion, J coupling or quantum hopping.  
The correlation between the chemical shift and the diffusion coefficient, called 
“diffusion ordered nuclear magnetic resonance spectroscopy (DOSYNMR),” has also 
been explored extensively [24]. 
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Fig. 4.4. The contour map of the signal intensity in the 2D domain represents the 2D spectroscopic correlation. 
 
During the preparation time, a single 90° pulse can be applied to generate 
transverse magnetization, or, for example, a set of pulses is applied to transfer 
magnetization from one nucleus to another (e.g. INEPT (105)). The t1-evolution period 
is incremented systematically in a series of separate experiments. During this period, 
magnetization evolves under influence of chemical shift and/or J coupling. The mixing 
period is applied to either transfer unobservable magnetization into observable 
magnetization (e.g. COSY) or to transfer magnetization from one nucleus to another by 
for example cross-relaxation (NOESY) or J-coupling (TOCSY). During the detection 
time t2, magnetization evolves under influence of chemical shift and J-coupling and is 
detected [25]. 
Subsequent Fourier transformation in both dimension (t1 and t2) results in 2D 
NMR spectra with frequency domains in both dimensions. Cross peaks in Correlation 
Spectroscopy (COSY) spectra reveal the network of J-couplings in a molecule. This 
information is of great value for structural determination and 2D COSY is therefore one 
of the most commonly used 2D NMR experiments. Double Quantum Filtered COSY 
(DQF-COSY) experiments have the preference over the conventional COSY 
experiment, since diagonal and cross peaks have absorption line shapes, whereas in 
conventional COSY spectra, there is a 90° phase difference between the diagonal and 
cross peaks. This leads to long dispersion tails of the diagonal peaks which hide cross 
peaks resonating close to the diagonal peaks [25]. 
 The only disadvantage of DQF-COSY experiments is the two-fold reduction in 
sensitivity compared to the conventional COSY experiment. Total Correlation 
Spectroscopy (TOCSY) is also a homonuclear 2D NMR experiment. TOCSY has large 
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similarities with COSY, since TOCSY gives also information about the network of J-
couplings in a molecule. In TOCSY spectra, however, also cross peaks between spins 
which are indirectly coupled to each other are present. For example, if spin A is coupled 
to spin B and spin B is coupled to spin C, a crosspeak between A and C will be present 
in a TOCSY spectrum, even though there is no J-coupling between those spins.  
TOCSY spectra have absorption mode lineshapes and are extremely valuable in 
identifying spins which belong to an extended network of couplings.  
Nuclear Overhauser effect spectroscopy (NOESY) spectra show cross peaks for 
all spins for which cross relaxation has occurred. In other words, NOESY spectra show 
only correlations between spins which are reasonable close in space to each other 
(<5Å).  
The intensity of a correlation in a NOESY spectrum is directly proportional to the 
distance between spins and NOESY spectra are therefore commonly used to obtain 
conformational and geometric information from biomolecules as well as small 
molecules.  
The final 2D NMR experiments which will be introduced here are the 
Hetereonuclear Single Quantum Coherence (HSQC) and Hetereonuclear Multiple Bond 
Coherence (HMBC) experiments.  
The resulting spectra of these experiments provide information about protons 
which are directly attached to a carbon (1H-13C HSQC) or between protons and carbons 
which are separated from each other with two or more chemical bonds (1H-13C HMBC).  
The latter one is commonly used to assign quaternary, carbonyl or other carbons 
which are not bound to a proton. NMR experiments with higher dimensionalities (e.g. 
three and four dimensional) are based on the same principle as 2D NMR experiments, 
with the main difference being the additional evolution periods.  
The spectra resulting from these experiments are simplified significantly, since 
spectral overlap is reduced. NMR experiments with higher dimensionalities are 
commonly applied to derive structural information of larger molecules like nucleic acids 
and proteins.  
The most important requirement of these NMR experiments is the isotope 
labelling (13C, 15N and/or 2H), since the natural abundance of these isotopes is in general 
too low to obtain spectra of sufficient quality [25]. 
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4.5. Molecular Dynamics Simulations (MD) 
 
The molecular dynamics method was first introduced by Alder and Wainwright in 
the late 1950's (Alder and Wainwright, 1957,1959) to study the interactions of hard 
spheres. Many important insights concerning the behavior of simple liquids emerged 
from their studies.  
The next major advance was in 1964, when Rahman carried out the first 
simulation using a realistic potential for liquid argon (Rahman, 1964).  
The first molecular dynamics simulation of a realistic system was done by 
Rahman and Stillinger in their simulation of liquid water in 1974 (Stillinger and 
Rahman, 1974).  
The first protein simulations appeared in 1977 with the simulation of the bovine 
pancreatic trypsin inhibitor (BPTI) (McCammon, et al, 1977).  
Today in the literature, one routinely finds molecular dynamics simulations of 
solvated proteins, protein-DNA complexes as well as lipid systems addressing a variety 
of issues including the thermodynamics of ligand binding and the folding of small 
proteins.  
The number of simulation techniques has greatly expanded; there exist now many 
specialized techniques for particular problems, including mixed quantum mechanical - 
classical simulations, that are being employed to study enzymatic reactions in the 
context of the full protein.  
Molecular dynamics simulation techniques are widely used in experimental 
procedures such as X-ray crystallography and NMR structure determination.  
Simulation of systems having ~50,000–100,000 atoms are now routine, and 
simulations of approximately 500,000 atoms are common when the appropriate 
computer facilities are available [25]. 
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Fig. 4.5. Summary of the frequent applications of Molecular Dynamic Simulations. 
 
This computational method calculates the time dependent behavior of a molecular 
system.  MD simulations have provided detailed information on the fluctuations and 
conformational changes of proteins and nucleic acids.   These methods are now 
routinely used to investigate the structure, dynamics and thermodynamics of biological 
molecules and their complexes. They are also used in the determination of structures 
from X-ray crystallography and from NMR experiments. 
Molecular dynamics simulations generate information at the microscopic level, 
including atomic positions and velocities. The conversion of this microscopic 
information to macroscopic observables such as pressure, energy, heat capacities, etc., 
requires statistical mechanics. Statistical mechanics is fundamental to the study of 
biological systems by molecular dynamics simulation. 
Simulations can provide the ultimate detail concerning individual particle motions 
as a function of time. Thus, they can be used to address specific questions about the 
properties of a model system, often more easily than experiments on the actual system 
The present generation of computers takes benefit of parallelism and accelerators 
to speed-up the process. The most popular simulation codes (AMBER [26], CHARMM 
[26], GROMACS [26], or NAMD [26]) have long been compatible with the messaging 
passing interface (MPI). When a large number of computer cores can be used 
simultaneously, MPI can greatly reduce the computation time. To benefit the locality of 
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interactions, the general strategy is to distribute the system to simulate among 
processors. This strategy is called spatial decomposition. Only a small fragment of the 
system has to be simulated in each processor. The most efficient division is not based in 
the list of particles, but in their position in space. Each processor deals with a region of 
space irrespective of which particles are present there [26]. 
One of the most practical application of the concept of molecular recognition are 
docking strategies, either small molecule or protein docking. To understand how a 
ligand, typically a substrate or a regulator, binds to its macromolecular counterpart is a 
key issue in the understanding of function itself, and it is the basis of structurally driven 
drug design. The recognition process is by nature dynamic. Molecules are flexible 
entities, and the recognition process itself implies structural rearrangements, and this 
shape adjustment is part of the binding process not only from the structural point of 
view, but also from the energetics. Although this is a generally well-accepted idea, 
docking algorithms are far from considering dynamic effects as a routine [26]. 
In a molecular dynamics simulation, one often wishes to explore the macroscopic 
properties of a system through microscopic simulations, for example, to calculate 
changes in the binding free energy of a particular drug candidate, or to examine the 
energetics and mechanisms of conformational change. The connection between 
microscopic simulations and macroscopic properties is made via statistical 
mechanics which provides the rigorous mathematical expressions that relate 
macroscopic properties to the distribution and motion of the atoms and molecules of the 
N-body system; molecular dynamics simulations provide the means to solve the 
equation of motion of the particles and evaluate these mathematical formulas. With 
molecular dynamics simulations, one can study both thermodynamic properties and/or 
time dependent (kinetic) phenomenon. 
An initial model of the system is obtained from either experimental structures or 
comparative modeling data. The simulated system could be represented at different 
levels of detail. Atomistic representation is the one that leads to the best reproduction of 
the actual systems [26]. 
There are three types of applications of simulation methods in the macromolecular 
area, as well as in other areas involving mesoscopic systems. The first uses simulation 
simply as a means of sampling configuration space. This is involved in the utilization of 
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molecular dynamics, often with simulated annealing protocols, to determine or refine 
structures with data obtained from experiments, as mentioned above. The second uses 
simulations to obtain a description of the system at equilibrium, including structural and 
motional properties (for example, atomic mean-square fluctuation amplitudes) and the 
values of thermodynamic parameters. For such applications, it is necessary that the 
simulations adequately sample configuration space, as in the first application, with the 
additional condition that each point be weighted by the appropriate Boltzmann factor.  
 
 
 
The third area uses simulations to examine the actual dynamics. Here not only is 
adequate sampling of configuration space with appropriate Boltzmann weighting 
required, but it must be done so as to correctly represent the development of the system 
over time. For the first two areas, Monte Carlo simulations can be used, as well as 
molecular dynamics. By contrast, in the third area where the motions and their 
development with time are of primary interest, only molecular dynamics can provide the 
necessary information. The three sets of applications make increasing demands on 
simulation methods as to their required accuracy and precision [27]. 
Solvent representation is a key issue in system definition [26]. 
The essence of molecular modeling resides in the connection between the macroscopic 
world and the microscopic world provided by the theory of statistical mechanics. 
Computational tools involved are: 
  
46 
 
 
• Quantum Mechanics (QM), Electronic structure (Schrödinger) 
 
• Classical Molecular Mechanics (MM), Empirical forces (Newton) 
 
• Mixed Quantum/Classical (QM/MM) 
 
 
For an atomic system, the potential energy function consists of a set of equations 
that empirically describe bonded and non-bonded interactions between atoms. This 
energy function together with the set of its empirical parameters is referred to as the 
“force field.” Molecular dynamics force fields usually consist of two major components. 
The first part describes interactions between atoms connected via covalent bonds, which 
typically includes bonds, bond angles, and dihedrals. The second part treats non-bonded 
interactions, typically as electrostatic interactions between the (partial) charges on each 
atom and a Lennard-Jones potential to model dispersive van der Waals interactions. 
Each molecule in the simulation is described by its ‘topology’, the combination of the 
set of all atoms with their non-bonded and bonded interaction parameters and the 
connectivity of those atoms in the molecule [28]. 
When a small molecule like a drug (for example, a ligand) approaches its target 
(for example, a receptor) in solution, it encounters not a single, frozen structure, but 
rather a macromolecule in constant motion. 
MD studies are also limited by the short time scales typically simulated. To 
reproduce thermodynamic properties and/or to fully elucidate all binding-pocket 
configurations relevant to drug design, all the possible conformational states of the 
protein must be explored by the simulation. Unfortunately, many biochemical 
processes, including receptor conformational shifts relevant to drug binding, occur on 
time scales that are much longer than those amenable to simulation. With some 
important exceptions, simulations are currently limited to at most millionths of a 
second; indeed, most simulations are measured in billionths of a second. 
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5. Capillary Electrophoresis  
 
5.1. Basic Principles 
 
Capillary electrophoresis (CE) was born of the marriage of the powerful 
separation mechanisms of electrophoresis with the instrumentation and automation 
concepts of chromatography [29]. 
Capillary Electrophoresis (CE) had a very significant impact on the field of 
analytical chemistry in recent years as the technique is capable of very high-resolution 
separations, requiring only small amounts of samples and reagents. Furthermore, it can 
be readily adapted to automatic sample handling and real-time data processing.  
Many new methodologies based on CE have been reported.  
Rapid, reproducible separations of extremely small amounts of chemicals and 
biochemicals, including peptides, proteins, nucleotides, DNA, enantiomers, 
carbohydrates, vitamins, inorganic ions, pharmaceuticals and environmental pollutants 
have been demonstrated.  
A wide range of applications have been developed in greatly diverse fields, such 
as chemical, biotechnological, environmental and pharmaceutical analysis [30]. 
Electrophoresis can be defined as the differential migration of charged species 
(ions) in an electric field, and was first described as a separation technique by Tiselius 
in 1937.  
In its simplest form, capillary electrophoresis involves the separation of charged 
analytes, based on the difference in their electrophoretic mobilities, resulting in different 
migration velocities.  
These separations are carried out in fused silica capillaries, typically 25–75 µm 
i.d. and 50–100 cm in length, filled with a background electrolyte (BGE) [30]. 
Capillaries were introduced into electrophoresis as an anti-convective and heat 
controlling innovation [30]. 
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When an electrical 
field is applied, the 
components begin to 
move in the field as 
previously described. The 
narrow capillary reduces 
lateral diffusion and 
insures that temperature 
differences between the 
center of the capillary and 
the wall are quite small. 
The geometry and other 
properties of the capillary 
electrophoretic separation also lead to a condition known as plug flow [29]. The 
capillary electrophoresis mechanism is based on two basic principles: electroosmotic 
flow and electrophoretic mobility. 
 
 
Electroosmosis 
 
The small diameter of the capillary contributes to another aspect of the separation 
process. This is the phenomenon known as electroosmosis, electroendoosmotic flow, or 
simply EOF. EOF exists in any electrophoretic system. 
 It will occur whenever the liquid near a charged surface is placed in an electrical 
field resulting in the bulk movement of fluid near that surface.  
Because the surface to volume ratio is very high inside a capillary, EOF becomes 
a significant factor in CE.  
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Fig. 5.1. The migration of the EOF inside the fused silica capillary by the application of a electric field. 
 
 
The velocity of the electroosmotic flow through a capillary is given by the 
Smoluchowski equation [31]: 
 
𝜈𝑒𝑜𝑓 = −(𝜀𝜁/4𝜋𝜂)𝐸 
 
  
where ɛ is the dielectric constant of the 
electrolyte, ζ is the zeta potential (Volts), η is 
the viscosity (Poise), and E is the potential 
applied (Volts/cm). In CE the zeta potential (ζ) 
is a measure of the charge on the wall of the 
capillary.  
This charge arises from both the nature 
of the material that composes the capillary and 
the composition of the electrolyte (buffer). The 
most commonly employed capillary material is 
fused silica.  
The surface of a fused silica capillary 
can be ionized to yield a negatively charged 
surface.  
The negatively charged wall attracts cations that are hydrated from the electrolyte 
solution, creating an electrical double layer. In an electrical field they migrate toward 
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the cathode, pulling water along and creating a 
pumping action. The zeta potential increases 
with the density of the charge on the surface. 
For fused silica and many other materials 
charge densities will vary with pH [31]. Bare 
fused silica behaves much like a weak acid with 
a pKa of 6.25. The relationship between EOF 
and pH is depicted in the graph above. 
EOF also decreases with the square root of the concentration of the electrolyte, i.e., 
increasing buffer concentration decreases the velocity of EOF. Although the 
aforementioned discussion has focused on bare fused silica capillaries, other types of 
surfaces can be chemically created from fused silica.  
The new surface may be positive, negative, or neutral. The direction of the 
electroosmotic flow will therefore depend on the sign of the charge on the wall of the 
capillary. Flow is always toward the electrode that has the same charge as the capillary 
wall. Thus, an uncharged wall will have, in theory, no EOF. In reality this is difficult to 
accomplish. In the narrow confines of the capillary the velocity of liquid is nearly 
uniform across the i.d. of the capillary resulting in what has been termed “plug flow”.  
This is in contrast to the laminar flow exhibited by pumps systems, which creates a 
velocity profile across the diameter of the tube. On the other hand, plug flow greatly 
reduces the band broadening seen in system such as HPLC that are pumped by a 
pressure differential.  
A comparison of laminar flow and plug flow is shown in the picture above. In 
practice it is very difficult to completely eliminate EOF, although it can be reduced to a 
value near zero. In many separations it is a significant factor, and it may affect the net 
movement of the analyte molecules more than does the electrophoretic force. The 
movement (vectors) due to the electrophoretic and electroosmotic forces may even be in 
opposite directions.  
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Electrophoretic migration in capillary tubes 
 
The CE system consists of a buffer-filled capillary placed between two buffer 
reservoirs, and a potential field which is applied across this capillary. 
 In general, the flow of electroosmosis is towards the cathode, and hence a 
detector is placed at this end. Separation by electrophoresis is based on differences in 
solute velocity in an electric field. The velocity of an ion can be given by 
        
 v = µe E                                             (1) 
 
where v = ion velocity; µe = electrophoretic mobility; E = applied electric field. 
The electric field is simply a function of the applied voltage and capillary length 
(in volts/cm). The mobility, for a given ion and medium, is a constant which is 
characteristic of that ion. The mobility is determined by the electric force that the 
molecule experiences, balanced by its frictional drag through the medium reported in 
the equation below: 
 
 µ𝑒 𝛼 =
𝐸𝑙𝑒𝑐𝑡𝑟𝑖𝑐 𝑓𝑜𝑟𝑐𝑒 (𝐸𝐹)
  𝐹𝑟𝑖𝑐𝑡𝑖𝑜𝑛𝑎𝑙 𝑓𝑜𝑟𝑐𝑒 (𝐹𝐹) 
                            (2) 
 
 
The electric force can be given by FE = q E (3) and the frictional force (for a 
spherical ion) by FF = -6 η π r v (4) , where q = ion charge;  η  = solution viscosity;  r = 
ion radius;  v = ion velocity. During electrophoresis a steady state, defined by the 
balance of these forces, is attained. At this point the forces are equal but opposite are 
expressed by this equation: 
 
 q E = 6 η π r v                             (5) 
 
Solving for velocity and substituting equation (5) into equation (1) yields an 
equation that describes the mobility in terms of physical parameters 
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The electrophoretic mobility usually found in standard tables is a physical 
constant, determined at the point of full solute charge and extrapolated to infinite 
dilution. This usually differs from that determined experimentally. The latter is called 
the effective mobility and is often highly dependent on pH (expressed by solute pKa) 
and composition of the running buffer [29]. 
 
 
Sample Injection 
 
In CE only minute volumes of sample are loaded into the capillary in order to 
maintain high efficiency. These small volumes are, of course, proportional to the small 
volumes of the capillaries. With respect to sample overloading, the injection plug length 
is a more critical parameter than volume [29]. The two most common are hydrodynamic 
and electrokinetic.  
Hydrodynamic sample injection is the most widely used method. It can be 
accomplished by application of pressure at the injection end of the capillary, vacuum at 
the exit end of the capillary, or by siphoning action obtained by elevating the injection 
reservoir relative to the exit reservoir. 
The volume of sample loaded will be a function of the capillary dimensions, the 
viscosity of the buffer in the capillary, the applied pressure, and the time. This volume 
can be using the Hagen-Poiseuille equation: 
 
t
c
L
tdP
V


128
4
  
 
Where P = pressure difference across the capillary; d = capillary inside 
diameter; t = time; η = buffer viscosity; L = total capillary length [33]. 
Electrokinetic, or electromigration, injection is performed by replacing the 
injection-end reservoir with the sample vial and applying the voltage. 
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Usually a field strength 3 to 5 times lower than that used for separation is applied. 
In electrokinetic injection, analyte enters the capillary by both migration and by the 
pumping action of the EOF. A unique property of electrokinetic injection is that the 
quantity loaded is dependent on the electrophoretic mobility of the individual solutes. 
Discrimination occurs for ionic species since the more mobile ions are loaded to a 
greater extent than those that are less mobile. 
The injected moles can be calculated by this equation: 
 
Crt
k
k
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

  
 
where r is the capillary radius, C  is sample concentration and cs kk  is 
conductivity BGE sample [32]. As described, sample loading is dependent on the EOF, 
sample concentration, and sample mobility. Variations in conductivity, which can be 
due to matrix effects such as a large quantity of an undetected ion such as sodium or 
chloride, result in differences in voltage drop and quantity loaded. Due to these 
phenomena electrokinetic injection is generally not as reproducible as its hydrodynamic 
counterpart. Despite quantitative limitations, electrokinetic injection is very simple, 
requires no additional instrumentation, and is advantageous when viscous media or gels 
are employed in the capillary and when hydrodynamic injection is ineffective [29]. 
 
 
Detection system 
 
Detection in CE is a significant challenge as a result of the small dimensions of 
the capillary. Although CE requires only nanoliter volumes of sample, it is not a “trace” 
analysis technique since relatively concentrated analyte solutions or pre-concentration 
methods are often necessary.  
A number of detection methods have been used in CE to meet this challenge, 
many of which are similar to those employed in liquid column chromatography. As in 
HPLC, UV Visible detection is by-far the most common [29]. 
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UV-Visible absorption is the most widely used detection method primarily due to 
its nearly universal detection nature. With fused-silica capillaries, detection below 200 
nm up through the visible spectrum can be used. The high efficiency observed in CE is 
due in part to on-capillary detection. Since the optical window is directly in the capillary 
there is no zone broadening as a result of dead-volume or component mixing. In fact the 
separation is still occurring while in the detection window [29].  
As with all optical detectors, the width of the detection region should be small 
relative to the solute zone width to maintain high resolution. This is best accomplished 
with a slit designed for specific capillary dimensions. Since peaks in CE are typically 2 
to 5 mm wide, slit lengths should be maximally one third this amount. Detector design 
is critical due to the short optical path length.  
The optical beam should be tightly focused directly into the capillary to obtain 
maximum throughput at the slit and to minimize stray light reaching the detector. These 
aspects are important to both sensitivity and linear detection range [29]. 
 
5.2. Modes of operation 
 
A CE system can be operated in several different modes. These modes offer the 
analyst a variety of ways to approach an analytical problem. The choice of mode will be 
based on the analytical problem under consideration [34]. 
 
5.2.1. Capillatry Zone Electrophoresis (CZE) 
 
Capillary zone electrophoresis (CZE) is the most widely used mode due to its 
simplicity of operation and its versatility.  
The application range of CZE is diverse. Application areas include the analysis of 
amino acids, peptides, ions, a wide range of enantiomers, and numerous other ionic 
species.  CZE is fundamentally the simplest form of CE, mainly because the capillary is 
only filled with buffer. Separation of both anionic and cationic solutes is possible by 
CZE due to EOF.  
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Neutral solutes do not migrate and all coelute with the EOF. The name CZE is 
somewhat confusing in that it implies that it is the only mode in which “zonal” 
electrophoresis occurs [35].  
In CZE, selectivity can most readily be altered through changes in running buffer 
pH or by use of buffer additives such as surfactants, co-surfactant or chiral selectors 
generally named pseudostationary phases (PSP). In this condition the mechanism of 
separation between analytes and PSP is based on their diffent mobilities and ripartition 
with PSP and BGE [36]. 
 
5.2.2. Micellar Electrokinetic Chromatography MEKC 
 
Micellar electrokinetic chromatography (MEKC or MECC) is a hybrid of 
electrophoresis and 
chromatography. 
Introduced by Terabe 
in 1984, MEKC is 
one of the most 
widely used CE 
modes [35]. Its main 
strength is that it is 
the only electrophoretic technique that can be used for the separation of neutral solutes 
as well as charged ones. The separation of neutral species by MEKC is accomplished by 
the use of surfactants in the running buffer. At concentrations above the critical micelle 
concentration, aggregates of individual surfactant molecules, micelles, are formed. 
Micelles are essentially spherical with the hydrophobic tails of the surfactant molecules 
oriented towards the center to avoid interaction with the hydrophilic buffer, and the 
charged heads oriented toward the buffer. A representation of micelles is here depicted. 
It is the differential interaction between the micelle and the neutral solutes that causes 
the separation. The surfactant and thus the micelles are usually charged and migrate 
either with or against the EOF (depending on the charge). Anionic surfactants such as 
SDS migrate toward the anode, that is, in the opposite direction to the EOF. Since the 
EOF is generally faster than the migration velocity of the micelles at neutral or basic 
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pH, the net movement is in the direction of the EOF. During migration, the micelles can 
interact with solutes in a chromatographic manner through both hydrophobic and 
electrostatic interactions. For neutral species, it is only partitioning in and out of the 
micelle that effect the separation [35]. 
The more the solute interacts with the micelle the longer is its migration time 
since the micelle carries it against the EOF. When the solute is not in contact with the 
micelle it is simply carried with the EOF. The more hydrophobic compounds interact 
more strongly with the micelle and are “retained” longer. The overall MEKC separation 
process is schematically represented in Fig. 5.2.2. 
 
 
 
Fig. 5.2.2. The migration order in a MEKC separation process. 
 
 The separation mechanism of neutral solutes in MEKC is essentially 
chromatographic and can be described using modified chromatographic relationships. 
The ratio of the total moles of solute in the micelle (that is, the pseudostationaryphase) 
to those in the mobile phase, the capacity factor, k', is given by:      
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where tR = retention time of the solute; t0 = retention time of unretained solute 
moving at the EOF rate (or “dead time”); tmc = micelle retention time. In the separation 
of neutral solutes, all solutes elute between t0 and tmc. Hydrophilic solutes that do not 
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interact with the micelle elute with the EOF and those that are totally retained by the 
micelles elute with the micelles. The selectivity can easily be manipulated in MEKC. In 
addition, MEKC can be performed using bile salts or microemulsions. In all cases, 
variations in buffer concentration, pH, temperature, or use of additives such as urea, 
metal ions, or chiral selectors can also be used to affect selectivity. Surfactants used for 
MEKC can also interact with the capillary wall and have dramatic effects on the EOF as 
well as solute-wall interactions. The direction of solute and micelle migration varies and 
depends on the micelle charge and the rate of EOF. Generally, high pH buffers are used 
to maintain reasonable EOF and ensure migration direction. 
 
5.2.3. Microemulsion Electrokinetic Chromatography (MEEKC) 
 
Microemulsion electrokinetic chromatography is a powerful technique employed 
in separation with neutral and charged analytes with a high range of solubility. The 
BGE consists in a microemulsion system [37]. 
Microemulsion, which is a dispersion of oil and water stabilized by surfactant 
molecules and/or short-chain alcohol (cosurfactant), was first introduced to 
electroseparation fields when microemulsion electrokinetic chromatography (MEEKC) 
was proposed by Watarai in 1991 [38].  
MEEKC can separate analytes in a similar fashion as micellar electrokinetic 
chromatography (MEKC). Two effects determine the separation results of both MEEKC 
and MEKC systems. One is the difference of the partition coefficients of analytes in 
pseudostationary and aqueous phases (chromatographic effect), and the other one is the 
difference of migration velocities of analytes in electric fields (electrophoresis effect) 
[38]. Unlike the micelle that is regarded as pseudostationary phase for MEKC, the 
surfactant-coated oil droplets in microemulsion are employed as the pseudostationary 
phase for MEEKC. 
 Most papers which compared separations obtained by MEEKC and MEKC had 
concluded that highly hydrophobic compounds tend to be strongly retained by the 
micelles, thus MEEKC has a greater separation capability for highly hydrophobic 
compounds. In addition, since analytes are able to more easily penetrate the surface of 
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oil droplets when compared to micelles’ more rigid surfaces, as a result MEEKC is 
applicable to a wider range of analytes than MEKC [38].  
 
 
 
Fig. 5.2.3. Schematic representation of a microemulsion, which is a dispersion of oil and water stabilized by 
surfactant molecules and/or short-chain alcohol (cosurfactant). 
 
Microemulsions solutions containing dispersed nanometre-sized droplets that 
allows chromatographic separation to 
be oblets of an immiscible liquid. 
Microemulsions are solutions 
containing dispersed nanometre-sized 
droplet of an immiscible liquid. In 
particular the microemulsions used in 
MEEKC are oil droplets dispersed in 
an aqueous buffer. The oil and water 
components are totally immiscible and do not mix together as there is a high surface 
tension between them [39]. 
The oil droplets are coated with a surfactant to reduce the surface tension between 
the two liquid layers which allows the emulsion to form. The surface tensions further 
lowered by the addition of a short-chain alcohol such as butan-1-ol which stabilies the 
microemulsion system. The microemulsion is therefore optically transparent as a larger 
droplet scatter white light. 
Disintegration of the emulsion system actually represents an activation barrier, as 
the surface separationsion of the system is at an energy low. Therefore, if the 
combination of oil, surfactant and co-solvent is appropriate then the microemulsion 
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systems are highly stable and remain intact indefinitely. Use of a microemulsion 
containing ionic surfactant solutions allows chromatographic separation to be obtained 
as solutes can partition between the charged oil droplet and the aqueous buffer phase.  
Water insoluble compounds will favour inclusion into the oil droplet rather than into the 
buffer phase. This situation allows partitioning of the solute between the oil and water 
phases in a chromatographic fashion.  
Solutes chromatographically interact with the micelles to achieve separation. 
Solutes are more easily able to penetrate the surface of the droplet than the surface of a 
micelle which is much more rigid. This ability allows MEEKC to be applied to a wider 
range of solutes. Sodium dodecyl sulphate (SDS) is the most widely used emulsifier 
surfactant in MEEKC. The oil droplet is coated with SDS surfactant molecules making 
the droplet negatively charged. The C12 alkyl chain of the surfactant penetrates into the 
oil droplet whilst the negatively charged hydrophilic sulphate groups resides in the 
surrounding aqueous phase. Charge repulsion of the negatively charged sulphate group 
on the SDS prevents highly efficient packing and prevents formation of an emulsion as 
the surface tension cannot be sufficiently reduced. A co-surfactant, usually a medium-
chain-length alkyl alcohol such as butan-1-ol, is therefore essential in the formation and 
improved stability of the microemulsion. The co-surfactant bridges the oil and water 
interface and further reduces the surface tension of the system to zero. The Fig. 5.2.3 
provides a schematic of the emulsion droplet showing the short-chain alcohol, SDS, the 
octane droplet and the sodium ions surrounding the droplet [39]. 
The microemulsion is a dynamic entity and it has a lifespan in the microsecond 
range.  
The emulsion droplets exist in a variety of shapes with an average that is 
spherical. The range of droplet shapes that an individual emulsion system contains has 
been measured and is known as the polydisperity. A highly ordered microemulsion 
system has a low polydisperity and highly spherical droplets. The surfactant and co-
surfactant act together to reduce the surface tension between the two liquid phases to 
zero. The presence of the co-surfactant helps the droplets to pack more effectively and 
create a more stable environment [39]. 
The options available in method development in MEEKC will be described which 
include type and concentration of surfactant, buffer pH and the type of oil. Selectivity 
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can also be affected by organic solvents, type of co-solvent, addition of cyclodextrins 
ion-pair reagents and the manufacture process for the microemulsion. MEEKC is a 
relatively recent technique and it has not been widely applied to a range of application 
types. However, there are currently sufficient applications to demonstrate the 
widespread potential uses of MEEKC. The reported application range will be 
summarised to provide an appreciation of the separation possibilities that MEEKC may 
offer [39]. 
Overall it is concluded that MEEKC can offer the possibility of highly efficient 
separations of a range of solute types. The technique can be equally applied to water-
soluble and insoluble compounds and to charged or neutral solutes. It is predicted that 
use of MEEKC will increase rapidly as awareness of these possibilities increases. 
 
 
 
Surfactant type and concentration 
 
Surfactants are molecules with detergent properties, which are composed of a 
hydrophilic water-soluble head group and a hydrophobic water-insoluble hydrocarbon 
chain group. Although a large number of surfactants are commercially available, a 
limited number are widely used in MEKC separations. The surfactants suitable for 
MEKC must be soluble in the buffer solution to form micelles and the micellar solution 
must be homogeneous, UV transparent and also have a low viscosity [40]. 
There are four major classes of surfactants: anionic, cationic, zwitterionic and 
nonion. The most common and frequently used are listed below. 
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Of these, ionic surfactants are generally used in MEKC. Every surfactant has a 
characteristic CMC (Critical Micellar Concentration) and aggregation number n (the 
number of surfactant molecules necessary to form a micelle). Another important 
parameter is the Kraft point, which represents the minimum value of temperature to 
whom the solubility of surfactants increases steeply due to the formation of micelles 
The choice of surfactant has a marked effect on the separation achieved in 
MEEKC as it affects the oil droplet charge and size, the level and direction of the EOF, 
and the level of any ion-pairing with charged solutes. SDS is an anionic surfactant with 
a C12 alkyl chain, which penetrates into the oil droplet. Anionic bile salt surfactant such 
as sodium cholate has also been used to generate negatively charged droplets. Use of 
bile salt microemulsions gave different selectivity compared to when SDS was used to 
make the microemulsions [37]. 
Higher concentrations of the surfactant increase the capacity factor of neutral 
solutes as it increases the charge density on the oil droplet. If a mixture of charged and 
neutral solutes is employed, then altering the surfactant concentration will have an 
effect on peak migration order. Increasing the surfactant concentration also increases the 
ionic strength of the buffer which reduces the EOF level and increases analysis time. 
Higher levels of surfactant reduce surface tension to a greater extent which 
generates more stable microemulsions.  
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Nonionic surfactants do not posses electrophoretic mobility and cannot be used, as 
“pseudostationary phase” in conventional MEKC, however can be useful for the 
separation of charged analytes. This technique using nonionic micelles can be classified 
as an extension of MEKC [40]. 
Micelles are amphiphilic aggregates of surfactants. Above a specific surfactant 
concentration, the surfactant molecules begin to self-aggregate, forming micelles, 
spherical aggregates that exhibit electrophoretic migration like any other charged 
particle. Micelles are a long chain molecules and are characterized as possessing a long 
hydrophobic chain and a hydrophilic head group. Generally, micelles are formed in 
aqueous solution with the hydrophobic tails oriented towards the center of the 
aggregated molecules and the hydrophilic heads pointing outward into the aqueous 
solution. 
Micelle formation is a very dynamic process, as micelle disaggregate and 
reconstruct continuously, composing the “pseudostationary phase” which can include 
hydrophobic analytes. 
Micellar solutions can solubilize hydrophobic compounds which otherwise would 
be insoluble in water. Micelles have the ability to interact with the analytes at molecular 
level based on hydrophobic and electrostatic interactions.  
Even neutral analytes can bind to micelles due to the very strong solubilization 
power of the hydrophobic core [40]. 
The micelles used in MEKC are charged on the surface, so an analyte with the 
opposite charge will strongly interact with the micelle through electrostatic forces while 
an analyte with the same charge will interact weakly due to the electrostatic repulsion. 
Therefore, the use of a cationic or an anionic surfactant will result in an entirely 
different result. The micellar phase can be modified by adding two different surfactants 
to form a mixed micelle; addition of an ionic and a nonionic surfactant can provide 
different selectivity in separation. A mixed micelle has a lower surface charge and a 
larger size; consequently, its electrophoretic mobility will be lower than the one of a 
simple ionic micelle [40]. Some surfactants like bile salts are chiral and can be used for 
enantiomers separation. Typically, SDS concentrations in the region of 110 mM (3%, 
w/w) are used which produces highly stable microemulsions with shelf lives exceeding 
several months. SDS concentrations as high as 6.5% (w/w) have been used [40]. 
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Oil type 
 
Generally, octane or heptane has been used to generate the oil droplet. Heptane 
may be preferred as the odd numbered alkanes have lower toxicity than the even 
numbered alkanes [41]. However, octane has been reported to give more repeatable 
microemulsions than heptane. Hexane, heptane and octane have been shown to give 
similar selectivity and migration times for separation of a range of neutral compounds 
[39]. 
 
 
 Addition of organic solvents 
 
In MEKC highly water insoluble solutes partition strongly into the micelles and 
are therefore highly retained with poor resolution of mixtures. In these instances, 
organic solvent are often added into MEKC buffers to reduce retention and improve 
resolution. Standard solvents used are acetonitrile, methanol and isopropanol. This 
approach has also been used in MEEKC [39]. 
The levels of solvent that can be added to 
MEKC buffers is generally limited to a 
maximum such as 30% (v/v). At levels greater 
than this the micelle are disrupted and 
selectivity is lost. It was found that there were 
also limits to the maximum solvent contents 
that could be used in MEEKC. When these 
limits were exceeded the microemulsion buffers disintegrated into a cloudy two-phase 
system, which could not be used for separation [39]. 
 
 
Co-surfactant type and concentration 
 
Butan-1-ol is the most frequently employed co-surfactant. Studies have shown 
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that the separation selectivity is unaltered by variation of the butan-1-ol concentration. 
Higher butan-1-ol concentrations reduce migration times for water-insoluble solute but 
do not alter the capacity factors [42].  The migration times are altered with varying co-
surfactant concentration as it affects the solution viscosity which in turn affects the EOF 
rate [39].  
The size of the oil droplet increases with increased co-surfactant concentration 
which will affect the charge density on the droplet. Variation of co-surfactant 
concentration over a wide range affected the migration times of hop bitter acids [43]. 
This short chain alcohol is the most commonly applied cosurfactant for MEEKC, 
has a log P value (1-octanol/water partition coefficient) of 0.84, is considerably soluble 
in water [42], and due to medium chain length simultaneously exhibits properties, 
which are typical both for hydrophilic (propanol) and hydrophobic (pentanol) alcohols. 
In both MEKC and MEEKC, nBuOH is present in the aqueous buffer phase and in the 
Stern layer of the micelles, but also can penetrate into the micelles/microemulsion 
droplets, acting as a true class I modifier [42]. 
 By using the two-dimensional NOE spectroscopy, it has been demonstrated that 
the nBuOH headgroup is located in contact with the SDS micellar headgroups, while 
the hydrocarbon chain is directed to the micelle core [40]. In particular, adding the 
alcohol to micelles, the size-to-charge ratio of the micelles increases because nBuOH 
reduces the charge density and promotes the formation of micelles with a more open 
structure [42].  
Mixed SDS–nBuOH micelles have been recently reviewed in terms of 
micellization parameters and structure [41]. 
 
 
 Normal Polarity 
 
In normal polarity, the positive pole, is set at the beginning of the capillary (inlet) 
and the cathode, the negative pole, at the end (outlet). A negative PSP (Pseudostationary 
Phase), carrying a negative effective mobility, migrates to the anode, is necessary the 
use of an alkaline BGE in order to obtain a high EOF and carry analytes and PSP to the 
detector. In this condition the analytes are negative charged or uncharged. 
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Fig. 5.2.3. The migration order in Normal Polarity. 
 
Inverse Polarity 
 
In inverse polarity the anode, the positive pole, is set at the end (outlet) of the 
capillary and the cathode, the negative pole, at the beginning (inlet).  
In order to carry a negative PSP (Pseudostationary Phase), carrying a negative 
effective mobility, to the anode, is necessary to avoid the EOF (Electroosmotic Flow).   
The use of BGE with low pH and high ionic force lead to the migration of 
analytes and PSP that are positive charged or uncharged 
 
 
Fig. 5.2.3. The migration order inInverse Polarity. 
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5.3. Cyclodextrins in CE (CD) 
 
Several forms of CE have been developed extensively over the last decade as 
powerful tools for rapid and efficient separation of charged and uncharged components 
present in small sample volumes. 
 Cyclodextrin-based complexation phenomena have received considerable 
attention in analytical separation science and particularly in capillary electrophoresis 
[44]. Cyclodextrins are oligosaccharides prepared by enzymatic degradation of starch 
and glycosyl transferases or cyclodextrinases producing a mixture of different CDs that 
can be separated by using, e.g., chromatography, crystallisation etc. 
They have a shape of a 
truncated cone with an 
open cavity, relatively 
hydrophobic and an 
outside hydrophilic 
due to the presence of 
hydroxyl groups 
(positions 2, 3 and 6 of glucopyranose). Nevertheless, CDs with 6 to 12 glucose units 
have been separated, only those with six, seven and eight units (with the Greek names 
α-, β- and γ-CD, respectively) are currently used in analytical chemistry. The physical 
properties of the three native CDs are quite different, e.g., width of the cavity, 
solubility, molecular mass etc., however they possess the same depth [45]. 
Enhancement of selectivity using cyclodextrins in CE can be attributed to their 
ability to selectively include a wide variety of water-insoluble organic and inorganic 
molecules into their hydrophobic cavity.  
The ability of cyclodextrins to act stereoselectively upon complexation with a 
guest molecule has also been well recognized in liquid chromatography, both as a 
mobile-phase additive and as a chiral stationary phase. The most frequent use for CDs 
in capillary electrophoresis has been as modifiers to effect chiral separation of 
enantiomers of charged compounds. Together with a micelle agent, neutral CDs can be 
extended for the chiral resolution of small neutral and hydrophobic compounds as a 
result of their partition between the micellar phase and the cyclodextrin-modified buffer. 
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Negatively charged CDs with their own electrophoretic mobility can also be prepared 
and used in CE to increase the separation window which enables better resolution or 
enantioresolution of analytes which weakly complex with or are poorly differentiated by 
neutral CDs [44]. Since two enantiomers possess similar physico–chemical properties, 
for a successful enantiomer resolution in CE, it is necessary to selectively modify the 
effective mobilities of the two analytes. This can be obtained on forming stereoselective 
complexes where hydrophobic, hydrogen, π–π, dipole, van der Waals interactions can 
be involved. 
In CE the separation of chiral compounds is achieved mainly by the direct 
separation method where the chiral selector is simply added to the BGE or bonded to 
either the capillary wall or to a stationary phase. Using CDs, analytes fit the cavity 
either with the whole molecule or with their hydrophobic part on forming inclusion-
complexes stabilised by secondary bonds between the rim of the chiral selector and 
substituent groups of the analyte asymmetric centre. The complex formed during the 
electrophoretic process, in equilibrium with the free analyte, possesses a different mass 
responsible for the change of the effective mobility [45]. 
While not as common, neutral and charged cyclodextrins have been used as 
additives in CE to optimize the separations of peptides, proteins, and small achiral 
molecules such as plant regulators, food colors, positional isomers, and toxic pollutants. 
Native CD and their nonionic derivatives are very effective in enhancing both 
selectivity and resolution through judicious partitioning of net charged guest molecules 
into their hydrophobic cavity. Together with a micelle agent, they have proven very 
useful for resolving numerous neutral and hydrophobic compounds in biological or 
environmental samples [44]. 
Neutral CD such as α, β, and γ and their derivatives are only useful to separate 
solutes with a net charge. In general, CD enhance both selectivity and resolution 
through judicious partitioning of guest molecules into the host hydrophobic cavity. 
Formation of the inclusion complex is facile on the electrophoretic time scale and 
the apparent mean mobility of a solute can be related to the intrinsic mobility of the 
solute (μA) and the solute–cyclodextrin inclusion complex (μACD): 
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[ACD]/([A]+[CD]) where [CD], [A], and [ACD] are the concentrations of 
cyclodextrin, solute, and inclusion complex, respectively [44].  
Therefore, the quality of a resolution and sensitivity are governed by the 
cyclodextrin concentration in the electrolyte solution, and the selectivity is dependent 
upon whether the solute will form a strong or weak complex with the cyclodextrin.  
In pharmaceutical and drug analysis, several cyclodextrin modified CE methods 
have been developed for separation and quantitation of important drugs in biological 
samples.  
The use of CE to determine drug-related impurities has also become established 
within industrial pharmaceutical analysis laboratories [46]. 
 
 
Fig. 5.3. Schematic representation of CD-MEKC operative condition. 
 
Adding CD to the MEKC system has been shown to increase the versatility of the 
CE technique, particularly in separation of geometrical isomers of water-insoluble 
compounds. Sodium dodecyl sulphate (SDS) is the most used surfactant forming 
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micelles in CE for the enantiomers separation in presence of CDs. The method, called 
cyclodextrin-modified micellar electrokinetic chromatography (CD-MEKC) was firstly 
used by Terabe et al. [47] for the separation of hydrophobic achiral compounds such as 
chlorinated benzene congeners, polycyclic aromatic hydrocarbons, etc.   
A micellar (SDS) and an aqueous phase containing the CD compose the system. A 
relatively high EOF transports the hydrophobic analytes to the detector (cathode) while 
SDS particles, negatively charged, possess their own mobility opposite to that of EOF. 
The analytes interact with SDS and CD modifying their mobility according to the 
different partition between the micellar and the aqueous phases. 
Several types of CDs: α-CD, β-CD, 2,6-di-O-methyl-β-CD, 2,3,6-tri-O-methyl-β-
CD and γ-CD were used together with SDS to manipulate the selectivity in CD-MEKC. 
Cyclodextrin-modified MEKC has found a variety of important applications in food, 
pharmaceutical, clinical analysis and biotechnology. Under normal electrophoretic 
conditions, the micellar mobility is of a smaller magnitude than the electroosmotic flow; 
thus, both the running buffer and micellar phases are transported at different velocities 
towards a common outlet of the separation capillary. Normally, the negatively charged 
micelle migrates at a significantly slower rate than the buffer phase, and functions as a 
pseudo-stationary phase. Both charged and neutral compounds can partition between the 
two phases, resulting in retention based on differential solubilization by the micelles. 
Neutral CDs can be added as an additive in micellar solutions for CD-MEKC 
separations to resolve lipophilic compounds which migrate close to the micelle and 
cannot be separated by the micellar solution alone. Since CDs are electrically neutral 
and their outside surface is hydrophilic, they do not interact with the micelle and move 
along with the buffer phase [46]. 
When a hydrophobic solute is introduced to the CD-MEKC system, it will be 
incorporated by either the micelle or CD. The capacity factor, k*, of a hydrophobic 
solute in CD-MEKC is expressed as αVmc/VC where Vmc and VCD are the volumes of 
micelle and CD, respectively. The distribution coefficient α indicates the relative 
affinity of the solute between the micelle and CD. The ratio of the solute incorporated in 
the micelle largely depends on its hydrophobicity, but the inclusion complex formation 
of the solute with CD will depend on the size of the solute and the internal cavity of CD 
in addition to the hydrophobicity. Therefore, the selectivity in CD-MEKC is mostly 
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governed by the tendency of the hydrophobic solute to form an inclusion complex with 
CD. A solute included more strongly in the CD cavity is expected to have a shorter 
migration time than a solute included less strongly in the CD cavity [44]. 
In food, pharmaceutical, and environmental analysis, measurement of trace levels 
of both charged and uncharged compounds is important and there is always a continuing 
need to develop better and faster separations using less and less materials. Besides the 
importance of cyclodextrins in chiral separation, there is little doubt that various forms 
of CE using cyclodextrins will be developed and become one of the most useful 
separation techniques to address `real world' problems in achiral separation and 
detection of small and neutral compounds [44]. 
 
 
5.4. Validation 
 
The objective of any analytical measurement is to obtain consistent, reliable and 
accurate data. Validated analytical methods play a major role in achieving this goal. The 
results from method validation can be used to judge the quality, reliability and 
consistency of analytical results, which is an integral part of any good analytical 
practice. Validation of analytical methods is also required by most regulations and 
quality standards that impact laboratories. 
The objective of validating an analytical procedure is to demonstrate “suitability 
for its intended purpose”.  
The intent of analytical measurement is to generate accurate and reliable data. 
Method validation alone cannot guarantee this, but it should be part of integrated quality 
assurance for analytical measurement. 
According to USP analytical methods should be validated through laboratory 
tests: “Validation of an analytical procedure is the process by which it is established, by 
laboratory studies, that the performance characteristics of the procedure meet the 
requirements for the intended analytical applications”.  
The required laboratory tests for method validation have been defined in different 
working groups of national and international committees and are described in the 
literature.  
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Unfortunately, some of the definitions vary between the different organizations.  
Therefore, laboratories should have a glossary with definitions on their 
understanding of the terms.  
In an attempt to standardize, representatives from the industry and regulatory 
agencies from the United States, Europe and Japan defined parameters, requirements 
and methodology for analytical methods validation through the Internation Conference 
of Harmonization (ICH). The parameters, as defined by the ICH and other organizations 
and authors, are summarized in the table below: 
 
 
 
Method validation is an essential component of the measures that a laboratory 
should implement to permit it to produce reliable analytical data [48]. At the same time, 
validation, following reputable international authorities has to be a cost-effective step of 
method development in order to encourage all scientists to make use of it. In fact, many 
academicians develop and optimise analytical methods using pure standards, leaving 
validation or application to those in the field [48]. These unvalidated methods are 
allowed to assume the aura of validity and authenticity, when, in practice, they may 
never be completely useful with samples that are typically encountered. A way to speed 
up the validation process consists of the use of experimental design, which can be very 
useful and advantageous for both the evaluation and the optimisation of some 
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performance parameters. Experimental design techniques are powerful tools for the 
exploration of multivariate systems [49]. In particular, statistical design is a way of 
choosing experiments efficiently and systematically to give reliable and coherent 
information. From a statistical standpoint, design means construction of experiments so 
that the analysis of results yields the maximum amount of information that can be 
extracted from the experiments. More specifically, experimental design helps the 
researcher to verify if changes in factor values produce a statistically significant 
variation of the observed response, and this approach can be used each time it is 
necessary to have this type of information. Typically, experimental design techniques 
are used to understand the effect of several variables on a system by a well-defined 
mathematical model [49]. The strategy is most effective if statistical design is used in 
most or all stages of development and not only for screening or optimising the process. 
A systematic use of statistical design in developing a method ensures traceability, 
supports validation, and makes the subsequent confirmatory validation much easier and 
more certain [49]. 
Experimental design strategies can be used in the pre-validation process 
(investigation of accuracy, precision and robustness) of analytical methods. In 
particular, the use of experimental design for the improvement of accuracy and 
precision is a very attractive goal, and the use of experimental design during validation 
constitutes a basic feature of multivariate optimisation, which, if appropriately used, can 
solve several problems and constitutes a powerful tool in the hands of researchers 
 
 
6. Quality by Design 
 
6.1. Introduction 
 
At the beginning of the twentieth century, Sir Ronald Fisher introduced the 
concept of applying statistical analysis during the planning stages of research rather than 
at the end of experimentation. When statistical thinking is applied from the design 
phase, it enables to build quality into the product, comprising system thinking, variation 
understanding, theory of knowledge, and psychology [41]. 
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The pharmaceutical sector is process-based and quality oriented, thus it would be 
expected to adopt the aforementioned paradigms early after their introduction [41].  
However, the US Food and Drug Administration introduced quality by design 
(QbD) as a fundamental pharmaceutical quality model to be considered in the 
development of pharmaceutical products and processes [50, 51].  
QbD principles have also been supported by International Conference on 
Harmonisation (ICH) guidelines Q8(R2), Q9, and Q10. ICHQ8(R2) on pharmaceutical 
development gives a basis for risk mitigation via the in-depth product and process 
understanding gained in pharmaceutical development, whereas ICHQ9 on quality risk 
management develops the principles and some of the tools of quality risk management 
for assessment, control, communication, and review of the risks of the quality of the 
medicinal product. ICHQ10 on pharmaceutical quality systems complements 
ICHQ8(R2) and ICHQ9 by establishing a model for a pharmaceutical quality-
management system that would facilitate innovation and continuous improvement 
throughout the lifetime of the product. 
Fortunately, with the development of the concept of QbD, there will be a 
significant transformation in pharmaceutical quality regulation, from an empirical 
process to a more scientific and risk-based approach [49]. 
QbD is defined as “a systematic approach to development that begins with 
predefined objectives and emphasizes product and process understanding and process 
control, based on sound science and quality risk management” [52].  
By means of QbD, quality is designed into the process at the onset, thus 
counteracting the traditional quality by testing (QbT) approach, which tests product 
quality by checking it at the end of the manufacturing process. QbD leads to the 
establishment of the design space (DS), defined as the “multidimensional combination 
and interaction of input variables and process parameters that have been demonstrated 
to provide assurance of quality” [52].  
According to this definition, DS should be characterized by multivariate 
techniques, therefore the use of design of experiments (DoE) has emerged as a 
fundamental activity for implementing QbD. 
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DoE is an excellent tool that allows pharmaceutical scientists to systematically 
manipulate factors according to a pre-specified design. A good design is based on sound 
cognition of product and effective management of whole process during manufacturing. 
DoE studies work together with mechanism-based studies to achieve better product and 
process understanding [48]. 
DoE is a reasonable method to determine the relationship between the inputs and 
outputs of a process. It can help identify optimal conditions, CMAs, CPPs, and, 
ultimately, the Design Space. It is wise to establish a Design Space through DoE for 
multivariate experiments [48]. 
QbD was originally intended for pharmaceutical product development, and has 
been mainly applied to small molecules, including formulation issues [53-54], synthesis 
of the active pharmaceutical ingredient (API) [55], and to biopharmaceuticals [55]. 
QbD has been attracting increased attention in the development of analytical 
separation methods, because these are intended to be used for quality control and 
analysis of API and drug products, to ensure product quality and thus patient safety 
[56].  
Thus, analytical methods can be regarded as an integral part of the QbD concept 
and should meet their intended purpose similarly to the product requirements for a 
dosage form [56]. Many of the terms used in QbD are very familiar to analytical 
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chemists, including DoE, which has already been extensively used in the development 
of chromatographic and capillary electrophoretic (CE) methods [57, 58]. DoE 
incorporates a set of characteristics which are essential in QbD, for example the 
possibility of detecting interactions between the factors, of being used for both 
screening of factors and process characterization and optimization, and for 
simultaneously optimizing multiple responses [59]. 
Not all of the reviewed examples implement each step of QbD, and the different 
aspects of QbD may have been interpreted differently by the different authors, even if 
there are important commonalities. The general QbD guide for separation method 
development is here shown. 
 
 
 
 
Fig. 6. 1. The general Quality by Design guide for separation method development. 
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6.2. Definition of quality target product profile and critical quality 
attributes 
 
The analytical target profile (ATP) is a set of criteria that define what will be 
measured (e.g. the level of a specified impurity) and the performance criteria to be 
achieved by the measurement (e.g. accuracy, precision and range), but without 
specifying the method itself [59]. On the basis of ATP, different analytical methods 
and/or techniques are evaluated in a preliminary investigation to approach the method 
objective, in general with the purpose of achieving maximum selectivity with adequate 
efficiency, and improving the reproducibility and repeatability of measurements. 
Investigation of HPLC methods can involve selection of basic conditions, for example 
type of column (size and composition), pH, and organic modifier [59]. Investigation of 
CE methods can include selection from the different modes of operation on the basis of 
background electrolyte composition, which may consist of a plain buffer or may contain 
a pseudostationary phase mostly based on micelles or microemulsions. After these 
preliminary experiments, the QbD workflow can start, first by defining the quality 
target product profile (QTPP) and the critical quality attributes (CQAs). 
Quality Target Product Profile (QTPP) is defined as a prospective summary of 
quality characteristics of a drug product to be achieved, taking into account dosage 
strength(s) and container closure system of the drug product, together with the attributes 
affecting pharmacokinetic characteristics (e.g., dissolution, aerodynamic performance) 
and drug product quality criteria (e.g., sterility, purity, stability and drug release) 
appropriate for the intended marketed product [48]. Applying this definition to 
analytical methods means that, first, the separation objectives should be well defined 
[60]. 
CQA is a “physical, chemical, biological or microbiological property or 
characteristic that should be within an appropriate limit, range, or distribution to ensure 
the desired product quality” [52]. In analytical methods, CQAs are key response 
variables, so the chromatogram or electropherogram will be related to a mathematical 
representation of quality [61]. CQAs can be classified into two major categories: “must 
have” and “intend to have”. For instance, resolution of a pair of adjacent peaks must be 
not less than 1.5, and is intended to be not less than 1.8 [59]. Some examples of CQAs 
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are the critical resolution RS, run time, efficiency and, in contrast with the QbT 
approach, robustness [61]. The separation criterion S was recently introduced [62, 63], 
and was defined as the difference between the retention times measured at the beginning 
of the second peak and at the end of the first peak of the critical pair. S was preferred to 
RS to define the quality of the separation, because RS modeling can lead to poor 
prediction, as a result of its non-linear and non-continuous behavior, when selectivity 
(order of the peaks) drastically changes. Moreover, even if S and RS are highly 
correlated, computation of S is easier and its associated uncertainty is lower [62, 63].  
 
 
6.3. Identification of critical process parameters by quality risk 
assessment 
 
Critical process parameters (CPPs) are defined as “parameters whose variability 
have an impact on a CQA and therefore should be monitored or controlled to ensure the 
process produces the desired quality”, and this statement can be fit perfectly to 
analytical methods. 
 
 
Fig. 6.3. Schematic representation of a Ishikawa diagram for the optimization of method performances. 
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 Lionberger et al. proposed classification of parameters into three categories: 
unclassified, critical or non-critical. The criticality of an unclassified parameter is 
undetermined or unknown, whereas a parameter is critical when a change in that 
parameter can cause the product to fail to meet the QTPP. Development studies should 
be able to move unclassified parameters to either non-critical or critical, otherwise they 
may need to be constrained at fixed values or narrow ranges because they might be 
critical [64]. The initial list of potential parameters which can affect CQAs can be quite 
extensive but can be reduced and prioritized by quality risk assessment (QRA). QRA is 
a sciencebased process [48] that can aid identification of CPPs and thus eliminating 
risk, resulting in high confidence that the analytical method will meet the QTTP under 
all conditions of use [48] Thus, a large number of parameters can actually be safely 
eliminated by use of QRA tools [4], for example failure mode effects analysis (FMEA) 
and Ishikawa diagrams [65] on the basis of prior knowledge and initial experimentation.  
In FMEA the variables are ranked on the basis of the likelihood failure will occur 
(probability), affect on the analytical results (severity), and difficulty of detection 
(detectability), resulting in a risk priority number (RPN). Factors with an RPN above a 
cut-off level can then be evaluated by subsequent studies whereas factors with a lower 
RPN can be eliminated from further study [59]. Ishikawa diagrams segregate risks into 
different categories, for example those associated with instrumentation, materials, 
methods, measurements, laboratory climate, and human factors.  
An Ishikawa diagram for an HPLC assay and impurities method was presented, 
highlighting the different sources of factors, followed by a CNX analysis to decide 
which factors should be controlled (C)—these were the potential noise (N) factors—and 
on which experiments (X) should be conducted to determine acceptable ranges [48]. In 
general, critical conditions in the overwhelming majority of HPLC separations are 
gradient time, temperature, pH of the aqueous phase, composition of organic modifier, 
and stationary phase [66]. The CPPs which are typically evaluated by DoE are shown; 
the other parameters are usually fixed by preliminary experiments and/or prior 
knowledge. 
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6.4. Investigation of knowledge space by Design of Experiments 
 
After QRA, screening studies by means of DoE-effect analysis can be used to 
evaluate the effect of the higher-ranked CPPs and further reduce the number of CPPs to 
be studied in greater detail by selecting the 
factors that have a greater effect [67]. QRA 
tools, prior knowledge, and preliminary 
experiments are used to define knowledge 
space (KS), which is the experimental 
region investigated by screening DoE [67, 
68]. Further preliminary experiments 
specifically aimed at proper selection of the 
investigation domain may be necessary, 
because the choice of a suitable KS 
minimizes the risk of not achieving good separation [63]. The object is to perform a 
minimum number of experiments on a maximum number of factors, so main-effects 
models are estimated mostly with fractional two-level and Plackett–Burman designs [11]. 
As an example, a Plackett–Burman design was used to screen the effects of mobile 
phase pH, flow rate, temperature, injection volume, and methanol concentration on peak 
resolution and USP tailing. Pareto ranking analysis by multivariate regression revealed 
that the statistically significant factors were pH, temperature and injection volume, 
which were further studied [69]. Screening is also typically used for discontinuous 
conditions, for example column, buffer and solvent choice; subsequent optimization by 
responsesurface methodology (RSM) is reserved for continuous conditions, for example 
temperature and gradient design [61]. Screening approaches can involve simple peak 
counting, followed by refinement of quality attributes reflecting resolution of specific 
components in RSM, thus automated peak tracking has recently become a valuable 
screening tool [61]. Sometimes DoE screening can be eliminated by conducting 
preliminary experiments and/or prior knowledge, enabling direct optimization by RSM 
[16, 60, 66]. In RSM, different designs, for example full factorial, fractional factorial, 
D-optimal, central composite, Box–Behnken, and Doehlert designs, can be used to 
evaluate the main, interaction and/or quadratic effects of the factors [11, 58]. Awotwe-
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Otoo et al. applied a Box–Behnken design to study the effects of pH, temperature, and 
injection volume on peak resolution and USP tailing [69]. Debrus et al. used a 
factorialdesign to simultaneously optimize the method and estimate its robustness, 
considering gradient time, temperature, and pH as factors. They also suggested that if 
method optimization is the only objective, lighter designs, for example the fractional 
factorial or central composite designs, can be used [63]. The same type of design was 
applied by Molnár et al. to evaluate the effects of gradient time, temperature, pH, and 
ternary composition [60].  
Another DOE approach has been proposed [71] in which the first phase of method 
development includes study of multiple analytical columns in combination with critical 
conditions, for example pH and organic solvent, and the second phase includes the 
remaining instrument factors. Data loss in the first step, as a result of both compound 
co-elution and peak exchanges, can be overcome by using DoE coupled with 
automatically computed trend responses, which can be of two general types: peak 
count-based and peak results-based [71]. Finally, mixture design, in particular, should 
be mentioned.  
This is a special RSM in which the response is a function of the different 
proportions of the components [17]. A Scheffé 13-runs matrix with an hypothesized 
Scheffé special cubic regression model has been extensively used for optimization of 
microemulsion composition in CE methods for analysis of pharmaceuticals, followed by 
RSM for optimization of process factors such as cyclodextrin concentration, voltage, 
buffer concentration, and temperature [72, 73].  
This matrix and this model have also been used to identify the range in which 
microemulsion formation is stable, instead of using traditional pseudo-ternary phase 
diagrams [43]. Piepel at al. joined the QbD initiative by using, as reported for the first 
time in the literature, a mixture-process variable (MPV) experimental design for 
simultaneously evaluating the effects of microemulsion composition (oil, surfactant 
and/or cosurfactant and buffer) and process conditions (voltage, buffer concentration, 
and pH) on peak efficiency in the development of and MEEKC method [16]. This new 
approach made it possible to identify significant interactive effects. 
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6.5. Definition of the Design Space (DS) 
 
The DS for analytical methods has been defined as a multidimensional space 
which includes any combination of the variables that have been demonstrated to provide 
assurance of quality of the data produced by the method [59].  
The DS is limited by the so-called edges of failure, outside which method 
performances are not acceptable [68]. Thus, the analytical method should be designed 
and validated not only under one fixed condition, but under a range of conditions [64, 
66, 67]. Changes within the DS are not regarded as changes of the method and need no 
further regulatory approval [74, 64]. 
 It is possible to either “establish independent Design Spaces for one or more 
unit operations, or to establish a single Design Space that spans multiple operations” 
[74]. This leads to the proposition by Monks et al. that DS in chromatography could be 
regarded as two entities: one column design space (CDS) and one eluent design space 
(EDS). When a robust column with a known equivalent column was found, 
establishment of the DS of all the other factors was carried out on the selected column 
[66]. DS can be presented graphically as a surface plot or can be explained 
mathematically by use of equations describing relationships between parameters for 
successful operation [74].  
When multiple responses are involved, the most frequently used approaches are 
response overlay [68, 71] and desirability function [76, 69, 76].  
In response overlay, multiple response objectives are displayed on a graph, 
computed by software. In desirability studies, the global quality is summarized by use 
of a desirability index D.  
This is obtained by assigning desired and accepted values to CQAs and by 
calculating the related partial desirabilities di, which have values between 0 and 1 where 
“1” corresponds to a highly desirable value and “0” to a unacceptable value. 
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Values which increase from 0 to 1 express an increase in the desirability of the 
criterion. Then, all di values are aggregated into D, which is to be maximized [76]. 
Piepel et al. specified an acceptable and an optimum limit for each response. On the 
basis of the calculated MPV models, the DS was defined by using the acceptable limits, 
and the optimum subregion within the DS by using the optimum limits.  
Different papers by the same team of authors pointed out that when defining DS 
the model uncertainty should be taken into account, by estimating the errors in the 
criteria; otherwise no indication is provided about how well and how often the process 
can meet the specifications [76, 77, 75].  
Thus, confidence in the predicted optimum conditions was investigated by 
means of a Monte-Carlo study of 
the propagation of the model’s 
predictive errors [76, 77].  
As an example, Debrus et al. 
estimated for each operating 
condition the expected probability 
that the CQAs are jointly within the 
specifications, and the results were 
presented as probability surfaces 
[77]. The probability that S is 
higher than a selected value 
(π(S>0)), known as quality 
threshold, was used to determine the DS. In this way quality in DS is not only predicted 
but also ensured by assessing the risk of not being within the acceptance limits. There 
are still no regulatory documents stating how to estimate the required quality level [7]. 
 
6.6. Selection of working points 
 
There are several potential working points within the DS to choose from. The 
operating working point can be selected by choosing the optimum with a high 
desirability index [69], or the point giving the highest probability that the CQAs are 
within the specifications [77]. It can also be selected inside the design space and/or 
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optimum subregion on the basis of practical considerations, because the only 
requirement is that the point is included in the DS [16]. An important trend is to choose 
working points taking into account robustness [79], thus directly integrating this aspect 
of validation into method development. In this case, more than finding a single 
maximum of a function, the objective is to locate a response plateau. In some cases the 
optimum conditions can be directly selected from the CQA diagrams, which can help 
reveal areas of low and high robustness [61]. As an example, Monks et al. selected 
robust working conditions directly by observing the response surfaces, according to the 
CQA critical resolution, robustness range, and run time [66]. Swartz et al. suggested 
that methods at or near the edge of failures will only perform acceptably on average, 
thus these boundaries should be moved inside the mean performance design space to 
accommodate robustness and to define a “process operating space” [68]. A Monte-Carlo 
simulation was used to provide, for a given candidate point, a quantitative measure of 
the variation of a modeled response, e.g. the process capability index Cp. The 
robustness Cp values were modeled as additional response data sets and factor level 
settings were identified that would simultaneously meet mean performance and 
robustness objectives for all responses [68]. 
 
 
Robustness 
 
In the past, robustness testing [74] was performed during validation, which often 
led to the late discovery of undesired surprises, with the method having to be re-
optimized. In the QbD approach, robustness can be directly incorporated into the 
desired method qualities and evaluated during method development when selecting the 
DS and the working points [61, 78]. DS itself can be considered as a zone of theoretical 
robustness, because modification of the method conditions will not significantly affect 
separation quality [61]. Different approaches have been used to evaluate robustness. As 
previously mentioned, DoE with Monte-Carlo simulation was used to successfully 
integrate quantitative robustness modeling into LC method development [68]. 
Another possibility is to perform a new DoE around the working point, 
forinstance with a Plackett–Burman design. Gavin et al. chose a two-level fractional 
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factorial design to consider the effect of mobile phase composition (pH, buffer 
concentration, organic solvent concentration, and ion-pair concentration) and column 
temperature on three critical aspects of performance (run time, tailing, and 
backpressure) [56]. Monks et al. visualized the region for method robustness as a 
geometric body within the resolution space in which critical resolution does not fall 
below a given value of RS. They then used a full factorial design centered on the 
working point to evaluate the robustness of the candidate points [78]. 
Molnár et al. discovered that the positions of critical pairs of peaks might not be 
constant between chromatograms, indicating the presence of several critical moving 
peaks. Thus, critical peak pairs within each individual resolution diagram were 
examined, and it was found that each robust region was made up of subregions 
corresponding to different critical peak pairs. Fixing the method in relation to a single 
critical band pair only was deemed both insufficient and impractical, because small 
changes in experimental conditions could change the critical peak pair. It was suggested 
it would be more reasonable to define the DS for several critical peak pairs above a 
certain value [70]. 
 
 
Method control 
 
A control strategy (CS) should be designed to ensure that a product of required 
quality will be produced consistently [74]. ICH Q10 defines the CS as “a planned set of 
controls, derived from current product and process understanding, that assures process 
performance and product quality” [79].  
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With an analytical adaptation, CS has been defined as the controls on input 
factors that ensure the method meets both traditional system-suitability criteria and 
wider performance-related objectives [59, 48].  
System suitability tests are a standard part of routine application and are typically 
established during method validation.  
A Control Strategy (CS) generally includes appropriate system-suitability criteria 
to manage risks, thus QRA can also help to identify a specific control strategy. 
 An appropriate system-suitability test may be the only control element needed to 
ensure performance of the selected method [59], because it helps to identify failure 
modes and can prevent the generation of erroneous results [56]. 
An interesting example of CS enabled by a QbD approach was presented by 
Gavin et al. [56].  
During robustness studies for an API impurity profile method, they found that 
resolution of the impurities of interest followed the same trend when method conditions 
such as n-propanol and temperature were varied.  As a result, an early impurity pair was 
chosen for system suitability and became a convenient method CS, because the two 
compounds involved were easily obtained [56].  
The system suitability test may need to be augmented with additional controls to 
properly manage risk. In this sense, a more common strategy could be the definition of 
accepted ranges for all the critical resolution values.  
This can be achieved on the basis of the values measured during the system-
repeatability study, because system precision provides valuable information about the 
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variability of the analytical system [10, 72, 73]. 
 
 
7. Results and Discussions 
 
 7.1. Fast analysis of glibenclamide and its impurities: quality by 
design framework in CE method development 
 
The Quality by Design (QbD) concept is increasingly applied in the 
pharmaceutical industry to improve the quality of products, as recently recommended 
by International Conference on Harmonisation of Technical Requirements for 
Registration of Pharmaceuticals for Human Use (ICH) guideline Q8(R2) [52]. 
The fundamental tenet of QbD is a science- and risk-based approach to 
pharmaceutical development, where by quality is built into the product and not merely 
established by testing the end product. 
Analytical QbD emphasizes the need to thoroughly understand the analytical 
system by an in-depth study of critical process parameters (CPPs) based on risk 
assessment and multivariate tools. The design space (DS) is determined as the 
multidimensional region of successful operating ranges for the CPPs, which lead to 
desired values for the critical quality attributes (CQAs). A fundamental aspect for the 
quality of the pharmaceutical product is the control of impurities, which often represents 
a critical analytical issue, owing to the similarity of the drug and the related substances 
in terms of chemical structure and behavior. Fast and validated methods should be 
available for the routine quality control of pharmaceutical dosage forms, which should 
allow the impurities to be determined at least at 0.1% w/w with respect to the main 
compound. For routine purity assessment, CE has been positioned as a complementary 
tool with respect to more commonly used high-performance liquid chromatography, 
owing to its several well-known benefits. Glibenclamide (GLI; CAS no. 10238-21-8), 
also known as glyburide, is a potent antidiabetic drug belonging to the second-
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generation sulfonylurea class, and is administered by mouth in the treatment of type 2 
diabetes mellitus [81]. Sulfonylureas appear to have several modes of action, apparently 
mediated by inhibition of ATP-sensitive potassium channels, from the initial increase of 
secretion of insulin from the β cells of the pancreas to the persistence of the 
hypoglycemic effect possibly due to inhibition of hepatic glucose production and to 
increased sensitivity to insulin [81]. In the European Pharmacopeia, GLI specified 
impurities are reported as A (IA) and B (IB) [82], and their structural formulas are 
reported below. 
 
 
 
 
The official chromatographic procedure described in the European Pharmacopeia 
for the analysis of GLI and its impurities has an analysis time of about 5 min. 
Hence, the aim of this work was to develop a fast and simple CE method for the 
simultaneous analysis of GLI and its related substances for the quality control of GLI 
tablets. In this way, the DS was defined by consideration of the probability for the 
selected CQAs to fulfill their acceptance requirements, thus introducing a concept of 
assurance of quality 
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Method scouting and critical quality attributes 
 
The analytical target profile of the method was represented by a CE method that 
baseline separates GLI and its impurities, allowing an accurate and precise 
determination of the analytes. 
The analytes are weak acids (GLI, pKa=5.3), thus leading to running preliminary 
experiments involving a simple capillary zone electrophoresis system based on borax 
buffer. The use of this separation system gave good results in terms of separation 
pattern, whereas the use of borate or borate/ phosphate buffer did not result in any 
improvement, and thus borax buffer was selected as the starting point for further 
method optimization. In these initial conditions, the migration order of the compounds 
was IA, GLI, and IB (with Rs1 and Rs2 indicating resolution values between the pairs 
IA/GLI and GLI/IB, respectively). Thus, the CQAs describing the global quality of the 
electropherogram were defined as IA efficiency N, critical resolution Rs2, and analysis 
time t. CQA requirements were set as logN≥4.50, Rs2≥0.40, and t≤2 min. The target 
value for Rs2 was selected as the value describing a baseline resolution between GLI 
and IB peaks, which were very different for width characteristics [83]. The duration of 
the analysis was required to be equal to or less than 2 min. 
 
Risk assessment, critical process parameters, and knowledge space 
 
The CPPs were screened to investigate their effects on the selected CQAs by 
means of a 35//16 symmetric screening matrix [8], where each CPP was studied at three 
levels covering the knowledge space: voltage, 16, 19, and 22 kV; temperature, 18, 20, 
and 22 °C; buffer concentration, 10, 20, and 30 mM; buffer pH, 9.20, 9.70, and 10.20; 
injection time, 6, 8, and 10s. The highest voltage testedwas set at 22 kV to avoid a high 
developed current. The shortest injection time was fixed at 6 s to obtain adequate 
sensitivity, whereas values greater than 10 s were not considered in order to maintain 
good selectivity. 
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The bar length is proportional to the amplitude of the difference of the relative 
effects between two levels. The confidence intervals were calculated from the estimate 
of the experimental variance; the selected threshold of significance was set as 95% and 
is indicated by the dotted lines. In the second type of plot (d–f) the levels corresponding 
to the best results can be readily identified, as the longer bars correspond to levels 
which lead to higher values of the response. The highest level of each variable is 
represented by a red bar, of the same arbitrary length for all the factors. The indication 
of the presence of a statistically significant effect when passing from one level to 
another can be found in the first type of graph. 
The maximization of logN was obtained with low voltages and medium–high 
buffer concentrations, and the higher increase of this CQA was undoubtedly noticed 
when switching from the lowest to the medium and to the highest level of buffer pH. As 
concerns Rs2 (b-e), as expected a high buffer concentration and a short injection time 
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were preferred for maximization of this response. Finally, the most important effects on 
t were exerted by the change of voltage, temperature, and buffer concentration.  
 
Response surface methodology and design space 
 
Response surface methodology [8] was applied to conduct an in-depth 
investigation of the effects of the four CPPs on the CQAs throughout the new 
experimental domain. The following quadratic model was postulated to relate the CPPs 
with the CQAs: 
 
y=β0+β1x1+β2x2+β3x3+β4x4+β11x21+β22x22+β33x23+β44x24+β12x1x2+β13x1x3+β14x1x4
+β23x2x3+β24x2x4+β34x3x4+ε 
 
where y represents the experimental response, xi the independent evaluated 
factors, β0 the intercept, βi the true coefficients, and ε the experimental error. 
Thus, a Box– Behnken design, which requires three levels for each factor, was 
selected to calculate the coefficients of the model. 
Box–Behnken designs are designs where the k variables are varied two at a time 
by 22 designs, while maintaining the remaining k-2 variables fixed at their middle level, 
and are usually very efficient in terms of the required runs. 
 Four-dimensional contour plots were drawn reporting the calculated isoresponse 
curves in order to obtain detailed information on the behavior of the CQAs throughout 
the experimental domain, and are reported in the figure below for log N, Rs2, and t, with 
the voltage maintained at its middle value. 
  
91 
 
 
 
 For logN, the maximization of this response was obtained at low buffer 
concentrations and high levels of buffer pH, which were also shown to be the only 
significant factors. For Rs2, the most important effect was obviously exerted by the 
injection time; however, buffer concentration and buffer pH also had a significant 
effect. Analysis time t was mainly influenced by voltage, but buffer concentration 
showed both linear and quadratic significant effects. 
Monte Carlo simulations were performed by MODDE to take into account the 
model parameter uncertainty namely, propagating uncertainty from parameters to 
responses [85, 86, 87]. The selected level of probability for the CQAs to reach the 
desired values was set at π≥ 90%. In this graph, the zone corresponding to the DS can 
be easily identified as the zone where the risk of error is 10% or less, and corresponds to 
the following ranges for the CQAs: voltage, 19-21 kV; buffer concentration, 26-34 mM; 
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buffer pH, 10.05-10.35. The original set point was selected as the working point, and 
the related electropherogram is shown, where all the compounds 
  
 
were baseline separated within 2 min with a generated current equal to 110 μA. 
Finally, a control strategy for the method was accomplished [52] on the basis of the data 
collected during method development. By means of a proper control strategy, the 
method performances can be monitored to ensure that the method remains in 
compliance with the defined analytical target profile. In this study, the extreme values 
of the CQAs measured during system repeatability studies were selected as limits for 
the system suitability intervals [88]: logN, 4.69-5.03; Rs2, 0.44-0.51; t, 1.77-1.92 min. 
 
 
7.2. Analytical Quality by Design in pharmaceutical quality assurance: 
Development of a CE method for the analysis of zolmitriptan and its 
impurities 
 
Recently, pharmaceutical quality assurance had to face up to the newly introduced 
Quality by Design (QbD) principles concerning pharmaceutical development, described 
in International Conference on Harmonization (ICH) guideline Q8 [52]. Nevertheless, 
the advantages of QbD application to analytical methods is very attracting because 
analytical QbD supports the development of a robust analytical method with adequate 
performances and increases the regulatory flexibility of the analytical method itself [83, 
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85]. This flexibility consists in the freedom to change method operating parameters 
within the DS, which can be realized by demonstrating an enhanced knowledge of 
method performances by a suitable Design of Experiments protocol [52]. The present 
study was aimed to comprehensively apply QbD principles to the development of a CE 
method suitable for the simultaneous analysis of zolmitriptan (ZOL) and its impurities. 
ZOL (CAS139264-17-8) is a single enantiomer selective serotonine (5HT1B/1D) receptor 
agonist, used for acute treatment of migraine attacks and of cluster headache [90]. ZOL 
belongs to the second generation triptans, which were developed with the goal of 
creating a more lipophilic, centrally active and rapidly absorbed drug than sumatriptan, 
the first triptan [91]. Different related impurities may be found in ZOL bulk samples and 
coated tablets [92]. The five main impurities considered in this paper were named 
zolmitriptan impurity 1 (I1), zolmitriptan impurity 2 (I2), zolmitriptan impurity 3 (I3), 
zolmitriptan impurity 4 (I4), zolmitriptan impurity 5 (I5) according to their final 
migration order, and their structures are here shown. 
 
 
 
 
 
 
 
Critical process parameters and investigation of knowledge space 
 
The critical process parameters (CPPs) were selected as the classical ones which 
are generally known to have the strongest impact on CZE analysis and consequently on 
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the CQAs, namely buffer concentration (CONC), pH (pH), V, and T. Other important 
factors as capillary length and injection time were fixed from scouting experiments, 
selecting the experimental conditions corresponding to the best compromise between 
selectivity and t.   
A screening study was performed, considering three levels for each of the CPPs 
covering the knowledge space: CONC, 50-100-150 mM, pH, 2.5-3.0-3.5; V, 20-25-30 
kV; T, 19-22-25°C. The responses were represented by the selected CQAs, and a 9-run 
screening symmetric matrix.  
The value of pH was very important for the response Rs4, and better separations 
were obtained at the lower pH values. A medium level of T was also preferable for 
maximizing this CQA. As for Rs5, the changes of level of each CPP were significant on 
this response. 
 Medium and high levels of CONC were highly preferred in order to increase the 
separation, as well as low and medium pH values. An unexpected effect was the 
increase of Rs5 with the increase of V, probably due to the general beneficial effect of 
high values of this factor on peak efficiency.  
Maximization of this response was also obtained by medium-high levels of T. As 
expected, the most important effect on t was exerted by a change of V value, even if 
significant effects were also noticed by varying CONC and T.  
Finally, as concerns efficiency, a drastic increase of this response was obtained by 
using medium-high levels of CONC. The other three factors had a comparable 
importance and for all of them an increase of Log N was observed at high levels. 
 
Response surface methodology and design space 
 
Response surface methodology was aimed to obtain detailed information on the 
effect of each CPP on the CQAs and to draw a predictive map for each of the CQAs 
covering the new experimental domain: CONC, 100–150mM; pH, 2.5–3.0; T, 21–25°C. 
A quadratic model describing the relationship between the factors and the 
responses was postulated as the following: 
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y=β0+β1x1+β2x2+β3x3+β11x21+β22x22+β33x23+β12x1x2+β13x1x3+β14x1x4+β23x2x3+β24
x2x4+β34x3x4+ε 
where y is the experimental response, xi the independent variables, β0 is the 
intercept, βi are the true coefficients, and ԑ is the experimental error. Box–Behnken 
design [8] was used to estimate the coefficients of the model. 
 In this type of design, each factor is studied at three levels; the three-factor Box–
Behnken design requires 12 runs plus the replicates at the center point, which were 
selected as three for a total of 15 runs. 
The ANOVA demonstrated that all the models were valid and significant, apart 
from the model for Log N, which resulted to be valid but not significant.  
This indicated that in the considered domain the value of I2 efficiency was not 
significantly influenced by the change of the factors.  
The obtained values of goodness of fit R2 and goodness of prediction Q2 for the 
other responses were, respectively: for Rs4, R2 =0.997, Q2 =0.953; for Rs5, R2 =0.983, 
Q2 = 0.810; for t, R2 = 0.992, Q2 = 0.908.  
The resulting 4D contour plots are reported for Rs4 (A–C), Rs5 (D–F), and t (G–I).  
  
96 
 
 
The isoresponse lines for Rs4 and Rs5 showed the same trend, pointing out that the 
best separations were obtained at low T, high concentration, and low pH, with the most 
important effect played by pH. Also, for both the responses graphic analysis of 
coefficients (not reported) evidenced quadratic effects of both pH and T, together with 
an important negative interaction between CONC and pH. As concerns t, the 
minimization of this CQA was obtained by applying high values of all the CPPs. A 
positive quadratic effect of CONC and a negative interaction between CONC and pH 
were also noticed. 
The original set-point selected by the software for calculating DS was the 
following: CONC, 138 mM, pH, 2.74, T, 25°C. By setting a risk of error equal to 1% (π 
≤ 99%), the probability maps reported were obtained, where the DS is colored in green.  
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The DS corresponded to the ranges: CONC, 115–150 mM; pH, 2.54–2.94; T, 24–
25°C, where the selected interval for each factor was limited inside the domain tested by 
response surface methodology highly reduced by introducing a probability concept. 
Applying the working point conditions, corresponding to the original set-point, an 
electropherogram was obtained where the baseline separation of the analytes was 
achieved in less than 5 min, with a generated current of about 133 µA.  
 
 
 
 
DS was validated by using a Plackett–Burman matrix where the considered −1 and +1 
levels for the factors corresponded to the extremes of the corresponding DS interval. 
The measured and calculated values for the CQAs showed a good agreement. 
 
 
  
98 
 
Validation and application 
 
A control strategy [52] was finally planned in order to ensure that the method has 
adequate analytical performances and thus can be used to obtain reliable analytical data. 
The control strategy was based on the definition of system suitability limits, which 
corresponded to the lower and the higher CQAs values observed during system 
repeatability studies [88]. The CQAs accepted intervals were the following: Rs4, 5.84–
6.40; Rs5, 0.66–0.86; t, 4.38–4.54; Log N, 5.55–5.72. The conclusions drawn from 
robustness test concerning the careful preparation of the BGE also constituted an 
important part of the control strategy of the method [52]. The developed method was 
validated according to ICH guidelines [88], and the performances were adequate for the 
method aim. Anyway, a validation issue concerning sensitivity was observed for I2, in 
spite of the good efficiency of the related peak. As a matter of facts, the dimeric 
structure of this impurity did not allow the desired LOQ to be reached (0.1% with 
respect to the main compound) due to its low absorbance (I2 LOQ: 0.0036 mg/mL, 
corresponding to 0.18%).  
 
Analysis of a real sample of Zomig® coated tablets. Working point conditions: temperature, 25 °C; voltage, 30 kV; BGE, 138 mM 
phosphate buffer pH 2.74. 
 
The developed method was finally applied to real samples of Zomig® coated 
tablets, labeled to contain 2.5 mg ZOL. Four analyses were performed, and the results 
were in agreement with the declared content (α/2 = 0.025): percentage of label claim, 
98.4 ± 1.1%; RSD, 0.7%. None of the five considered impurities was detected. 
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7.3. Cyclodextrin- and solvent-modified micellar electrokinetic 
chromatography for the determination of captopril, hydrochlorothiazide 
and their impurities. 
 
Among the analytical methods applied for impurity assay of pharmaceuticals, 
HPLC is the main method recommended by different pharmacopeias, but capillary 
electromigration methods represent a significant alternative.  
This is especially due to the inherent flexibility for the various available operative 
modes and to the orthogonality with respect to chromatographic principles, besides 
other well-known advantages including lower costs and higher eco-compatibility [2, 
94].  
The aim of this study was to set up a fast and simple capillary electrophoresis 
(CE) method for the simultaneous determination of captopril (CPT), 
hydrochlorothiazide (HCT) and their related substances in the combined dosage form, 
following QbD tenets. CPT is a thiol-containing angiotensin-converting enzyme 
inhibitor used in the management of hypertension, in heart failure, following myocardial 
infarction and in diabetic nephropathy. 
The structural formulas of the two drugs and of the related impurities considered 
in this thesis are here shown.  
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According to the European Pharmacopeia [95], HCT specified impurities are 
reported as IA, IB and IC. IA and IC are two main process impurities, while the primary 
HCT degradation pathway yields IB and formaldehyde by hydrolysis. CPT may present 
several impurities, but in aqueous solution undergoes spontaneous oxidative 
degradation at the sulphydryl group, generating the dimer captopril disulphide (IDIS), 
which represents the main degradation product [96, 97].  In general, CPT determination 
is very challenging mainly due to the aliphatic structure that lacks any strong 
chromophore, and to the vulnerability to oxidation of the sulphydryl group. The cis-
trans isomerization of CPT can be observed during chromatographic or electrophoretic 
separation, since the isomerization occurs on the time order of minutes. This chemical 
behavior can give rise to peak splitting or to a typical pattern constituted by a plateau 
between the two conformer peaks [73, 98]. 
In this study, the CE method development was carried out implementing each step 
of analytical QbD approach [99]. A large part of the experiments of the scouting phase 
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was dedicated to the selection among different pseudostationary phases based on 
micelles, with or without additives, in order to overcome CPT detection and 
isomerization issues. 
 
Analytical target profile, method scouting, critical quality attributes 
 
From the first experimental runs, the main analytical issues were evidenced and 
were mainly attributable to: i) presence of analytes with ionizable moieties presenting 
different acid-base properties; ii) low UV absorbance value and efficiency of IDIS; iii) 
possible peak broadening or splitting of CPT due to the interference between 
electrophoretic migration and cis-trans reaction of isomerization. In particular, this 
interference can depend on several factors including the chemical nature of the system 
(BGE, electro-osmotic flow, electrophoretic mobility of the molecules), effective length 
of the capillary, applied electric field and temperature [100]. In this study, the 
possibility of using high temperature for avoiding peak splitting was discarded and 
ambient temperature was selected in order to provide more practical experimental 
conditions. 
Hence, a large part of the experiments of the scouting phase was intended to the 
selection of a suitable operative mode enabling to overcome separation, detection and 
isomerization issues. In the scouting phase the concentration of all the compounds was 
kept low and equal to 0.06 mg ml-1, in order to obtain clear information on the 
separation pattern and the migration behavior of the compounds. Capillary zone 
electrophoresis (CZE) with plain buffers as well as MEKC with different 
pseudostationary phases, with or without additives, were examined in order to find an 
useful separation system.  
It was found that the use of γ-CD was fundamental for obtaining a great increase 
in IDIS peak efficiency, also producing a decrease in analysis time and an increase in 
selectivity. By adding n-butanol to this system, further beneficial effects on IDIS peak 
efficiency were observed, confirming that this organic modifier can exploit an active 
role in controlling the partitioning of the analytes, with a great potential for ameliorating 
the electrophoretic pattern [101, 102]. Hence, the sodium cholate-based MEKC 
operative mode with the addition of γ-CD and n-butanol enabled to overcome all the 
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main analytical issues which had been evidenced in the preliminary experiments, and 
was selected for further optimization steps. With this separative system, the migration 
order of the compounds was the following: MET (internal standard), IB, HCT, IC, CPT, 
IA, IDIS, with the resolution values indicated by Rs1 (IB/HCT), Rs2 (HCT/IC), Rs3 
(IC/CPT), Rs4 (CPT/IA), Rs5 (IA/IDIS). The responses which were selected as CQAs were 
critical resolution values Rs1 and Rs4, whose desired values were both set as ≥1.5, and 
analysis time (t), for which the accepted value was set as ≤3 min. 
 
Critical process parameters and investigation of knowledge space 
 
In the selected separative system, the separation mechanism was based on the 
different mobilities of the solutes, their partitioning in the sodium cholate micelles and 
on host-guest inclusion complexation in the cyclodextrin, with the consequence of a 
high number of experimental factors which could affect one or more CQAs. Seven 
CPPs were identified and were investigated by a multivariate screening procedure. The 
CPPs were both related to the BGE composition, e.g. borate concentration (B CONC), 
pH of the buffer (pH), sodium cholate concentration (CHOL CONC), n-butanol 
concentration (BUT CONC), γ-cyclodextrin concentration (CD CONC), and related to 
instrumental settings, e.g. temperature (T) and voltage (V). 
The effect of the change of levels of the CPPs was studied by the symmetric 
screening matrix 37//16. 
 
Exp. 
no. 
B 
CONC 
(mM) 
pH CHOL 
CONC 
(mM) 
BUT 
CONC 
(%v/v) 
CD 
CONC 
(mM) 
T 
(°C) 
V 
(kV) 
Rs1  Rs4  t 
(min) 
1 80 8.40 60 8 15 24 26 1.31 0.01 2.84 
2 120 8.00 60 6 20 21 26 0.74 0.01 2.92 
3 120 8.80 50 6 15 24 22 1.85 0.98 3.56 
4 100 8.80 70 4 15 21 26 2.18 1.10 2.41 
5 120 8.40 70 8 10 21 22 1.87 0.01 3.97 
6 100 8.80 60 8 20 18 22 2.16 1.71 4.00 
7 100 8.40 70 6 20 24 18 1.47 0.01 3.07 
8 100 8.40 60 6 15 21 22 1.38 0.78 3.71 
9 120 8.40 60 4 15 18 18 1.32 0.86 4.24 
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10 80 8.80 60 6 10 21 18 1.85 1.88 4.75 
11 80 8.00 70 6 15 18 22 0.01 0.01 3.87 
12 100 8.00 50 8 15 21 18 0.01 0.01 5.27 
13 80 8.40 50 4 20 21 22 0.01 0.01 3.20 
14 100 8.00 60 4 10 24 22 0.01 0.01 2.93 
15 100 8.40 50 6 10 18 26 1.63 0.88 2.76 
16 100 8.40 60 6 15 21 22 1.45 0.82 3.55 
Rs1, resolution between IB/HCT; Rs4, resolution between CPT/IA; t, analysis time. 
 
 Among the measured CQAs, for Rs1 and Rs4 a considerable number of 
experiments with a complete overlap of the peaks was reported, evidencing the 
particular criticism for selectivity responses; on the other hand, all the values obtained 
for t were lower than 5 min. 
The graphs showed that Rs1 was increased by medium-high levels of B CONC, 
CHOL CONC and BUT CONC and high levels of pH; for Rs4, the preferred settings 
were high level for pH, medium level for CHOL CONC, medium level for BUT CONC, 
while the maximization of this response was obtained at low levels of CD CONC. For 
both Rs1 and Rs4, the change of levels of pH was undoubtedly of outmost importance, 
confirming the important role of this factor. As regards t, the only factor which exerted 
a significant effect was voltage. 
 
 
 
Response surface methodology and design space 
 
A five-factors FCD was employed for building a second order quadratic model for 
the selected CQAs. Each CPP was studied at three levels, covering the new 
experimental domain, with the star points located at the center of each face of the 
factorial space, with α=±1. Twenty-nine experiments were required, including three 
replicates at the center point, and the experimental plan with the measured responses is 
here shown. 
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Exp. no. pH CHOL CONC 
(mM) 
BUT CONC 
(%v/v) 
CD CONC 
(mM) 
V 
(kV) 
Rs1  Rs4  t 
(min) 
1 8.20 55 5 8 28 1.61 0.8 2.19 
2 8.80 55 5 8 24 1.95 1.75 2.09 
3 8.20 75 5 8 24 1.46 0.34 2.92 
4 8.80 75 5 8 28 2.46 2.96 2.08 
5 8.20 55 7 8 24 1.44 0.01 3.25 
6 8.80 55 7 8 28 2.31 2.77 2.27 
7 8.20 75 7 8 28 1.54 1.40 2.50 
8 8.80 75 7 8 24 2.10 2.85 2.95 
9 8.20 55 5 16 24 1.59 0.01 2.94 
10 8.80 55 5 16 28 1.83 2.24 2.13 
11 8.20 75 5 16 28 1.61 0.35 2.21 
12 8.80 75 5 16 24 2.28 0.01 2.70 
13 8.20 55 7 16 28 1.76 0.01 2.22 
14 8.80 55 7 16 24 2.03 1.77 3.15 
15 8.20 75 7 16 24 1.53 0.01 2.88 
16 8.80 75 7 16 28 2.03 0.01 2.21 
17 8.20 65 6 12 26 1.73 0.01 2.60 
18 8.80 65 6 12 26 2.32 2.21 2.46 
19 8.50 55 6 12 26 1.58 1.27 2.64 
20 8.50 75 6 12 26 1.54 1.52 2.59 
21 8.50 65 5 12 26 1.65 1.42 2.25 
22 8.50 65 7 12 26 1.75 1.75 2.53 
23 8.50 65 6 8 26 1.75 1.89 2.25 
24 8.50 65 6 16 26 1.68 1.61 2.36 
25 8.50 65 6 12 24 1.72 1.39 3.09 
26 8.50 65 6 12 28 1.93 1.70 2.39 
27 8.50 65 6 12 26 1.68 1.48 2.69 
28 8.50 65 6 12 26 1.61 1.38 2.68 
29 8.50 65 6 12 26 1.69 1.29 2.70 
Rs1, resolution between IB/HCT; Rs4, resolution between CPT/IA; t, analysis time. 
 
 The calculated models were edited by removing some of the interaction or 
quadratic terms which did not exert a significant effect on the response, in order to 
ameliorate values of coefficient of determination R2 and coefficient of predicted 
variation Q2. The following final values were achieved: Rs1, Q2=0.923, R2=0.983; Rs4, 
Q2=0.821, R2=0.963; t, Q2=0.840, R2=0.976. The ANOVA demonstrated that the 
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regression models for Rs1 and Rs4 were statistically valid and significant, while the 
model for t was observed to be not valid due to the small experimental variance.  
The sweet spot plots were drawn maintaining CD CONC and V at their central 
values.  
These graphs made it possible to highlight by different colours the areas where 
one (white), two (pale blue) or three (dark blue) predicted CQAs fulfilled the 
requirements. The plots confirmed that it is necessary to set the pH value at medium-
high levels, but wide zones leading to required CQAs values were obtained for all the 
values of BUT CONC. 
 
 
 
Monte-Carlo simulations were performed to propagate the error in prediction of 
the models from the factors to the response, giving access to the distributions of the 
responses for each operating condition of the RSM [103]. The set-point was the 
following: pH, 8.55; CHOL CONC, 64 mM; BUT CONC, 6.1 %v/v; CD CONC, 12 
mM; V, 27 kV.  
The DS was calculated from this set-point by using a search function [104] that 
expands the possible factor ranges to the largest possible range where all the response 
predictions are still within the specifications at a probability level of π≥99%, and 
corresponded to the following intervals: pH, 8.48-8.62; CHOL CONC, 60-68 mM; BUT 
CONC, 5.4-6.8 %v/v; CD CONC, 11-13 mM; V, 26-28 kV.  
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The DS is highlighted in green and is included in the line corresponding to 1% 
risk of failure. In contrast to what was observed in the sweet spot plots, the DS cannot 
be calculated when setting BUT CONC at 7 %v/v. 
The working conditions corresponded to the set-point used for calculating the DS 
and made it possible to achieve the complete separation of the analytes in less than 3 
min. 
 
 
For robustness testing, the 8-run Plackett-Burman design was employed in order 
to calculate the main effects of small variations of all the seven CPPs considered in the 
screening phase, e.g. B CONC (98-102 mM), T (20-22 °C), pH (8.45-8.65), CHOL 
CONC (62-66 mM), BUT CONC (5.6-6.6 %v/v), CD CONC, 11-13 mM, V, 26-28 kV. 
The graphic analysis of effects revealed that pH was the only factor which exerted a 
significant effect on Rs1, while only V was influent on T. 
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Graphic analysis of effects in robustness study. The orange bars exceeding the dotted line are related to the 
factors which exert a significant effect on the response: (a) Rs1, resolution between IB/HCT; (b) Rs4, resolution 
between CPT/IA; (c) t, analysis time. 
 
 
Validation and application 
 
After method validation, Acediur® tablets containing 50 mg CPT and 25 mg HCT 
were analysed and a typical electropherogram is here shown. 
 
 
 
 The percentage of claimed amount of the drugs was: CPT, 98.2±2.4% with a 
RSD of 1.5%; HCT, 98.7±1.9% with a RSD of 1.2% (n=4, α/2=0.025). As for the 
impurities, IA was not detected, while the other impurities were detected at 
concentration values lower than the respective LOQ. The electropherogram of the real 
sample was also spiked with standard solutions of the impurities for verifying the 
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identity of the impurity peaks and for excluding the possibility of overlap of CPT and IA 
peaks. 
7.4. Chiral cyclodextrin-modified micellar electrokinetic 
chromatography and chemometric techniques for green tea samples 
origin discrimination 
 
Green tea (GT) is the second most traditional style of tea product, representing 20-
22% of world tea production, and is manufactured by steaming or drying fresh tea 
leaves and inactivating the enzymes to prevent the oxidation of the tea polyphenols 
[105].  
GT polyphenolic antioxidants are mostly represented by catechins, a group of 
compounds having a flavan-3-olic structure, which are easily extracted into water. 
Catechins may constitute up to 30% of the dry mass of tea leaves and are the major 
constituents of GT excluding carbohydrates, proteins and lignin [106]. 
GT has been extensively studied for its antioxidant activities and potential for 
reducing lifestyle-related diseases. The principal components of tea having biological 
effects have been identified as catechins and xanthines. 
Xanthines are responsible for the stimulating effects; caffeine (CF) is a central 
nervous system and cardiac stimulant and has a diuretic effect, while theobromine (TB), 
which is present in lower amounts, has also a diuretic effect [107, 108].  
Catechins are mainly responsible for the astringent and bitter taste of tea infusion, 
while CF can enhance observably tea flavor [109].  
The composition of tea varies according to the species, season, climate, age of the 
leaf (plucking position) and cultivation and also to the technologies applied during 
extraction, concentration and preservation process. The most abundant catechins in GT 
are (+)-catechin ((+) C)), (-)-catechin ((-) C), (-)-epicatechin (EC), (-)-epigallocatechin 
(EGC), (-)-epicatechin gallate (ECG), (-)-epigallocatechin gallate (EGCG), whose 
structures, together with those of CF and TB, are here reported. 
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 In the field of classification according to chemical composition, having at 
disposal a rapid and accurate analytical method is essential. The method was applied to 
the quantitation of catechins and methylxanthines in 92 GT samples of different 
geographical origin (Japan and China), having undergone different storage conditions 
and manufacturing processes. 
 
Analyte Range 
(μg mL-1) 
a sa b sb R2 
EC 0.005-0.300 1592.49 74.50 5.53 13.63 0.9828 
ECG 0.005-0.150 2530.60 63.55 -10.22 5.84 0.9950 
EGC 0.010-0.300 1052.18 21.76 -2.91 3.98 0.9966 
CF 0.010-0.500 1515.66 24.30 4.23 7.48 0.9979 
EGCG 0.020-0.600 3279.77 139.82 -61.23 51.74 0.9857 
(+)C 0.005-0.050 4681.74 109.22 6.91 3.44 0.9957 
(-)C 0.004-0.038 4718.20 175.09 24.82 3.63 0.9864 
TB 0.004-0.100 5649.80 188.78 6.53 9.09 0.9933 
Regression equation, y=ax+b, where x is the analyte concentration (mg mL-1), y is the ratio of area of the analyte to 
internal standard; sa, standard deviation for the slope; sb, standard deviation for the intercept, (n=5, k=2). 
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Unsupervised methods such as principal component analysis (PCA) and 
hierarchical cluster analysis (HCA) were used as exploratory techniques, while 
discrimination models were built using supervised methods such as linear discriminant 
analysis (LDA) and quadratic discriminant analysis (QDA) in order to obtain 
discrimination rules. 
 
 
Catechins, caffeine and theobromine content 
 
The CD-MEKC method was applied to the analysis of 92 commercially available 
GT samples, and a representative electropherogram of selected GT water extract of 
Chinese sample no. 38 is shown. 
 
 
 
 
The average content of catechins and methylxanthines in the investigated GT 
samples (mg g-1, dry basis) was calculated by the calibration. 
The average content, the standard deviation and the range of each chemical 
descriptor are reported considering all the samples and the separate classes of Japanese 
GTs and Chinese GTs. Considering the entire data set, the total amount of the chemical 
descriptors follows the order EGCG>CF>EGC>ECG>EC>(+)-C>TB> (-)-C . 
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In general, with exception of ECG, the amount of all the compounds was found to 
be higher in Chinese GTs compared to the samples from Japan.  
EGCG, which exhibits the highest antioxidant activity, is the most abundant 
catechin, with an average content of 27.14 mg g-1 in Chinese GT and 13.69 mg g-1 in 
Japanese GT, respectively, and values up to 68.10 mg g-1.  
Relatively high levels of EGC and ECG were also found, with average content of 
17.50 and 6.63 mg g-1 for EGC and 10.90 and 11.87 mg g-1 for for ECG in Chinese and 
Japanese GTs, respectively.  
Once the preliminary analysis of the data was carried out, pattern recognition 
procedures were then applied to the data matrix in order to achieve a more reliable GT 
differentiation. 
 
Principal Component Analysis 
 
In this study, PCA was performed after data centering, and the first 5 PCs were 
found to capture most of the variances needed to explain all variation in the data set. For 
visualising the information of the data set, a score plot using the first two PCs was 
chosen, which accounted for 86.92% of the total variance. 
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PC1 explained 71.63% and PC2 explained 15.29% of the total variance. From the 
scores, it was found that the first two PCs were able to evidence a good separation 
between Japanese and Chinese GT samples, even if a certain overlap was present and 
the complete separation between the classes was not obtained. The separation between 
the two groups was observed in particular along PC1. A larger dispersion of the Chinese 
teas appeared, whereas Japanese GTs formed a more compact group, located at the left 
side of the plot, at negative values of PC1.  
All samples were then divided into a training set, used to perform a new PCA, and 
a test set, using the KS algorithm [110].  
All samples in training test and test set were selected based on KS method; the 
assignment of the samples can be seen from Su, where the training set contained 75 
samples, while the remaining 17 samples constituted the test set. It was possible to note 
that the test set was perfectly superimposed. It is worth mentioning that a selected 
training set should be sufficiently representative that a model is supposed to encounter. 
As it can be seen in the figure, the training set covers the test set both from the X and 
the Y space data. The test set was used as a completely independent set (unseen data) in 
order to be able to measure the performance of the built classification model 
 
Hierarchical Cluster Analysis 
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All samples were gathered on the basis of similarities and the samples with the 
minimum variance were clustered preferentially. The dendrogram here shown was 
generated, finding that the samples were clustered in 3 different groups at a variance 
weighted distance between cluster centres of 20. 
 
 
The first cluster was composed by 47 samples, of which only 2 were Japanese 
GTs, i.e., no. 22 and no. 2. The second cluster, made by 24 samples, was composed by 
16 Japanese GTs and 8 Chinese GTs. In the third cluster, consisting of 21 samples, 19 
of them were Japanese GTs and 2 were Chinese GTs (no. 63 and no. 76). 
Thousands of bootstrap samples are generated by randomly sampling elements of 
the data, and bootstrap replicates of the dendrogram are obtained by repeatedly applying 
the cluster analysis to them [107]. p-value of a cluster is a value between 0 and 1, which 
indicates how strong the cluster is supported by data. Two types of p-values are 
provided: AU (Approximately Unbiased) p-value and BP (Bootstrap Probability) value. 
AU p-value, which is computed by multiscale bootstrap resampling, is a better 
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approximation to unbiased p-value than BP value computed by normal bootstrap 
resampling, which is the frequency that it appears in the bootstrap replicates. In Fig. S7, 
indicating the accuracy of classification, the values of AU/BP for the cluster 
dendrogram are reported. Red values at left branch are AU (Approximated Unbiased) p-
values; green values at right branch are BP (Bootstrap Probability) p-values in 
percentage, and cluster labels are at the bottom. Clusters with high AU values are 
strongly supported by the data, meaning that they really are very similar units that form 
a natural cluster. 
The variables are represented by the nodes and their correlations are represented 
as a set of edges that connect the nodes. The weights represent the intensity of a 
relationship: the thickest the edges between two nodes, the highest the correlation 
between the two connected variables, with green and red ties indicating a positive and a 
negative correlation, respectively. A strong positive correlation between the amounts of 
EC, EGC and (+) C and between EGCG and CF was found; only ECG shows negative 
correlations, which were evidenced with TB, (-)C and (+)C; anyway the negative 
correlations were much weaker with respect to all the other positive relationships. 
 
 
Linear and Quadratic Discriminant Analysis 
 
The classification model is developed on a training set of samples with categories. 
The model performance is evaluated by means of some samples from a prediction set by 
comparing their predicted categories with their own true categories. Therefore, all 
samples were divided into a training set, used to build model, and an external set (test 
set), used to test the model, using three different strategies. The first method was KS 
algorithm [111] as explained before. The second splitting was rationally performed in 
order to obtain a balanced distribution of the different Japanese types and Chinese zone 
in the different sets (the division was performed for each individual class separately, 
with 30% of the samples of each class in the test set). Finally, the third splitting 
consisted in a random splitting at half.  
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Two supervised pattern recognition techniques were applied: LDA and QDA. By 
using LDA, linear combinations of the selected descriptors can be performed, allowing 
the so-called discriminant functions to be obtained; the application of this approach best 
separates the classes according to the minimization of the ratio of within-class and 
between-class variances.  
The obtained latent variables are called canonical variates and for k classes, k-1 
canonical variates can be calculated [112]. QDA is identical to LDA, but class borders 
are quadratic curves instead of straight lines. 
To evaluate and validate the classification performances internally, a leave-five 
out Cross Validation method was used. Classification results are presented in the table 
below, reporting for both supervised methods the percentage of correct classification 
rate (%CCR) of the training set samples without cross-validation (%CCRTRAINING), of 
the training set samples using cross-validation (%CCRCV), and of the independent test 
set samples (%CCRTEST).  
 
 
 %CCR  %Sensitivity  %Specificity 
KS splitting TRAINING CV TEST  TRAINING CV TEST  TRAINING CV TEST 
LDA 96.00% 94.67% 82.35%  92.59% 96.15% 90.91%  97.92% 93.88% 66.67% 
QDA 92.00% 92.00% 76.47%  92.31% 88.46% 90.91%  91.84% 93.88% 50.00% 
Type and zone splitting            
LDA 95.38% 90.77% 92.59%  100.00% 92.31% 90.91%  92.31% 89.74% 93.75% 
QDA 92.31% 86.15% 85.19%  92.31% 84.62% 81.82%  92.31% 87.18% 87.50% 
Random splitting            
LDA 91.11% 88.89% 87.23%  88.89% 88.89% 84.21%  92.59%. 88.89% 89.29% 
QDA 100.00% 84.44% 76.60%  100.00% 77.78% 52.63%  100.00% 88.89% 92.86% 
 
 
For each set, %sensitivity and %specificity were also calculated, which are related 
to the true-positive rate and to the true-negative rate, respectively.  
The %sensitivity is the number of true positive predictions, divided by the number 
of true-positive and false-negative predictions. The %specificity is the number of true 
negative predictions divided by the number of true negative and false positive 
predictions [40]. Both LDA and QDA gave good results with each of the three splitting 
methods, evidencing that the model was not dependent on data structure, with very good 
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performances in terms of predictive ability (%CCRTEST ranging from 92.59% to 
76.47%). 
 
7.5. Enantioseparation and impurity determination of ambrisentan 
using cyclodextrin-modified micellar electrokinetic chromatography: 
visualizing the Design Space within Quality by Design framework  
 
Ambrisentan (AMB) is an orally active and potent ETA-selective ERA of the 
propanoic acid class, designated as an orphan drug for the treatment of PAH and 
chronic thromboembolic pulmonary hypertension. It is used in the treatment of patients 
with PAH classified as functional class II and III and in particular its efficacy has been 
shown in idiopathic PAH and in PAH associated with connective tissue disease.  
AMB is marketed as single (S)-enantiomer, representing the most active 
enantiomer, whose in vivo inversion to (R)-ambrisentan (R-AMB) is negligible [113]. 
R-AMB and other AMB impurities may be found in AMB bulk samples and dosage 
forms [92, 114, 115, 116]. 
The four main impurities considered were AMB impurity 1 (I1), AMB impurity 2 
(I2) and AMB impurity 3 (I3), which were named according to their migration order, and 
the impurity enantiomer (R-AMB). Their structures are here reported. 
In this study, the CE method development was carried out within QbD 
framework, with the target of establishing a Design Space (DS) where the analysis 
performances meet predefined quality attributes with a selected degree of probability. 
QbD scouting made it possible to select Micellar ElectroKinetic Chromatography 
(MEKC) with the addition of γ-cyclodextrin (γ-CD) as operative mode 
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. This system involved complex separation mechanisms, including electrophoretic 
mobility, partitioning into the micelles and inclusion complexation into the 
cyclodextrin, and was essential for obtaining the separation of AMB, its R-enantiomer 
and the other impurities. The incorporation of QbD strategy in CE method development 
enabled dealing with optimization challenges in a rational and systematic way, 
providing the key for a better comprehension of the separation. 
 
 
Method scouting and critical quality attributes 
 
By employing a simple SDS-based MEKC with a plain buffer made by 100 mM 
borate buffer pH 9.20, the separation between I2 and I3 could not be achieved, not even 
tuning SDS concentration values (from 50 to 150 mM). Thus, the addition of a suitable 
CD was not only mandatory for the chiral separation, but also could be resolutive for 
obtaining a good separation of these neutral impurities, by exploiting the formation of 
inclusion complexes. Different CDs were added to standard MEKC conditions made by 
100 mM SDS, 100 mM borate buffer pH 9.20, but only a few gave promising results. In 
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particular, α-CD was not useful neither for the enantioseparation nor for the separation 
of the neutral impurities. Instead, the derivatized β-CDs enabled the separation of I2 and 
I3, but did not allow the enantioseparation. The only CD that was decisive for the I2/I3 
resolution and simultaneously made it possible to obtain a great improvement in the 
chiral separation was γ-CD.  Hence, a CD-MEKC system based on SDS, borate buffer 
and γ-CD was selected for further optimization studies. In these experimental 
conditions, PABA was selected as suitable internal standard, being well separated from 
all the analytes, and the migration order of the compounds was the following: I1, R-
AMB, AMB, PABA, I2 and I3. The resolution between adjacent peak pairs was 
indicated by Rs1 (I1/R-AMB), Rs2 (R-AMB/AMB), Rs3 (AMB/PABA), Rs4 (PABA/I2), 
Rs5 (I2/I3). The only critical resolution value was represented by Rs2 between the 
enantiomers, whose target value was selected as Rs2≥0.7, corresponding to the value 
describing a baseline resolution between the enantiomers, which were very different for 
width characteristics [117]. Due the high complexity of the separation to be achieved, 
the target value for analysis time was deemed reasonable when equal or less than 20 
min. Thus, the two critical quality attributes (CQAs) with their requirements were 
selected as Rs≥0.7 and t≤20 min.  
 
 
Risk assessment, critical process parameters and screening phase 
 
All BGE parameters were considered of high risk on method performances. The 
CPPs were represented by: capillary length (L), temperature (T), borate concentration (B 
CONC), pH, γ-CD concentration (CD CONC), SDS concentration (SDS CONC) and 
voltage (V). The settings of all the other factors, for instance sample parameters as 
injection type and volume, were selected on the basis of preliminary and scouting 
experiments. Thus, the experiments run in the scouting phase were fundamental for the 
selection of the levels to be considered for the CPPs: L, 48.5-64.5 cm; T, 18-22 °C;  B 
CONC, 80-100-120 mM; pH, 8.20-9.20-10.20; CD CONC, 20-35-50 mM; SDS CONC, 
80-100-120 mM; V, 20-25-30 kV. A Free-Wilson model was postulated for describing 
the effects of the CPPs on the CQAs, containing one constant term A0 and for each CPP 
a number of coefficients equal to its number of levels minus one: 
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y=A0+A1A+B1B+C1C+C2C+D1D+D2D+E1E+ E2E +F1F+F2F+G1G+G2G  
 
where A is capillary length, B is temperature, C is borate concentration, D is 
buffer pH, E is γ-CD concentration, F is SDS concentration, G is voltage. A 16-run 
asymmetric screening matrix was applied to estimate the coefficients and the 
corresponding experimental plan is reported in the table.  
 
 
Exp. no. L 
(cm) 
T 
(°C) 
B CONC 
(mM) 
pH  CD CONC 
(mM) 
SDS CONC 
(mM) 
V 
(kV) 
Rs2  t 
(min) 
1 48.5 22 100 10.20 35 120 30 0.00 9.05 
2 48.5 18 100 9.20 50 100 30 0.96 17.51 
3 48.5 18 80 9.20 35 120 25 0.40 10.23 
4 64.5 18 120 8.20 35 100 30 0.42 16.28 
5 48.5 22 120 10.20 20 100 25 0.00 15.93 
6 64.5 18 100 10.20 50 80 25 1.78 23.33 
7 64.5 22 120 9.20 50 120 20 1.95 34.59 
8 64.5 22 100 9.20 35 100 25 0.42 20.19 
9 48.5 22 100 8.20 35 80 20 0.00 10.09 
10 48.5 18 100 9.20 20 100 20 0.00 14.39 
11 48.5 18 120 9.20 35 80 25 0.00 9.60 
12 64.5 18 80 10.20 35 100 20 2.02 33.57 
13 48.5 22 80 8.20 50 100 25 0.00 8.28 
14 64.5 18 100 8.20 20 120 25 0.15 21.18 
15 64.5 22 80 9.20 20 80 30 0.00 12.85 
16 64.5 22 100 9.20 35 100 25 0.50 19.99 
       Rs2, enantioresolution between R-AMB/AMB; t, analysis time. 
 
ANOVA showed that the models for both Rs2 and t were significant and graphical 
analysis of effects was carried out, as reported. 
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The change of buffer concentration was not significant on Rs2, while the low and 
medium levels were preferred for reducing t, thus this CPP was fixed at 100 mM. By 
increasing pH and CD CONC, both Rs2 and t increased, with a prevalent effect on Rs2; 
the experimental domain for both the CPPs was moved towards higher values for 
maximizing resolution. SDS CONC showed no significant effect on resolution; this CPP 
was fixed at the medium level in order to maintain a good balance with respect to CD 
CONC. Finally, voltage had the highest impact on t apart from capillary length; thus, 
due to the long analysis time observed during the screening, up to about 35 min, the 
experimental domain for V was moved to higher levels. Hence, the new domains for the 
factors to be further studied by RSM were the following: pH, 9.20-10.20; CD CONC, 
36-50 mM; V, 24-30 kV. 
 
 
  
121 
 
 
Response Surface Methodology and Design Space 
 
A Face Centered Design (FCD) was employed for estimating the second-order 
polynomial equation relating the CQA and the CPPs, which included linear, quadratic 
and interaction effects: 
y=β0+β1x1+β2x2+β3x3+ β11x12+β22x22+β33x32+ β12x1x2+β13x1x3+ β23x2x3+ε  
where y represents the experimental response, xi the independent evaluated 
factors, β0 the intercept, βi the true coefficients and ε the experimental error. The 
experimental region of the FCD for three factors represents a cube, where the star/axial 
points are located on the center of the faces of the cube, and only three levels are 
required for each factor. The experimental plan with the measured responses is shown 
and the statistical significance and validity of quadratic models was verified by 
ANOVA.  
Exp. no. V 
(kV) 
pH CD CONC 
(mM) 
Rs2 
 
t 
(min) 
1 24 9.20 36 0.45 21.29 
2 30 9.20 36 0.29 15.26 
3 24 10.20 36 0.55 27.06 
4 30 10.20 36 0.38 18.03 
5 24 9.20 50 1.74 20.33 
6 30 9.20 50 1.47 14.69 
7 24 10.20 50 0.79 25.45 
8 30 10.20 50 0.44 16.71 
9 24 9.70 43 0.49 23.89 
10 30 9.70 43 0.32 16.23 
11 27 9.20 43 0.55 17.57 
12 27 10.20 43 0.55 21.46 
13 27 9.70 36 0.32 20.42 
14 27 9.70 50 0.38 18.88 
15 27 9.70 43 0.41 17.67 
16 27 9.70 43 0.51 18.30 
17 27 9.70 43 0.52 18.73 
Rs2, enantioresolution between R-AMB/AMB; t, analysis time. 
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New reduced models were obtained by removing some of the coefficients 
(interactions or quadratic terms) which did not have a significant effect, in order to 
obtain higher values of coefficient of determination R2 and coefficient of predicted 
variation Q2. Values obtained after model refining were the following: Rs2, Q2=0.690, 
R2=0.861; t, Q2=0.958, R2=0.981.  
The predicted and accepted values for the CQAs were taken into consideration for 
drawing the sweet spot plots. In these graphs, the zone where the requirements of both 
the CQAs were fulfilled is depicted in dark blue, where the zone where only one CQA 
is fulfilled is depicted in pale blue. It is possible to note that when CD CONC was 
maintained at 36 mM no combination of the other two variables led to satisfactory 
performances. 
 
Sweet spot plots obtained by plotting pH vs. voltage, maintaining γ-CD concentration at (a) 36 mM; (b) 43 
mM; (c) 50 mM. The zones where the requirements for both the CQAs are fulfilled are colored in dark blue, while the 
zones where the requirement for only one CQA is fulfilled are colored in pale blue. 
 
 These could be achieved only by setting medium-high values of CD CONC, low 
pH values and medium-high voltage values. For defining the DS, Monte-Carlo 
simulations were carried out, in order to propagate the predictive error by using the 
model equation to the CQAs, so that the probability of reaching the desired objective 
was computed and shown as probability surfaces. The DS was established for a 
specified quality level of π≥90%, resulting enclosed within the following intervals: V, 
26-30 kV; pH, 8.80-9.60; CD CONC, 43-50 mM. The DS was graphically represented 
as the green zone in the probability, drawn maintaining CD CONC at 50 mM.  
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The DS was validated by performing 
experiments at its edges, selected by a 
Plackett-Burman design [8] where the -1 
and +1 levels corresponded to the extremes 
of the corresponding DS interval for each 
CPP [101], and verifying the fulfilment of 
the requirements. The working point was 
selected as 30 kV, pH 9.20 and 50 mM γ-
CD, corresponding to the original set-point 
from which the DS was calculated. The 
related electropherogram is here reported showing the baseline separation of all the 
peaks in about 15 minutes with a generated current of about 60 μA.  
 
 
 
 
A multivariate approach was applied for testing robustness, considering all the 
CPPs taken into account when performing the screening study, apart from capillary 
length, to which small variations could not be technically applied. The effect of the 
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CPPs on the CQAs was evaluated in a small interval around the working point, with the 
exception of voltage, which could not be set above the optimized value of 30 kV due to 
instrumental limitations. For testing robustness, in general linear models are advisable 
for the small experimental domain and for the reduction in the number of experiments. 
A Plackett-Burman design [100] was applied and the results of the eight runs are 
indicated. 
 
Exp. no. T 
(°C) 
V 
(kV) 
pH B CONC 
(mM) 
SDS CONC 
(mM) 
CD CONC 
(mM) 
 Rs2 
 
t 
(min) 
1 23 30 9.3 96 102 48  1.38 15.56 
2 21 30 9.3 104 98 52  0.88 15.61 
3 21 29 9.3 104 102 48  1.35 17.85 
4 23 29 9.1 104 102 52  1.37 16.53 
5 21 30 9.1 96 102 52  0.93 15.48 
6 23 29 9.3 96 98 52  1.12 15.92 
7 23 30 9.1 104 98 48  1.18 15.08 
8 21 29 9.1 96 98 48  1.13 15.91 
                        Rs2, enantioresolution between R-AMB/AMB; t, analysis time 
 
 The treatment of the responses by ANOVA demonstrated that no one of the CPPs 
exerted a significant effect on the CQAs in the small interval considered, pointing out 
the high robustness of the method. 
 Information for planning an adequate system control were obtained by the lower 
and the higher values of enantioresolution and analysis time measured during system 
repeatability studies [101] and corresponded to the following system suitability criteria: 
Rs2, 0.99-1.25; t, 13.28-15.92. 
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7.6. A comprehensive strategy in the development of a cyclodextrin-
modified microemulsion electrokinetic chromatographic method for the 
assay of diclofenac and its impurities: mixture-process variable 
experiments and quality by design 
 
In the European Pharmacopeia (Ph. Eur.) [113] DIC specified impurities are 
reported as IA, IB, IC, ID, IE and their nomenclature with the structures and CAS is shown 
below. 
 
 
 
 
 The official procedure in the Ph. Eur. for the test of related substances reports a 
HPLC method with a run time of about 40 min. 
The selected CE operative mode was MicroEmulsion ElectroKinetic 
Chromatography (MEEKC) with the addition of methyl-β-cyclodextrin (MβCD).  
This technique uses an aqueous buffer containing nanometer-sized oil droplets, a 
surfactant and a cosurfactant to form a microemulsion background electrolyte (BGE) 
[118]. MEEKC can claim a great flexibility because the high number of involved 
variables makes it possible to finely modulate the resulting electrophoretic pattern.  
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The critical process parameters (CPPs) include both the mixture components 
(MCs) and the process variables (PVs). MCs are the ingredients in the microemulsion, 
expressed as proportions that sum to 1, while PVs are independent factors related to 
instrumental parameters and buffer. The critical quality attributes (CQAs) may depend 
on both the proportions of the MCs and on the settings of the PVs, with the consequence 
of the need of an effective support by multivariate techniques during the optimization 
[119]. 
 
Risk assessment, critical process parameters and screening phase 
 
Several operating parameters have to be considered when optimizing a MEEKC 
method, including both MCs of the microemulsions and PVs, as recently highlighted in 
the Ishikawa diagram proposed for the risk assessment of a generic microemulsion 
method [120].  
In this study, the selected CPPs were seven, including the PVs, e.g. voltage (V), 
buffer concentration (BC), buffer pH (pH), MβCD concentration (CD) and the MCs of 
the microemulsion, e.g. aqueous phase (W, borate buffer), oil (O, n-heptane), 
surfactant/cosurfactant (S, SDS/n-butanol in 1:2 ratio).  
Other factors can have an important impact on the selected CQAs, including 
capillary length, injection time and pressure, temperature, type of buffer, but they were 
fixed at optimal levels according to the experiments performed in the scouting phase, in 
order to obtain a good compromise between selectivity, sensitivity and analysis time.  
A linear MPV model for MCs and PVs was postulated and a 16-run D-optimal 
Design [65] was generated including 3 replicates at the centre of the domain. 
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Exp. No. Process variables  Mixture components    
 V (kV) BC (mM) pH CD (mM)  W O S  Rs3 t (min) 
1 24 10 8.20 4.0  0.8600 0.0150 0.1250  1.00 24.00 
2 24 30 8.20 4.0  0.9200 0.0090 0.0710  1.48 14.3 
3 30 30 8.20 4.0  0.8660 0.0090 0.1250  0.74 12.9 
4 30 10 10.20 4.0  0.9200 0.0090 0.0710  0.79 6.99 
5 24 30 10.20 4.0  0.8660 0.0090 0.1250  0.99 22.72 
6 30 30 10.20 4.0  0.9150 0.0150 0.0700  1.04 8.44 
7 24 10 8.20 8.0  0.8660 0.0090 0.1250  1.29 21.74 
8 30 10 8.20 8.0  0.9150 0.0150 0.0700  0.72 8.04 
9 24 30 8.20 8.0  0.9150 0.0150 0.0700  1.06 12.93 
10 30 30 8.20 8.0  0.8600 0.0150 0.1250  0.71 12.71 
11 24 10 10.20 8.0  0.9150 0.0150 0.0700  0.59 8.87 
12 30 10 10.20 8.0  0.8600 0.0150 0.1250  0.64 9.63 
13 24 30 10.20 8.0  0.8600 0.0150 0.1250  1.03 20.21 
14 30 30 10.20 8.0  0.9200 0.0090 0.0710  0.72 7.71 
15 30 30 10.20 8.0  0.8962 0.0116 0.0922  0.57 9.23 
16 30 30 10.20 8.0  0.8962 0.0116 0.0922  0.66 9.46 
17 30 30 10.20 8.0  0.8962 0.0116 0.0922  0.63 9.60 
Rs3, resolution between DIC/ID; t, analysis time. 
 
 The models fitted by PLS resulted significant and the PLS solution was converted 
into the plot of the regression coefficient overview of the PLS model [65], shown 
below, which can give the best overview of the effect of each factor on each response.  
 
 
Regression coefficient overview of the screening PLS model. 
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V and S were found to be the variables with the most important effect on the 
responses; an increase in V led to a decrease of both the responses, while a low 
percentage of S was important for decreasing t. pH and CD had a negative effect on 
both the CQAs, with the consequence that the levels necessary for optimizing the two 
CQAs were opposite: low levels for maximizing Rs3 and high levels for minimizing t. 
 
Response Surface Methodology and design space 
In RSM a second order MPV model for PVs and MCs was postulated, where all 
the main, quadratic and interaction effects were considered. The experiments were run 
in two days and a blocking factor was taken into account. A 36-run MPV D-optimal 
Design was generated, with 4 experiments at the centre of the domain for obtaining an 
estimation of the experimental variance. The D-Optimal Design with the measured 
responses, had a G-efficiency value of 53.2% and a condition number of 14.29, 
respectively [65].  
 
Exp. No. Process variables  Mixture components    
 V (kV) BC (mM) pH CD (mM)  W O S  Rs3 t (min) 
1 24 10 8.20 4.0  0.8600 0.0150 0.1250  1.00 24.00 
2 24 30 8.20 4.0  0.9200 0.0090 0.0710  1.48 14.3 
3 30 30 8.20 4.0  0.8660 0.0090 0.1250  0.74 12.9 
4 30 10 10.20 4.0  0.9200 0.0090 0.0710  0.79 6.99 
5 24 30 10.20 4.0  0.8660 0.0090 0.1250  0.99 22.72 
6 30 30 10.20 4.0  0.9150 0.0150 0.0700  1.04 8.44 
7 24 10 8.20 8.0  0.8660 0.0090 0.1250  1.29 21.74 
8 30 10 8.20 8.0  0.9150 0.0150 0.0700  0.72 8.04 
9 24 30 8.20 8.0  0.9150 0.0150 0.0700  1.06 12.93 
10 30 30 8.20 8.0  0.8600 0.0150 0.1250  0.71 12.71 
11 24 10 10.20 8.0  0.9150 0.0150 0.0700  0.59 8.87 
12 30 10 10.20 8.0  0.8600 0.0150 0.1250  0.64 9.63 
13 24 30 10.20 8.0  0.8600 0.0150 0.1250  1.03 20.21 
14 30 30 10.20 8.0  0.9200 0.0090 0.0710  0.72 7.71 
15 30 30 10.20 8.0  0.8962 0.0116 0.0922  0.57 9.23 
16 30 30 10.20 8.0  0.8962 0.0116 0.0922  0.66 9.46 
17 30 30 10.20 8.0  0.8962 0.0116 0.0922  0.63 9.60 
Rs3, resolution between DIC/ID; t, analysis time 
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The calculated models were refined 
by deleting some of the interaction and/or 
quadratic terms in order to increase the 
values of coefficient of determination R2 
and goodness of prediction Q2.  
The obtained PLS models were 
characterised by high values of both R2 and 
Q2: Rs3, R2=0.921, Q2=0.784; t, R2=0.964, 
Q2=0.847. Analysis time t was inversely 
transformed by t-1 and ANOVA evidenced 
that both the PLS models for Rs3 and t were 
significant and valid and could be 
visualized by drawing PLS loading plots 
and contour plots.  
The plots of the PLS loadings of the 
second model dimension w*c2 vs. the loadings of the first model dimension w*c2 made 
it possible to visualize the impact that each variable has on the model considering the 
distance to the plot origin [65].  
From the plot (a) abreast appeared that W, V and CD had an important negative 
effect on Rs3, while S had an important positive effect. Moreover, some quadratic and 
interaction terms had an important influence on Rs3, in particular a quadratic effect of S 
and interaction effects between S and W but also between MCs and PVs, such as V and 
W, pH and O. From the plot (b), which should be interpreted keeping in mind that the 
response t was transformed to t-1, V, pH and CD had a negative effect on t, while S had 
a positive effect.  
Quadratic effects were noticed for pH and S and the interactions with the higher 
impact were between S and W and between CD and S. The variable importance can be 
better clarified from the variable importance in projection (VIP plot) shown below, 
which is useful for revealing which are the dominating terms.  
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VIP plot in Response Surface Methodology. (a) Rs3, resolution between DIC/ID; (b) t, analysis time. 
 
The trend of the predicted responses throughout the experimental domain could be 
easily visualized by means of the contour plots, which were drawn for both PVs and 
MCs. In the figure below the isoresponse surfaces obtained by plotting pH vs. V and 
maintaining CD at its central value of 6 mM are shown for Rs3 (a,c) and for t (Fig. b,d). 
In figure (a) and (b) refer to the reference microemulsion, made by 91.18% W, 1.13% 
O, 7.68% S, while figure (c) and (d) refer to a microemulsion with the lower possible 
value of S, namely composed by 92.17% W, 1.33% O and 6.50% S.  
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The maximization of Rs3 
was in general obtained by 
setting low levels of V and 
medium values of pH, but the 
predicted values with the two 
microemulsions were different. 
By comparing figure (a) and 
(c) it was also evidenced that 
the trend of the response Rs3 
can be different when MCs 
settings are varied: as a matter 
of facts, in (a) there is a 
marked curvature due to the 
quadratic effect of pH, but the 
curvature is much less evident in (c). By analyzing the plots related to t, the same trend 
could be observed for the two microemulsion compositions; the minimization of this 
response was obtained in the same zone for the PVs, e.g. at high levels of V and pH. 
Anyway, the predicted values were lower in the case of the microemulsion with lower S 
content (d).  
The plots show the MCs contour plots for Rs3 (a,c,e) and t (b,d,f), calculated at 
different values of V: 24, 27 and 30 kV. The minimization of the triangular shape of the 
investigated domain was adjusted according to the imposed constraints and the 
isoresponse lines were obtained in function of the different percentages of the MCs.  
In agreement with the information from the loading plots, the zone which led to 
the maximization of Rs3 was characterised by high levels of S, low levels of W and low 
V, while the opposite conditions were required for minimizing t.  
It is worthwhile to note that at high levels of V a curvature was observed, thus 
confirming that the simultaneous study of MCs and PVs is fundamental for obtaining a 
detailed and complete information on the system.  
Hence, the DS was calculated by MODDE software by means of Monte-Carlo 
simulations [87], using a search function which expands the possible CPP ranges from 
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an optimum set-point to the widest possible zone where all the CQA predictions are 
within the specifications at the selected probability level of 99%. 
 
Working points, robustness and method control 
The working point coincided to the original set-point for calculating the DS. The 
typical electrophoretic pattern obtained applying the working point conditions is 
reported, evidencing that the baseline separation of all the peaks was obtained in about 
10 min and the generated current was about 60 μA. 
  
 
 
Ten additional verification points, selected according to a D-optimal design for a 
linear model, and using the limits of the DS as extremes of the investigated 
experimental domain, were tested [101], confirming that all the measured CQAs 
fulfilled the requirements inside the DS. 
A linear MPV model was postulated and a 17-run D-optimal Design [65] was 
generated including one experiment in triplicate. The model was found not significant 
for Rs3, but it resulted significant for t.  
For this CQA an important effect of V was evidenced, as it is possible to see from 
the plot of the regression coefficient overview of the PLS model [65], shown below. 
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Robustness testing: regression coefficient overview of the PLS model for t. 
 
 Actually, this factor is often observed to exert a significant effect on analysis time 
when performing CE robustness studies, and also in this case the need of a careful 
control of V value was confirmed. Method control was then established by defining an 
accepted range for the CQAs, corresponding to the system suitability criteria determined 
from system repeatability study [101]: Rs3, 0.93-1.12; t, 9.43-10.21. 
The method has been validated according to ICH guideline Q2(R1) [121]. Real 
samples of tablets of Dicloreum®, labeled to contain 50 mg DIC, were analyzed by 
applying the developed method and performing four replicates (n=4, α/2=0.025). The 
percentage of label claim was in agreement with the declared content (98.2±1.8%, RSD 
1.2%). Among the impurities, only ID was detected and was quantified at 0.67±0.04% 
with respect to the main compound, with a RSD value equal to 3.8%. 
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7.7. Combination of capillary electrophoresis, molecular modeling 
and NMR to study the enantioselective complexation of sulpiride with 
double cyclodextrin systems 
 
Chiral recognition using CDs is based on the different inclusion interaction 
affinity between the chiral selector and the enantiomers and on the different 
electrophoretic mobilities of the complexes with the enantiomers [122]. The chemical 
modification of the native CDs leads to significant changes in their physicochemical 
properties and in their chiral recognition ability [123]. Several types of forces are 
involved in the inclusion complex formation, including hydrophobic interactions, 
reduction of conformational strain, hydrogen bonding, dipole-dipole and electrostatic 
interactions, van der Waals and dispersion forces, and their relative contribution 
depends on the guest and CD type [124]. 
Charged CDs have been shown to be superior to neutrally substituted CDs in 
several studies and they often have chiral resolving capabilities at lower concentration 
value [126, 123]. The high effectiveness of the charged CDs towards ionizable solutes is 
generally due to the opportunity of additional electrostatic interaction between the 
charged CD and oppositely charged enantiomers, thus resulting in the opposite 
electrophoretic mobility of the chiral selector with respect to that of the analytes. 
Moreover, in contrast with neutral CDs, charged CD derivatives have a self 
electrophoretic mobility, which allows their use as carriers in electrokinetic 
chromatography. Among the many charged CDs investigated, studies with sulfated CDs 
repeatedly demonstrated the widest application range [127]. In particular, sulfated-β-CD 
(SβCD) is known to be a powerful chiral selector, which has been used to separate 
many chiral compounds. SβCD is ionized at all pH values and the multiple ionogenic 
groups (and the counter ions) on each cyclodextrin contribute significantly to the 
conductivity of the running buffer [128]. The developed CE method was able to 
adequately discriminate between the enantiomers, but could not provide any 
information on the stability and structure of the inclusion complexes. Other techniques 
have to be applied to investigate the involved enantioseparation mechanism; in this 
context, Molecular Modeling constitutes an essential tool for exploring the mechanism 
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of molecular recognition. In particular, this approach provides good insights into host-
guest interactions between CDs and enantiomers [129], making it possible to obtain the 
possible geometrical structures of the inclusion complexes. Spectroscopic methods in 
general, and NMR in particular, should be used to confirm the results of molecular 
dynamics (MD) simulations and to provide complementary information about the 
intermolecular interactions that take place [129].  
 
Chiral separation of sulpiride by CE  
In the previously developed CE method, the scouting phase was carried out with 
the aim of finding a chiral selector which could allow both a baseline resolution 
between S-SUL and its enantiomeric impurity in a reasonable analysis time.  
The scouting experiments were run at a concentration of both the enantiomers of 
0.0200 mg mL-1, a value which is one hundred fold lower with respect to the test 
concentration of S-SUL, in order to obtain clear information on the enantioseparation 
ability of different CDs used as chiral selectors.  
Thus, further CE experiments were carried out using the negatively charged SβCD 
in the presence of acidic BR (pH=3.0) buffer and operating in reverse polarity mode. In 
these conditions, the electroosmotic flow is negligible, and the complexed analytes were 
found to migrate at the anode.  
Different SβCD concentration values in the range 1.8-10 mM were tested, 
discarding higher concentration values which led to extremely high electric current and 
very noisy baselines. When increasing SβCD concentration, a decrease of both analysis 
time (t) and resolution (Rs) were observed, and a good compromise was obtained at 10 
mM.  
From these experiments, SβCD was demonstrated to be a suitable chiral selector 
for enantiorecognition, but the resolution values obtained could not be sufficient to 
maintain a baseline resolution in the case of enantiomeric excess determination, where 
the test sample is characterized by an overloading of S-SUL (test value, 2 mg mL-1). 
Hence, a dual system using SβCD in combination with a neutral CD, was 
considered to enhance enantioseparation. Several dual CD systems listed in the table 
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below were tested, keeping constant SβCD concentration at 10 mM and setting the 
neutral CD at two concentration values (10 and 30 mM). 
  
 
Neutral CD Rs t μR 
(cm2 V-1 s-1) 
μS 
(cm2 V-1 s-1) 
α 
10 mM αCD 1.04 8.39 -1.64 x10-4 -1.63 x10-4 9.33 x10-3 
30 mM αCD 0.78 5.46 -2.21 x10-4 -2.19 x10-4 8.89 x10-3 
10 mM γCD  0.70 6.53 -1.87 x10-4 -1.85 x10-4 9.84 x10-3 
30 mM γCD 0.92 7.44 -1.67 x10-4 -1.66 x10-4 1.06 x10-2 
10 mM MβCD 1.50 6.87 -1.86 x10-4 -1.83 x10-4 1.69 x10-2 
30 mM MβCD 2.39 13.32 -1.23 x10-4 -1.12 x10-4 9.61 x10-2 
10 mM HPαCD 0.93 6.21 -1.92 x10-4 -1.90 x10-4 1.19 x10-2 
30 mM HPαCD 0.93 7.19 -1.62 x10-4 -1.60 x10-4 1.18 x10-2 
10 mM HPβCD 0.88 6.27 -2.28 x10-4 -2.26 x10-4 1.21 x10-2 
30 mM HPβCD 1.37 8.45 -1.82 x10-4 -1.79 x10-4 1.30 x10-2 
10 mM HPγCD 0.88 6.27 -1.80 x10-4 -1.78 x10-4 1.11 x10-2 
30 mM HPγCD 0.80 7.41 -1.47 x10-4 -1.46 x10-4 1.09 x10-2 
10 mM HEβCD 1.19 7.51 -1.95 x10-4 -1.93 x10-4 1.25 x10-2 
30 mM HEβCD 1.52 16.87 -1.03 x10-4 -1.00 x10-4 2.80 x10-2 
 
 
The increase of the concentration of the neutral CDs caused an increase of both 
enantioresolution (Rs) and analysis time (t). Representative electropherograms with the 
tested neutral CDs set at 10 mM are reported.  
The selection of MβCD was made on the basis of the possibility of achieving 
slightly higher values of Rs and the final optimized conditions were: BGE, 5 mM BR 
buffer pH 3.45, 10 mM SβCD, 34 mM MβCD, voltage 14 kV.  
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Molecular Modeling  
Inclusion complexes of R- and S-SUL with all the considered neutral CDs and 
with SβCD were drawn. R- and S-SUL were drawn with the protonated pyrrolidinic 
nitrogen ring, while SβCD was drawn with all the sulfated groups in anionic form. Two 
types of inclusion complexes were considered according to the moiety included into the 
CD. The complex type 1 was simulated with the aminosulfonyl group into the 
cyclodextrin cavity, while the complex type 2 was simulated with the pyrrolidinic group 
into the cyclodextrin cavity, as shown. 
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The complexes were submitted to 3 ns of MD simulations in implicit solvent at 
constant pH. Thirty conformations were collected and “minimized” during the 
simulation and the potential and the gain energy of the inclusion complexes were 
calculated on the minimized conformations. The mean values of potential energy Ep for 
the inclusion complex between R-, S-SUL and CDs are reported in the table. 
 
CDs complexes Edock average 
(Kcal/mol) 
R-SUL 
Edock SD 
(Kcal/mol) 
R-SUL  
Edock average 
(Kcal/mol) 
S-SUL 
Edock SD 
(Kcal/mol) 
S-SUL 
αCD-1  -10.1 2.2 -9.3 2.5 
αCD-2  -14.0 3.3 -9.4 2.5 
γCD-1  -12.6 3.5 -14.8 3.0 
γCD-2  -14.9 3.1 -12.8 4.1 
MβCD-1  -19.4 2.7 -22.9 3.8 
MβCD-2  -19.8 4.4 -20.6 3.0 
HPαCD-1  -10.1 3.1 -9.4 2.2 
HPαCD-2  -7.0 3.7 -9.8 2.7 
HPβCD-1  -15.5 3.6 -13.2 4.1 
HPβCD-2  -13.7 3.3 -14.4 3.1 
HPγCD-1  -19.0 4.4 -21.0 3.7 
HPγCD-2  -15.1 3.5 -20.9 4.6 
HEβCD-1  -18.6 4.6 -16.4 2.9 
HEβCD-2  -13.6 3.8 -18.7 4.7 
SβCD-1  -23.3 3.6 -25.3 7.5 
SβCD-2  -27.6 2.2 -18.9 2.6 
Edock values (average and standard deviation) of complexes type 1 and complexes type 2 between R- and S-SUL and CDs. 
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 With the exception of αCD, the most favored complexes using all of the studied 
neutral CDs were found to involve S-SUL; conversely, using the charged SCD, the 
energetically favored complex was calculated to be that with R-SUL. Even though the 
energy differences between the complexes are not statistically significant, this result 
was found to be in agreement with the migration order observed in CE experiments. 
The docking average energies (Edock) of both types of complexes between R- and 
S-SUL with CDs, calculated as the gain in potential energy.  
NMR 
A set of 2-D ROESY experiments was performed providing information on 
relative inter- and intramolecular proton distance, confirming the formation of 
complexes of S-SUL with the CDs. Samples containing S-SUL and either MβCD or 
SβCD or MβCD/SβCD dual CD system were analyzed and the related spectra are 
reported in the figures below. 
 
  
 
The 2-D NMR spectra related to MβCD (a) and SβCD (b) showed several 
intermolecular cross peaks between H3 and H5 protons of both CDs and aromatic ring 
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protons close to the aminosulfonyl moiety of S-SUL, demonstrating the inclusion of this 
group in the CDs cavity. In the spectrum of the solution where both CDs are present (c), 
there was a greater intensity in the signals that relate to the NOE interaction with 
internal protons of MβCD.  
This can be explained by the higher molar concentration, about 3 times, for 
MβCD with respect to SβCD. 
From the results obtained by MD, two types of complexes could form according 
to the moiety included in the hydrophobic cavity. NMR studies were able to confirm the 
formation of complexes, also suggesting predominance of the complexes of type 1, 
characterized by the inclusion of aminosulfonyl moiety of S-SUL in CD cavity. 
Under the applied electrophoretic conditions involving the strong suppression of 
the EOF, the addition of a neutral CD to the buffer containing the enantioselective 
carrier SβCD, is expected to increase the migration time of the cationic solute, merely 
because of the effect of the inclusion into neutral CD, on the analyte mobility.  
One of the variables affecting the migration time values in the studied systems is 
the stability of the complex of the analyte with the neutral CDs. 
This result was shown to be in general agreement with the experimental CE data 
and in particular with those obtained when either MβCD and HEβCD were used in 
combination with SβCD, suggesting that the use of MD in the early phase of method 
development should be encouraged, as it could support the selection of the suitable 
chiral selector approaching the analytical target profile. 
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7.8. Combined approach using capillary electrophoresis, NMR and 
molecular modeling for ambrisentan related substances analysis: 
investigation of intermolecular affinities, complexation and separation 
mechanism 
 
CyD-modified MEKC (CyD-MEKC) is an operative mode of CE where 
surfactants above the critical micelle concentration (CMC) and CyDs are added to the 
BGE, and can be effectively used both in the enantioseparation of chiral compounds and 
in the separation of compounds of similar structure such as a drug and its impurities 
[119].  
SDS is commonly used as the micellar system [118], and CyDs can form host-
guest inclusion complexes, providing a hydrophobic environment for a variety of guest 
molecules [130]. 
CyDs and surfactants are able to form complexes with most surfactants in 1:1 
(CyD)1(surfactant)1 or 2:1 (CyD)2(surfactant)1 stoichiometries with high binding 
constants by including surfactants’ hydrophobic tails into CyD cavities [131, 132]. 
However, since a surfactant is a long and fine molecule, its 1:2, 1:3, 1:4 complexes with 
CyD in theory may also occur. In the specific case of SDS as a guest, the driving force 
for complex formation is the hydrophobic effect associated to three main contributions, 
i.e. the dehydration of the guest molecule chemical groups that are inserted into the 
CyD cavity, the interaction of those groups with the interior of the CyD, and the release 
of water molecules from the CyD cavity to bulk water [130]. 
In particular, (γCyD)1(SDS)2 complexes with head-by-head conformation of SDS 
are very stable, probably due to Na+ mediated salt bridges between sulfate groups [130]. 
Moreover, water molecules released by the formation of 1:1 complexes make the cavity 
more hydrophobic and promote further inclusion of another compound [133] with the 
formation of ternary 1:1:1 complexes. It has been also demonstrated that in ternary 
complexes the two guests can present a cooperative effect [133].  
As a matter of facts, CE does not provide any direct information regarding 
chemical and structural mechanisms of analyte-CyD interactions, therefore further 
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techniques such as NMR spectroscopy and molecular dynamics (MD) simulation have 
been used in combination in order to elucidate these intermolecular interactions.  
NMR is valuable for enabling conclusions about the spatial proximity of 
functional groups of host and guest, thus providing information on the involvement of 
different moieties of the molecules in the intermolecular complex formation.  
Moreover, CyDs can be studied in solution under comparable conditions by NMR 
as well as CE, allowing direct correlations between the complex structure and the 
electrophoretic behavior of the guest molecules. On the other hand, MD can clarify 
different aspects of the dynamics of complex formation as well as structural aspects of 
the formed complexes. 
 
Molecular modeling 
Different aggregates and inclusion complexes of the analytes were drawn 
involving all the species present in the BGE.  
All the tested CyDs and SDS micelles were included in the study, with a special 
focus on the complexes with γCyD.  
 
       Aggregates between SDS micelle and analytes  
Simulations of the aggregates between the analytes and SDS micelles were 
performed by building SDS aggregates corresponding to 1/6 of the micelle in spherical 
form, in order to decrease the calculation time.  
The SDS micelles were anchored to a rigid structure in order to avoid the 
modification of the system geometry. For each of the analytes, complexes in three 
different conformations were built, as reported below for the aggregate between the 
micelle and S-AMB.  
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The average of potential energy (Ep) with the respective SD values and the gain in 
potential energy (EGAIN) for the aggregates of all the considered compounds. From the 
obtained data, the formation of aggregates with the micelles by S-AMB and R-AMB 
was not energetically favorable, and this could be explained by the repulsion between 
the negative charge on the analytes and the sulphate polar head of SDS. All the other 
compounds showed a significant EGAIN when included in the SDS micelles, thus 
indicating a high tendency of forming aggregates 
 
 Ep average 
(Kcal mol-1) 
Ep SD 
(Kcal mol-1)  
EGAIN 
(Kcal mol-1) 
I1 -941.9 3.2 -7.5 
R-AMB -1109.5 2.8 -1.2 
S-AMB -1110.7 4.5 -1.1 
I2 -876.5 2.8 -6.2 
I3 -884.6 3.4 -8.1 
Potential energy (Ep) and gain in potential energy (EGAIN) of the aggregates of analytes and micelles (n=90). 
 
Inclusion complexes between γCyD and analytes 
 
Simulations of the 1:1 inclusion complexes between γCyD and each compound 
were drawn considering for each complex two conformations, according to the molecule 
moiety located inside γCyD cavity. The two conformers of the complex (γCyD)1(S-
AMB)1 are shown.  
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  The complex between γCyD and SDS seemed to be favored with respect to the 
complex between γCyD and any other compound.  
As a matter of facts, the average EGAIN values for all the analytes were statistically 
different (p<0.05) from the SDS value, with the consequence that SDS could be able to 
successfully compete with the other analytes for the formation of the 1:1 complexes 
with γCyD.  
 
Mixed inclusion complexes 
The γCyD cavity is wide enough to suggest the possibility of the formation of 
mixed inclusion complexes.  
Each analyte could be inserted in γCyD together with 1 or 2 molecules of SDS, 
thus forming ternary complexes of different stoichiometry, i.e. (γCyD)1(SDS)1(analyte)1 
or (γCyD)1(SDS)2(analyte)1.  
For each mixed complex 1:1:1 and 1:2:1 four conformations were drawn, by 
combining all the possible orientations of the molecules included in the cavity.  
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The four conformers of the complex (γCyD)1(SDS)1(S-AMB)1 are reported. two 
conformers of the complex (γCyD)1(SDS)2(S-AMB)1 are shown.  
 
 
 
 
The Ep and the EGAIN values of the mixed complexes 1:1:1 and 1:2:1 are shown in 
the table. In general, by comparing the EGAIN of 1:1 and 1:1:1 complexes, it appears that 
the formation of mixed complexes is preferred.  
The probability of formation of the mixed complex is significant for the one 
between (γCyD)1(SDS)1(I1)1, with the average EGAIN (-19.7 Kcal mol-1) but not 
statistically different (p>0.05) with respect to the EGAIN for the complex (CyD)1(SDS)2 (-
19.9 Kcal mol-1).  
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  1:1:1 complexes  1:2:1 complexes 
  Ep average 
(Kcal mol-1) 
Ep SD 
(Kcal mol-1) 
EGAIN 
 (Kcal mol-1) 
t test 
(P 
value) 
 Ep 
average 
(Kcal 
mol-1) 
Ep SD 
(Kcal 
mol-1) 
EGAIN 
(Kcal 
mol-1) 
t test 
(P 
value) 
I1  116.4 3.4 -19.7 0.813  28.3 5.2 -22.8 0.031 
R-AMB  -54.4 4.8 -14.8 <0.001  -144.8 4.2 -22.0 0.003 
S-AMB  -48.6 10.8 -8.2 <0.001  -144.6 2.9 -20.6 <0.001 
I2  188.6 3.1 -11.6 <0.001  91.1 3.5 -24.1 0.146 
I3  176.8 4.1 -17.3 0.015  83.9 3.0 -21.4 0.531 
SDS   63.0 4.0 -19.9   -27.2 2.9 -25.2  
 
 In general, by comparing the EGAIN of 1:1 and 1:1:1 complexes, it appears that the 
formation of mixed complexes is preferred.  
The probability of formation of the mixed complex is significant for the one 
between (γCyD)1(SDS)1(I1)1, with the average EGAIN (-19.7 Kcal mol-1) but not 
statistically different (p>0.05) with respect to the EGAIN for the complex (CyD)1(SDS)2 (-
19.9 Kcal mol-1).  
For all the other compounds the probability of formation of the mixed complex is 
lower. As for 1:2:1 stoichiometry, the calculated  EGAIN values indicate that there is a 
high probability of formation for I2 and I3 complexes, which present an average EGAIN 
not statistically different with respect the complex (γCyD)1(SDS)3 (p>0.05). R-AMB 
and S-AMB have a similar and lower tendency of formation of this type of complexes.  
 
          NMR 
2-D NOESY experiments were carried out analyzing different samples, each 
containing γCyD in combination with SDS, and/or S-AMB or I1, either as two-
components or three-components samples.  
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The spectra of the samples made of γCyD:S-AMB and γCyD:I1 in 1:1 molar ratio 
showed no evident interaction between the compounds. Instead, by observing the 
spectra of γCyD:SDS in 1:2 ratio, reported in the figure, cross peaks were found 
between the SDS aliphatic chain and the γCyD internal (H3,H5) and external (H2,H4) 
protons. 
 
 
 
 
The possible existence of mixed complexes was investigated by means of samples 
containing γCyD:SDS:S-AMB and γCyD:SDS:I1 in 1:2:1 ratio, for elucidating the 
interactions between the different compounds. 
 In the case of S-AMB, shown below, cross peaks were evidenced between S-
AMB aromatic protons and γCyD internal proton H3 (a), and cross peaks between SDS 
and all γCyD protons were also found (b).  
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As for I1, evident cross peaks were present between the proton of I1 pyrimidine 
ring of and γCyD internal proton H5.  
 
 
 
Also in this case, cross peaks were found between the protons of SDS aliphatic 
chain and both the γCyD internal and external protons. These findings led to confirm 
the existence of mixed complexes in the involved equilibrium. 
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Discussion 
The EGAIN values of binary 1:1 complexes (γCyD)1(analyte)1 highlighted the high 
propensity of SDS to be included in γCyD with respect to the other compounds, 
indicating that the most favoured complexes were in the order SDS>I1>I3>I2>S-
AMB>R-AMB. Up to 3 SDS molecules could be included in the cavity (EGAIN -25 kcal 
mol-1) and the interactions between the SDS aliphatic chain and both the internal and 
the external γCyD protons were demonstrated by NMR spectra. These results suggested 
the possible existence of a competition between SDS and the different compounds to be 
included in the γCyD cavity and this could be a possible explanation of the fact that 
γCyD was necessary for obtaining the separation of I2 and I3, which could not be 
resolved in a simple SDS micellar system. Unexpectely, NMR spectra of γCyD:S-AMB 
e γCyD:I1 did not reveal any interactions, but the CZE results clearly showed that γCyD 
could be able to separate the enantiomers even without SDS addition. 
Finally, the EGAIN values of the mixed 1:1:1 and 1:2:1 complexes between γCyD, 
SDS and the different compounds showed the much greater tendency of forming ternary 
complexes with respect to the formation of binary 1:1 complexes. Focusing on 1:1:1 
complexes, SDS and I1 showed the highest stability, with the enantiomers characterized 
by a lower but significant propensity of forming this type of complexes. On the other 
hand, for 1:2:1 complexes the higher stability was observed for I2, I3 and SDS. The 
formation of mixed complexes for S-AMB and I1 was confirmed by the NMR spectra. 
 
 
7.9. Exploring the intermolecular interactions acting in solvent-
modified MEKC by Molecular Dynamics and NMR: the effect of n-
butanol on the separation of diclofenac and its impurities 
 
In both MEKC and MEEKC, nBuOH is present in the aqueous buffer phase and 
in the Stern layer of the micelles, but also can penetrate into the micelles/microemulsion 
droplets, acting as a true class I modifier [4, 130, 134]. By using two-dimensional NOE 
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spectroscopy (2-D NOESY) it has been demonstrated that the nBuOH headgroup is 
located in contact with the SDS micellar headgroups, while the hydrocarbon chain is 
directed to the micelle core. In particular, adding the alcohol to micelles, the size-to-
charge ratio of the micelles increases because nBuOH reduces the charge density and 
promotes the formation of micelles with a more open structure [135].  
nBuOH shows a complicated influence on the structure of the micelles and can 
either decrease or increase the size of the aggregates. 
The present study was aimed to providing insight into the separation mechanism 
and into the interactions between the analytes and the components of the separation 
system (SDS, nBuOH, MβCyD). Due to the high complexity of the MEEKC system, 
and due to the fact that for obtaining the separation the use of nBuOH resulted to be 
compulsory, in the present study an analogue solvent-modified MEKC system was 
taken into consideration, with similar composition of the optimized microemulsion but 
made only by SDS and nBuOH, without the n-heptane oil phase. 
The combination of NMR and Molecular Dynamics (MD) has been already 
demonstrated to be anuseful tool for increasing the knowledge on the mechanisms 
controlling the separation in electrophoretic analyses. 
 A special interest was focused on elucidating the important role of nBuOH, 
whose presence in the BGE was compulsory for obtaining the separation. MD 
simulations of SDS micelles, nBuOH aggregates, mixed micelles and aggregates of the 
analytes with the latter supramolecular structures were performed. Inclusion complexes 
of the analytes, SDS, nBuOH with MβCyD were also simulated. 
 
Capillary Electrophoresis 
The important role of nBuOH for obtaining the separation was confirmed by 
carrying out a series of experiments on a test sample where all the analytes were at low 
concentration values (0.040 mg ml-1), as shown here.  
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The working point conditions were applied for pH, concentration of borate buffer 
and percentage of SDS (2.63%, corresponding to about 90 mM), while the 
concentration of nBuOH was varied so that the SDS/nBuOH molar ratios tested were 
1:2, 1:5, 1:8. The latter value corresponded to the same molar ratio present in the 
optimized microemulsion (1:2 weight ratio).  
By applying these separation systems, it was clear that the increase of nBuOH 
concentration led to an increase of analysis time and to an increase of the separation 
between IE and DIC, and that the use of a 1:8 molar ratio as in the MEEKC optimal 
conditions could enable a complete separation of IA, IB and IC. 
Information on the extent of solute association with micelles and mixed 
SDS/nBuOH micelles was then obtained by calculating the capacity factors for neutral 
and weakly ionized solutes (IA, IB, IC, IE) and corrected capacity factors for charged 
analytes (DIC, ID). 
Information on the extent of solute association with micelles and mixed 
SDS/nBuOH micelles was then obtained by calculating the capacity factors for neutral 
and weakly ionized solutes (IA, IB, IC, IE) and corrected capacity factors for charged 
analytes (DIC, ID). For charged analytes the migration phenomenon does not only 
involve the partition mechanism between the aqueous phase and the micellar phase as 
for the neutral compounds, but also their electrophoretic mobility.  
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Three BGEs were prepared 
with a SDS/nBuOH molar ratio 
equal to 1:1, 1:4 and 1:8, and three 
analyses were run for each BGE. 
The extent of association of the 
charged compounds is much lower 
than that of the neutral solutes, due 
to the repulsion of the negative 
charges. The association of DIC 
and ID is higher for the SDS micelle 
than for the mixed micelle 1:1 and 
then increases with the increase of 
nBuOH concentration. As concerns 
the most hydrophobic compounds, 
IA, IC and IB, the affinity of these 
solutes for the mixed micelles 
increases when increasing nBuOH 
concentration, but then undergoes a decrease from the molar ratio SDS/nBuOH 1:4 to 
the ratio of 1:8. IE has a much lower affinity than the other neutral compounds for both 
the micelles and the mixed micelles.  
 
 90 mM SDS  SDS/nBuOH 1:1   SDS/nBuOH 1:4   SDS/nBuOH 1:8  
k’ corr 
 
sd 
 
sd  
 
sd   sd 
DIC 1.03±0.55 0.22 0.30±0.22 0.09  1.37±0.23 0.09  2.48±0.11 0.04 
ID 1.25±0.84 0.34 0.32±0.23 0.09  1.61±0.27 0.11  2.78±0.05 0.02 
k’           
IE 1.51±0.09 0.04 1.60±0.21 0.09  1.24±0.23 0.09  0.92±0.02 0.01 
IA 11.29±1.90 0.77 13.81±6.98 2.81  22.61±6.12 2.46  14.24±2.17 0.87 
IC 11.29±1.90 0.77 13.81±6.98 2.81  22.61±6.12 2.46  18.19±3.21 1.29 
IB 11.29±1.90 0.77 13.81±6.98 2.81  34.07±17.34 6.98  28.09±6.86 2.76 
  
 
SDS micelles and n-butanol aggregates 
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The preliminary step of MD study was focused on analyzing different types of 
micelles and aggregates, made by SDS only, by nBuOH only and by SDS with 
increasing concentration values of nBuOH.  
The SDS micelle formation was simulated in both spherical and rod-like shape, 
with a parallel orientation of the hydrocarbon tails in both the dispositions.  
The progressive introduction of a number (n) of SDS molecules in these two 
forms involved changes in terms of potential energy (Ep) gain. 
 The trend of Ep for the spherical shape is shown in red, while the trend for rod-
shape is shown in blue. Initially, with a low number of SDS molecules (n<15), the Ep 
gain for the rod-like shape is greater than for the spherical one, and it can assumed that 
SDS aggregates with a small number of molecules presumably tend to organize in rod-
like shape; but by increasing n, and therefore when increasing SDS concentration, the 
Ep gain decreases. On the contrary, for the spherical form, the Ep gain increases up to 
30-40 units of SDS and then tends to decrease, but less markedly than for the rod-like 
shape. Further increase of n over 70-80 units does not entail a gain in Ep, therefore for 
the MD simulations spherical SDS micelles, formed by 80 monomers, were taken as 
reference.  
As for nBuOH aggregates, the same criterion for SDS micelle was employed, and 
aggregates of rod-like and of spherical shape were simulated with random orientation of 
hydroxilic groups in both forms. The trend of Ep gain due to the progressive increase of 
number of molecules n of nBuOH is shown in (b). 
Both the values and the trend of Ep gain were quite similar for both the shapes 
(with a maximum gain of about 2.0-2.5 kcal/mol). 
 
Aggregates of SDS, BuOH and analytes 
MD simulations were then directed to evaluate the Ep gain due to the formation of 
aggregates between the considered analytes and SDS micelle. For each aggregate, three 
different conformations were built in the case of DIC. 
MD simulations were then performed considering a quarter of SDS/nBuOH mixed 
micelle in 1:2 molar ratio, where the analyte was inserted.  
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The Ep gain obtained due to the formation of an aggregate of the analyte and the 
mixed micelle. From the histogram it can be noticed that in general the Ep gain of the 
analyte-mixed micelle aggregates is generally lower than the Ep gain calculated for the 
aggregates with only SDS, but the general trend is similar. 
 From the electrophoretic experiments, the addition of nBuOH increases the 
resolution among the neutral species IA, IB and IC, explaining the trend of migration 
order and playing a fundamental role for obtaining the electrophoretic separation.  
The number k was estimated based on the surface of the molecules exposed to the 
solvent, with the equation k= (Sa/(Sb/2)), where Sa is the value of the surface exposed 
to the solvent of the analyte and Sb is the value of the surface exposed to the solvent of 
nBuOH (this is halved because only one face is able to interact).  
 
 
Inclusion complexes with MβCyD 
The MD simulations of inclusion complexes with MβCyD were performed for 
each analyte, but also for SDS e nBuOH, assuming the formation of 1:1 complexes and 
considering two different conformations according to the side of entrance of the 
molecule inside the cavity. The average values of obtained Ep gain for the formation of 
the inclusion complexes are reported in form of histogram. 
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 MβCyD is capable of forming inclusion complexes with all the analytes, with an 
Ep gain on average higher than that calculated for the formation of aggregates with 
mixed micelles, and this explains the increase in migration velocity, due to the fact that 
MβCyD acts as a second pseudostationary phase and competes with the mixed micelle 
to include the analytes. The Ep gain calculated for the formation of the inclusion 
complex between MβCyD and SDS is of the same order of magnitude of the Ep gain for 
the formation of the SDS micelles, thus the latter is not prevented by the presence of 
MβCyD. 
 
NMR 
In order to support the findings of MD 
simulations, a set of 2-D NOESY spectra was 
performed on samples of mixed micelles in 
different SDS/nBuOH ratios (1:1, 1:4, 1:8), as 
reported.  
Some cross peaks between methylene 
group in position 3 of nBuOH and methylene 
group in position 2 of SDS were evidenced, 
highlighting the insertion of the short chain of 
the alcohol in the lipophilic portion, keeping 
the hydroxylic group outside the micelle.  
Taking as a reference the peak of the 
SDS methylene group in position 2, the 
integral of the cross peak measured in the 
different molar ratios between SDS and BuOH 
presented approximately a similar value (0.09 
for 1:1 ratio, 0.08 for 1:4 ratio and 0.06 for 1:8 
ratio). Hence, it can be hypothesized that the 
composition of the micelles does not vary 
when increasing nBuOH, confirming that a 
SDS/nBuOH ratio between 1:1 and 1:2 is the most probable for mixed micelles.  
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The NOESY spectra of DIC and IE in presence of SDS/nBuOH mixed micelles 
(1:8 molar ratio), unexpectedly only showed interactions of the analytes with SDS and 
not with nBuOH. This suggests the presence of a competition within the micelle 
between the analytes and nBuOH, where the insertion of the analyte seems to be 
preferred.  
This behavior confirmed the MD simulations of aggregates including micelles and 
analytes, where the Ep gain was demonstrated to be lower in mixed aggregates. 
 
 
 
 
Finally, NOESY experiments were performed providing information on the 
formation of complexes between MβCyD and either nBuOH, SDS, DIC or IE.  
The obtained spectra are reported below, together with the most probable 
conformation of the complex. It is already well known that SDS can exist in free, 
complexed and micellized states and the spectrum confirmed the presence of inclusion 
complexes with MβCyD.  
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For both DIC and IE inclusion complexes could form, as evidenced by some cross-
peaks with H3 proton, located in the wider portion of the internal cavity of the CyD. 
Instead, for nBuOH no cross peak was evidenced, maybe because the possible inclusion 
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complex with MβCyD is of low stability due to the small dimensions of nBuOH and its 
solubility in water, as also indicated by MD histogram. 
From the results of CE experiments, it was evident that the presence of SDS 
micelles in the BGE could make it possible the separation of acidic analytes (DIC, ID) 
and IE, but the presence of nBuOH was necessary in order to obtain the separation of IA, 
IB and IC. The addition of nBuOH to SDS micellar solution led to similar results both in 
MEEKC and in solvent-modified MEKC, pointing out that the presence of the oil n-
heptane was not necessary for the separation. Furthermore, the addition of MβCyD to 
the BGE was useful for reducing analysis time. 
Further CE experiments showed that when keeping the percentage of SDS 
constant and adding increasing amounts of nBuOH, the molar ratio between 
SDS/nBuOH which led to the best results in terms of selectivity was 1:8, namely the 
ratio corresponding to that present in the optimized microemulsion (1:2 in terms of 
weight). Thus, it was hypothesized that the high resolving power of the separation 
buffer was due to the combination of SDS and nBuOH in adequate proportions. The 1:8 
ratio also corresponded to significant values of capacity factors for DIC and ID and high 
values for IA, IB and IC, with the exception of IE. 
MD simulations and NMR experiments contributed to a possible explanation of 
the effects of the addition of nBuOH to the SDS micellar solution. 
The results indicated that nBuOH could be present not only in the mixed micelles 
but also as monomer and nBuOH aggregates in the aqueous buffer. MD simulations 
also investigated the insertion of the analytes into the SDS micelle and in the mixed 
micelle with molar ratio 1:2.  
Indeed, NMR highlighted the presence of inclusion complexes with SDS but not 
with nBuOH, probably due to the fact that nBuOH presents a lower affinity for the 
lower lipophilicity and the smaller dimensions with respect to SDS. The presence of 
MβCyD in the BGE may lower the availability of both SDS and nBuOH and mostly 
could compete with the mixed micelle for the insertion of the analytes, thus reducing 
their migration time. 
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7.10. Quality by Design applied to Dried Blood Spot liquid 
chromatography-mass spectrometry analysis. 
In the sixties, Guthrie and Susi reported the blood collection on adsorbent papers 
in order to determine phenylalanine to detect phenylketonuria in newborns. This was the 
early days of Dried Blood Spot (DBS), a sample preparation technique which became, 
in the nineties, the method of choice to screen various metabolic disorders in newborn. 
The DBS collection is simple; spots of capillary blood from a finger are spiked 
onto a cellulose-based filter paper and dried. The analytes are then extracted from the 
DBS with solvent. Clean extracts are commonly obtained for laboratory analyses, even 
if it seems to be necessary to develop an extraction protocol depending of the matrix 
and the target analytes (pharmaceutical susbtances, metabolites…) regarding the type 
and volume of solvent or the extraction duration, in order to ensure good recovery rates 
and minimize the matrix effects, for a maximum number of analytes from the same 
punch [137]. 
Several parameters such as spot homogeneity, blood-to-plasma ratio of the drug, 
sample volume or hematocrit effects (Htc) (it is the volume fraction of blood occupied 
by erythrocytes) can have an influence on quantitative analyses. Theses parameters and 
especially Htc need to be considered for Therapeutic Drug Monitoring (TDM), in order 
to have precise quantitative analysis to adapt the therapeutic treatment. This 
phenomenon influences blood viscosity and affects spreading of the matrix onto the 
filter paper.  It is possible to override this drawback by spotting a precise volume of 
blood and an innovative approach has recently been developed to fix the taken blood 
volume independently from the Hct: Volumetric Absorptive Microsampling (VAMS) 
[138]. On another hand, an alternative is to use plasma spot instead of blood spot to 
counter the possible rupture of erythrocytes. 
DBS extraction reaches several prerequisites for a sample preparation technique 
such as easy storage, shipments and logistics because the DBS has been reported to be 
stable under ambient conditions and do not need any freezing; it is thereby cheap and 
the other advantage it that it limits biohazard risks [139]. Moreover, this technique can 
be automated in order to reach high throughput extraction method [139]. The spot is 
usually made of blood but plasma or even urine and cerebrospinal fluid can also be 
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spiked. Another advantage which could be taken in consideration is the low sample 
consumption and micro-sampling, especially for pharmaceutical and newborn clinical 
field.  
Micro-sampling helps the pharmaceutical companies to reach the 3R’s (Reduce, 
Refine, Replace) doctrine, being more ethical. In clinic, it allows a newborn screening 
(NBS) of several metabolic disorders thanks to the less painful and less invasive sample 
collection, since a really low blood volume is collected (of the order of the microliters), 
contrary to venipuncture [139].  
For Therapeutic Drug Monitoring (TDM) of adult patients, this micro-sampling is 
not really a challenge, except for phlebitis, cancer and weak patients, but the DBS 
sample preparation has the advantage to allow self-testing. [140]. 
Nowadays, the increasing affordability of sensible LC–MS/MS techniques 
enables precise drug quantification in matrices incorporating even vast interfering 
compounds. 
The liquid chromatography/tandem mass spectrometry (LC/MS/MS) technique 
can be considered as the method of choice for TDM of various critical dose drugs 
including PI and NNRTI. 
The significant sensitivity improvement of current MS instruments is adequate for 
routine analysis of xenobiotics in DBS, with some applications also reported from 
hospitals for therapeutic drug monitoring (TDM) [140]. 
 
The present work investigates the effect of the different parameters such as drying 
time, extraction duration, extraction volume or extraction solvent on the extraction 
efficiency from DBS of protease inhibitors, since these analytes are of interest in TDM, 
but we wanted to investigate steroids also, in order to have another class of molecules 
and because these endogenous compounds can also be of interest, in order to get a better 
understanding of what are the critical parameters of DBS for future developments. 
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Chemical and reagents 
 
Methanol (MeOH) was purchased from Fischer Scientific (Loughborough, UK), 
ethyl acetate (EtOAc) from Acros Organics (Morris Plains, NJ, USA) and acetonitrile 
(ACN) from Biosolve B.V. (Valkenswaard, Netherlands). Formic acid (FA) (>98%) 
was provided from Merck Millipore Corporation (Darmstadt, Germany). Amprenavir 
(AMP) was obtained from Moravek Biochemicals (Brea, CA, USA), atazanavir (AZV) 
was obtained from American Radiolabeled Chemicals (St. Louis, MO, USA), lopinavir 
(LPV) and ritonavir (RTV) were obtained from Ontario Chemicals Inc. (Ontario, 
Canada), darunavir (DRV), amprenavir-d4 (APV-d4), darunavir-d9 (DRV-d9), 
atazanavir-d5 (AZV-d5), ritonavir-13C3 (RTV-13C3) and lopinavir-d8 (LPV-d8) were 
obtained from Santa Cruz Biotechnology, Inc. (Dallas, TX, USA), propranolol, estrone, 
progesterone, testosterone were purchased from Sigma-Aldrich (St. Louis, MO, USA), 
bosentan (I) was obtained from F. Hoffman-La Roche Ltd. (Basel, Switzerland).  
 
LC analysis 
For the screening phase, LC analyses were carried out on a Nexera HPLC system 
(Shimadzu Corporation, Kyoto, Japan) equipped with a CBM-20Alite controller module, 
a quaternary pump LC-30AD with low pressure gradient mode, a SIL-30AC auto 
sampler and a CTO-30A oven. LC separations were achieved on a XB C18 column 
(Kinetex, Phenomenex, 2.1 x 100 mm, 2.6 µm) at 40°C, with a mobile phase constituted 
of A (H2O with 0.1% formic acid) and B (ACN with 0.1% formic acid) at a flow-rate of 
0.3 mL/min, with a gradient from 40 to 76% of B in 5 minutes. For the Response 
Surface Methodology (RSM), the Design Space (DS) and the Robustness, LC analyses 
were carried out on a UltiMate 3000 HPLC system (Dionex) equipped with a TCC 3200 
controller module, a HPG 3400 M quaternary pump and a WPS 3000 TSL auto sampler. 
LC separations were achieved on an Luna C18(2) column (Phenomenex, 2.1 x 100 mm, 
3 µm) at 40°C, with a mobile phase constituted of A (H2O with 0.1% formic acid) and 
B (ACN with 0.1% formic acid) at a flow-rate of 0.3 mL/min, with a gradient from 40 
to 76% of B in 5 minutes. 
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MS conditions 
The Nexera system was coupled to a triple quadrupole mass spectrometer LCMS-
8050 (Shimadzu) through an electrospray ion source operated in positive mode.  
MS conditions were as follows: capillary voltage = 4 kV, temperature of 
desolvation line = 300°C, temperature of heating block = 400°C, interface temperature 
= 400°C, nebulizing gas = 3 L/min (nitrogen), drying gas = 10 L/min (nitrogen), heating 
gas = 10 L/min, collision induced dissociation (CID) gas = 270 kPa (argon). For 
quantitation analysis, selected reaction monitoring (SRM) mode was used with a dwell 
time of 50 ms for each transition. SRM transitions and collision energies (CE) were 
optimized with the LabSolutions software. The voltages at Q1 prebias, collision cell and 
Q3 pre bias were optimized for each analyte to obtain the highest sensitivity.  
The UltiMate 3000 system (U3000) was interfaced with a Turbo-V IonSpray 
electrospray source to a 4000 Q TRAP (AB Sciex, Concord, ON, Canada). MS source 
conditions were as follows: curtain gas = 40 psi, gas 1 = 30 psi, gas 2 = 25 psi, 
electrospray voltage = 5200V, source temperature = 350°C. Collision gas (N2) setting 
set to high. Experiments were performed in the Selected Reaction Monitoring (SRM) 
mode with 10 ms dwell time transitions.  
 
Software for data acquisition and processing 
The Nexera system and the LCMS-8050 mass spectrometer were controlled and 
the data acquisitions were collected by the LabSolutions software (Shimadzu). 
The U3000 was controlled by the Chromeleon software (Thermo Fisher), and the 
4000 Q TRAP was controlled, and the data acquisitions were collected by the Analyst 
software (Sciex). 
Nemrod-W software was used for generating the asymmetric screening matrix and 
the Plackett-Burman designs. MODDE10 software was employed for generating 
Central Composite Centered design (CCD) and to draw risk of failure maps by Monte-
Carlo simulations. Projection to Latent Structures regression (PLS) was employed as 
regression technique. The definition of DS was based on the obtained PLS models and 
Monte-Carlo simulations, by taking into account the error in prediction of the models. 
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Preparation of stock and spiking solutions and sample collection  
Stock solutions of AMP, AZV, DRV, LPV, NFV and RTV were prepared by 
dissolving them in methanol at concentration of 1 mg/mL, and a spiking solution 
containing all the protease inhibitors was prepared at 50 µg/mL for AMP, AZV, DRV, 
LPV, NFV and RTV, respectively. Organic bovine blood was provided by the 
slaughterhouse of Meinier (Meinier, Switzerland). Sample preparation was performed 
on dried blood spot (DBS) according to a published procedure. 15 µL of a solution 
constituted of 980 µL of plasma and 20 µL of spiking solution of sample were spiked 
onto a paper disk. After spiking, DPS was dried for 30 to 120 minutes and 100 to 900 
µL of extraction solvent were added, following by 5 to 15 minutes of sonication. Then, 
filter paper was removed, and extraction solvent was evaporated by centrifugation. The 
sample was reconstituted in 200 µL of injection solvent (ACN/water), containing 20 
ng/mL of the labelled protease inhibitors, used as internal standards. This was followed 
by the mixing at 1400 rpm for 5 minutes (Thermomixer comfort, Eppendorf). The 
samples were let 5 minutes at 4°C and after a centrifugation step at 12000 rpm of 2 
minutes, 150 μL of supernatant were transferred in vial prior to injection (injection 
volume was of 5 µL). 
 
Critical process parameters (CCPs) and investigation of knowledge space 
QbD emphasizes the need to thoroughly understand the analytical system by an 
in-depth study of CPPs and their interactions using DoE to find cause-and-effect 
relationships. To get a better understanding of the criticality of the parameters involved 
in the sample preparation procedure for DBS-LC-MS/MS assay for specific compound, 
several parameters, such as volume of solvent, sonication time, the times of dry and 
type of solvent were evaluated. 
The selected CPPs to be investigated by DoE were represented by volume of 
solvent (SOLVENT VOL), time of sonic (SONIC TIME), time of dry (DRY TIME), 
type of solvent (SOLVENT). The considered CQAs were the peak area ratios 
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(analyte/IS) of the five protease inhibitors Rs1, Rs2, Rs3, Rs4, Rs5, and the three 
steroids Rs6, Rs7, Rs8. The aim of a sample preparation is to get the highest extraction 
recovery, that is why peak area ratios were chosen as representative of extraction 
quality. The volume of the solvent, the time of sonic and the time of dry were studied at 
three levels, instead the type of solvent was studied at five levels in order to compare 
the extracting power and reach a truly understanding on sample preparation process. 
The type of solvent variable was chosen as the most pertinent to investigate at five 
levels because it was a qualitative variable and it allowed covering more physico-
chemical properties of solvent. Indeed, this parameter effectively affects the extraction 
depending on the solvent / analyte affinity.  
Nemrod-W software was employed to postulate the screening asymmetric matrix 
used to estimate the coefficients of the following Free-Wilson model: 
 
 
 
where X1 is SOLVENT VOL, X2 is SONIC TIME, X3 is DRY TIME, X4 is 
SOLVENT, b0 is the constant term and bi the linear coefficients of each factor. 
 The 18-run experimental plan is here reported with the measured responses; each 
analysis was repeated five times in order to obtain a reliable estimate of the 
experimental variance. 
ANOVA showed that the models for all the responses were significant and 
graphical analysis of effects was carried out, as reported in Fig. 1-2. 
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The graphic analysis of effects made it possible to obtain two types of plots; the 
first type of plot, reported in Fig. 1(a-h), the bars are related to the effects on the CQAs 
of the changes of level of the CPPs and the bar length is proportional to the amplitude of 
the difference of the relative effects between two levels.  
The low level and the high level for the CPPs studied at three levels are indicated 
by 1,2 and 3, respectively. Instead for the type of solvent, investigated at five levels, are 
indicated with 1 to 5 respectively.  
Thus, the bar indicated by b1/2-1 is related to the effect on the considered 
response of the change from level 2 to level 1 of the first factor, namely solvent volume. 
As another example, the bar indicated by b4/5-4 is related to the effect of the change 
level from level 5 to level 4 of the type of solvent.  
The significant effects correspond to the orange bars, exceeding the reference line, 
calculated by means of the experimental error.  
The second type of plot, shown in Fig. 2 (i-p), the bars correspond to the effects of 
the different levels of the factors, giving the possibility of identifying which are the 
levels which maximize or minimize the response, and thus which are the best levels for 
each considered CQAs. 
Rs2 Rs3 Rs4
Rs5 Rs6 Rs7 Rs8
(i)
(n)
(k)
(o)
(l)
(p)(m)
(j)
Rs1
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From the investigation of these plots, we can underline that all our responses were 
maximized by a medium-high level volume of solvent except for Rs4, the effect of the 
change of level of this parameter was not significant, and Rs7, on the contrary was 
maximized by a medium level of this factor.  Medium or high level of the time of sonic 
maximized all the responses without a marked difference, however the changing of this 
factor wasn’t significant for Rs4. 
The change of the time of dry wasn’t significant for both Rs1 and Rs4, and 
medium-low level of this factor were preferred for the remaining CQAs.  
The change of levels of type of solvent was undoubtedly of outmost importance, 
confirming the important role of this factor. All the responses were maximized by 
methanol except for Rs4.  
The information from the two types of plots was matched, mediating the best 
values and ranges of the CPPs with respect to the different CQAs.  
Hence, the final outcome of the screening phase consisted in fixing methanol as 
election exctracting solvent, moving to high values for volume of solvent and time of 
sonic and defining a new experimental domain for time of dry, in order to be focused on 
by RSM. 
Futher experiments will consequentially carry out in order to obtain the restrain of 
the domain for each critical process parameters by RSM and finally reach the DS, where 
all the combinations of the variables lead to optimal values of the responses with a 
certain level of probability. 
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8. Conclusions 
 
The projects developed during my PhD thesis have thoroughly highlighted the 
potential of capillary electrochemical chromatography in pharmaceutical analysis 
through the study and development of methods exploiting and fully investigating its 
different operating modes. 
Capillary electrophoresis has been confirmed to be a flexible analytical technique 
since it allows the modulation of different operating conditions in order to obtain the 
desired separation and short analysis time and thus solving different analytical issues. 
The wide range of applications for which the use of this method has proved to be 
successful includes identification of pharmaceutical substances, assay of drugs, 
determination of drug-related impurities, physicochemical measurements of drug 
molecules or chiral separations.  
For pharmaceutical analysis, the range of applications for which CE can be used is 
extensive, possibly eclipsing the applications of the more frequently used HPLC. 
MEKC is a branch of CE, which has become during the years one of the most popular 
techniques in CE due to its high resolving power and capability of separating both ionic 
and neutral analytes. 
 MEKC solvent modified in particular is the most flexible of all CE techniques, 
offering the greatest selectivity to the widest range of compounds and can be considered 
the separation method of choice when performing CE analysis for pharmaceutical 
substances, relating its power to combine the separation mechanism of chromatography 
with the electrophoretic and electroosmotic movement of analytes and solutions for the 
separation of constituents in a sample.  
Molecular Dynamics Simulations as a complement to Nuclear Magnetic 
Resonance provides claryfing informations for the investigation of intermolecular 
affinities, complexation and separation mechanisms involved in capillary 
electrophoresis analysis.  
The systematic use of a multivariate approach has confirmed its potential 
especially in the presence of complex systems, not only for obtaining final optimized 
conditions, but also for the initial research of the correct experimental domain to be 
explored. 
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Chemiometry has proved to be complementary to analytical techniques to ensure 
the reliability of experimental data and a greater understanding of the phenomena in the 
study. 
However, it is important to point out that the correct use of chemiometric 
techniques is of great help both in pharmaceutical analysis, leading to significant 
benefits in terms of time spent, sustained costs and results obtained, but also in any 
other study where the aim is to know the relationships between the variables studied and 
the optimization of the experimental system. 
Regulatory documents, indeed, are strongly recommending the implementation of 
QbD approach, a systematic approach to development that begins with predefined 
objectives and emphasizes product and process understanding. 
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